10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number: 001-34292

ORRSTOWN FINANCIAL SERVICES, INC.

(Exact Name of Registrant as Specified in its Charter)

Pennsylvania				23-2530374
(State or Other Jurisdiction of Incorporation or Organization)				(I.R.S. Employer Identification No.)
	77 East King Street	P. O. Box 250	Shippensburg	Pennsylvania	17257
	(Address of Principal Executive Offices)				(Zip Code)
	Registrant’s Telephone Number, Including Area Code:		(717)	532-6114

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, no par value	ORRF	Nasdaq Stock Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	☒
Non-accelerated filer	¨	Smaller reporting company	☒
		Emerging growth company	☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.			o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.).    Yes  ☐    No  x

Number of shares outstanding of the registrant’s Common Stock as of May 2, 2022: 11,054,814.

ORRSTOWN FINANCIAL SERVICES, INC.

INDEX

 

		Page
Part I – FINANCIAL INFORMATION
	Glossary	3
Item 1.	Financial Statements	4
	Consolidated Balance Sheets (Unaudited)	4
	Consolidated Statements of Income (Unaudited)	5
	Consolidated Statements of Comprehensive (Loss) Income (Unaudited)	7
	Consolidated Statements of Changes in Shareholders’ Equity (Unaudited)	8
	Consolidated Statements of Cash Flows (Unaudited)	9
	Notes to Consolidated Financial Statements (Unaudited)	10
Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	42
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	60
Item 4.	Controls and Procedures	61
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	62
Item 1A.	Risk Factors	62
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	62
Item 3.	Defaults upon Senior Securities	62
Item 4.	Mine Safety Disclosures	62
Item 5.	Other Information	62
Item 6.	Exhibits	63
SIGNATURES		64

2

Glossary of Defined Terms

The following terms may be used throughout this Report, including the unaudited condensed consolidated financial statements and related notes.

Term	Definition
ALL	Allowance for loan losses
AFS	Available for sale
AOCI	Accumulated other comprehensive income
ASC	Accounting Standards Codification
ASU	Accounting Standards Update
Bank	Orrstown Bank, the commercial banking subsidiary of Orrstown Financial Services, Inc.
CDI	Core deposit intangible
CMO	Collateralized mortgage obligation
ERM	Enterprise risk management
Exchange Act	Securities Exchange Act of 1934, as amended
FASB	Financial Accounting Standards Board
FDIC	Federal Deposit Insurance Corporation
FHLB	Federal Home Loan Bank
FRB	Board of Governors of the Federal Reserve System
GAAP	Accounting principles generally accepted in the United States of America
GDP	Gross Domestic Deposit
GSE	U.S. government-sponsored enterprise
IRC	Internal Revenue Code of 1986, as amended
LHFS	Loans held for sale
LIBOR	London Interbank Offered Rate
MBS	Mortgage-backed securities
MSR	Mortgage servicing right
NIM	Net interest margin
OCI	Other comprehensive income
OREO	Other real estate owned
OTTI	Other-than-temporary impairment
2011 Plan	2011 Orrstown Financial Services, Inc. Incentive Stock Plan
PCI loans	Purchased credit impaired loans
PACE	Property Assessed Clean Energy loans
PPP	Paycheck Protection Program
Repurchase Agreements	Securities sold under agreements to repurchase
ReRemic	Re-securitization of Real Estate Mortgage Investment Conduits
ROU	Right of use (leases)
SBA	U.S. Small Business Administration
SEC	Securities and Exchange Commission
Securities Act	Securities Act of 1933, as amended
SOFR	Secured Overnight Financing Rate
TDR	Troubled debt restructuring
Unless the context otherwise requires, the terms “Orrstown,” “we,” “us,” “our,” and “Company” refer to Orrstown Financial Services, Inc. and its subsidiaries.

3

PART I – FINANCIAL INFORMATION

Item 1.     Financial Statements

Condensed Consolidated Balance Sheets (Unaudited)

ORRSTOWN FINANCIAL SERVICES, INC.

(Dollars in thousands, except per share amounts)	March 31, 2022		December 31, 2021
Assets
Cash and due from banks	$	26,446	$	21,217
Interest-bearing deposits with banks	187,792		187,493
Cash and cash equivalents	214,238		208,710
Restricted investments in bank stocks	6,791		7,252
Securities available for sale (amortized cost of $548,305 and $466,806 at March 31, 2022 and December 31, 2021, respectively)	529,730		472,438
Loans held for sale, at fair value	7,403		8,868
Loans	1,978,307		1,979,986
Less: Allowance for loan losses	(21,508)		(21,180)
Net loans	1,956,799		1,958,806
Premises and equipment, net	33,704		34,045
Cash surrender value of life insurance	70,622		70,217
Goodwill	18,724		18,724
Other intangible assets, net	3,891		4,183
Accrued interest receivable	8,642		8,234
Other assets	49,993		43,088
Total assets	$	2,900,537	$	2,834,565
Liabilities
Deposits:
Noninterest-bearing	$	557,756	$	553,238
Interest-bearing	1,988,236		1,911,691
Total deposits	2,545,992		2,464,929
Securities sold under agreements to repurchase	24,624		23,301
FHLB advances and other borrowings	1,788		1,896
Subordinated notes	31,978		31,963
Other liabilities	41,351		40,820
Total liabilities	2,645,733		2,562,909
Commitments and contingencies
Shareholders’ Equity
Preferred stock, $1.25 par value per share; 500,000 shares authorized; no shares issued or outstanding	—		—
Common stock, no par value—$0.05205 stated value per share 50,000,000 shares authorized; 11,247,545 shares issued and 11,078,990 outstanding at March 31, 2022; 11,258,167 shares issued and 11,183,050 outstanding at December 31, 2021	585		586
Additional paid - in capital	188,033		189,689
Retained earnings	84,943		78,700
Accumulated other comprehensive (loss) income	(14,674)		4,449
Treasury stock—168,555 and 75,117 shares, at cost at March 31, 2022 and December 31, 2021, respectively	(4,083)		(1,768)
Total shareholders’ equity	254,804		271,656
Total liabilities and shareholders’ equity	$	2,900,537	$	2,834,565

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

4

Condensed Consolidated Statements of Income (Unaudited)

ORRSTOWN FINANCIAL SERVICES, INC.

	Three Months Ended
(Dollars in thousands, except per share amounts)	March 31, 2022		March 31, 2021
Interest income
Loans	$	21,369	$	21,511
Investment securities - taxable	1,598		1,879
Investment securities - tax-exempt	722		500
Short-term investments	101		39
Total interest income	23,790		23,929
Interest expense
Deposits	685		1,392
Securities sold under agreements to repurchase	7		9
FHLB advances and other borrowings	22		171
Subordinated notes	503		502
Total interest expense	1,217		2,074
Net interest income	22,573		21,855
Provision for loan losses	300		(1,000)
Net interest income after provision for loan losses	22,273		22,855
Noninterest income
Service charges on deposit accounts	920		737
Interchange income	981		955
Other service charges and fees	153		148
Swap fee income	953		53
Trust and investment management income	1,941		1,912
Brokerage income	928		811
Mortgage banking activities	721		2,189
Income from life insurance	566		557
Investment securities (losses) gains	(146)		145
Other income	457		37
Total noninterest income	7,474		7,544
Noninterest expenses
Salaries and employee benefits	11,337		10,197
Occupancy	1,288		1,240
Furniture and equipment	1,279		1,278
Data processing	1,053		1,019
Automated teller and interchange fees	305		249
Advertising and bank promotions	355		425
FDIC insurance	283		194
Professional services	808		721
Directors' compensation	231		234
Taxes other than income	564		451
Intangible asset amortization	292		334
Other operating expenses	1,569		1,441
Total noninterest expenses	19,364		17,783
Income before income tax expense	10,383		12,616
Income tax expense	2,015		2,409
Net income	$	8,368	$	10,207

5

Per share information:
Basic earnings per share	$	0.77	$	0.93
Diluted earnings per share	0.76		0.92
Dividends paid per share	0.19		0.18

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

6

Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited)

ORRSTOWN FINANCIAL SERVICES, INC.

 

	Three Months Ended
(Dollars in thousands)	March 31, 2022		March 31, 2021
Net income	$	8,368	$	10,207
Other comprehensive (loss) income, net of tax:
Unrealized losses on securities available for sale arising during the period	(24,353)		(721)
Reclassification adjustment for losses (gains) realized in net income	146		(145)
Net unrealized losses on securities available for sale	(24,207)		(866)
Tax effect	5,084		182
Total other comprehensive loss, net of tax and reclassification adjustments on securities available for sale	(19,123)		(684)
Unrealized gains on interest rate swaps used in cash flow hedges	—		739
Reclassification adjustment for losses realized in net income	—		87
Net unrealized gains on interest rate swaps used in cash flow hedges	—		826
Tax effect	—		(173)
Total other comprehensive gains, net of tax and reclassification adjustments on interest rate swaps used in cash flow hedges	—		653
Total other comprehensive loss, net of tax and reclassification adjustments	(19,123)		(31)
Total comprehensive (loss) income	$	(10,755)	$	10,176

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

7

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited)

ORRSTOWN FINANCIAL SERVICES, INC.

	Three Months Ended March 31, 2022
(Dollars in thousands, except per share amounts)	Common Stock		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Total Shareholders’ Equity
Balance, January 1, 2022	$	586	$	189,689	$	78,700	$	4,449	$	(1,768)	$	271,656
Net income	—		—		8,368		—		—		8,368
Total other comprehensive loss, net of taxes	—		—		—		(19,123)		—		(19,123)
Cash dividends ($0.19 per share)	—		—		(2,125)		—		—		(2,125)
Share-based compensation plans:
10,622 net common shares acquired and 93,438 net treasury shares acquired, including compensation expense totaling $338	(1)		(1,656)		—		—		(2,315)		(3,972)
Balance, March 31, 2022	$	585	$	188,033	$	84,943	$	(14,674)	$	(4,083)	$	254,804

 

	Three Months Ended March 31, 2021
(Dollars in thousands, except per share amounts)	Common Stock		Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Income		Treasury Stock		Total Shareholders’ Equity
Balance, January 1, 2021	$	586	$	189,066	$	54,099	$	3,346	$	(848)	$	246,249
Net income	—		—		10,207		—		—		10,207
Total other comprehensive loss, net of taxes	—		—		—		(31)		—		(31)
Cash dividends ($0.18 per share)	—		—		(2,004)		—		—		(2,004)
Share-based compensation plans:
8,671 net common shares issued and 40,970 net treasury shares issued, including compensation expense totaling $467	—		(555)		—		—		582		27
Balance, March 31, 2021	$	586	$	188,511	$	62,302	$	3,315	$	(266)	$	254,448

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

8

Condensed Consolidated Statements of Cash Flows (Unaudited)

ORRSTOWN FINANCIAL SERVICES, INC.

	Three Months Ended
(Dollars in thousands)	March 31, 2022		March 31, 2021
Cash flows from operating activities
Net income	$	8,368	$	10,207
Adjustments to reconcile net income to net cash provided by operating activities:
Net premium amortization / (discount accretion)	68		(738)
Depreciation and amortization expense	1,210		1,353
Provision for loan losses	300		(1,000)
Share-based compensation	338		467
Gains on sales of loans originated for sale	(319)		(1,320)
Mortgage loans originated for sale	(32,903)		(55,720)
Proceeds from sales of loans originated for sale	32,749		56,959
Gains on sale of portfolio loans	(271)		—
Net loss on disposal of premises and equipment	12		—
Deferred income taxes	1,638		(1,600)
Investment securities (losses) gains	146		(145)
Income from life insurance	(566)		(557)
Increase in accrued interest receivable	(408)		(143)
Increase in accrued interest payable and other liabilities	531		12,095
Other, net	(4,251)		(3,225)
Net cash provided by operating activities	6,642		16,633
Cash flows from investing activities
Proceeds from sales of AFS securities	3,075		75,736
Maturities, repayments and calls of AFS securities	9,536		11,406
Purchases of AFS securities	(94,903)		(29,233)
Net redemptions of restricted investments in bank stocks	461		256
Distributions from investments in limited partnerships	1,146		—
Net decrease (increase) in loans	52		(64,634)
Proceeds from sales of portfolio loans	3,913		—
Purchases of bank premises and equipment	(235)		(156)
Net cash used in investing activities	(76,955)		(6,625)
Cash flows from financing activities
Net increase in deposits	81,060		190,198
Net increase in borrowings with original maturities less than 90 days	1,323		3,328
Payments on FHLB advances and other borrowings	(108)		(103)
Dividends paid	(2,125)		(2,004)
Acquisition of treasury stock	(4,166)		—
Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting	(232)		(514)
Proceeds from issuance of employee stock purchase plan shares	89		74
Net cash provided by financing activities	75,841		190,979
Net increase in cash and cash equivalents	5,528		200,987
Cash and cash equivalents at beginning of period	208,710		125,258
Cash and cash equivalents at end of period	$	214,238	$	326,245
Supplemental disclosures of cash flow information:
Cash paid during the period for:
Interest	$	710	$	1,629
Supplemental schedule of noncash activities:
Loans transferred from LHFS to portfolio loans	1,510		—
Securities purchases not yet settled	—		11,699

The Notes to Unaudited Condensed Consolidated Financial Statements are an integral part of these statements.

9

Notes to Condensed Consolidated Financial Statements (Unaudited)

(All dollar amounts presented in the tables, except per share amounts, are in thousands)

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

See the Glossary of Defined Terms at the beginning of this Report for terms used throughout the unaudited condensed consolidated financial statements and related notes of this Form 10-Q.

Nature of Operations – Orrstown Financial Services, Inc. is a financial holding company that operates Orrstown Bank, a commercial bank providing banking and financial advisory services in Berks, Cumberland, Dauphin, Franklin, Lancaster, Perry and York Counties, Pennsylvania, and in Anne Arundel, Baltimore, Howard and Washington Counties, Maryland. The Company operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services, including checking, savings, time, and money market deposits. The Company also provides fiduciary, investment advisory, insurance and brokerage services. The Company and the Bank are subject to regulation by certain federal and state agencies and undergo periodic examinations by such regulatory authorities.

Basis of Presentation – The accompanying unaudited condensed consolidated financial statements include the accounts of Orrstown Financial Services, Inc. and its wholly owned subsidiary, the Bank. The Company has prepared these unaudited condensed consolidated financial statements in accordance with GAAP for interim financial information, SEC rules that permit reduced disclosure for interim periods, and Article 10 of Regulation S-X. In the opinion of management, all adjustments (all of which are of a normal recurring nature) that are necessary for a fair statement are reflected in the unaudited condensed consolidated financial statements. The December 31, 2021 consolidated balance sheet information contained in this Quarterly Report on Form 10-Q was derived from the Company's 2021 audited consolidated financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. All significant intercompany transactions and accounts have been eliminated.

The Company's management has evaluated all activity of the Company and concluded that subsequent events are properly reflected in the Company's unaudited condensed consolidated financial statements and notes as required by GAAP.

To prepare financial statements in conformity with GAAP, management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ.

Derivatives - FASB ASC 815, Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments.

As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge.

The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Company's objectives in using interest rate derivatives are to add stability to interest income and to manage its exposure to interest rate movements. To accomplish this objective, the Company uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of fixed amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount.

10

Changes to the fair value of derivatives designated and that qualify as cash flow hedges are recorded in AOCI and are subsequently reclassified into earnings in the period that the hedged transaction affects earnings. The Company discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in AOCI are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. At March 31, 2022 and December 31, 2021, the Company had no interest rate derivative designated as a hedging instrument.

Derivatives not designated as hedges are not speculative and result from a service the Company provides to certain customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting derivatives that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions. As the interest rate derivatives associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer derivatives and the offsetting derivatives are recognized directly in earnings. At March 31, 2022 and December 31, 2021, the Company had interest rate swaps not designated as hedges with a total notional value of $120.6 million and $75.8 million, respectively.

Leases - The Company evaluates its contracts at inception to determine if an arrangement either is a lease or contains one. Operating lease ROU assets are included in other assets and operating lease liabilities in accrued interest payable and other liabilities in the unaudited condensed consolidated balance sheets. The Company had no finance leases at March 31, 2022.

ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company's leases do not provide an implicit rate, so the Company's incremental borrowing rate is used, which approximates its fully collateralized borrowing rate, based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is reevaluated upon lease modification. The operating lease ROU asset also includes any initial direct costs and prepaid lease payments made less any lease incentives. In calculating the present value of lease payments, the Company may include options to extend the lease when it is reasonably certain that it will exercise that option.

In accordance with ASU 2016-02, “Leases (Topic 842)” (“ASU 2016-02”), the Company keeps leases with an initial term of 12 months or less off of the balance sheet. The Company recognizes these lease payments in the unaudited condensed consolidated statements of income on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components and has elected the practical expedient to account for them as a single lease component.

The Company's operating leases relate primarily to bank branches and office space. The difference between the lease asset and lease liabilities primarily consists of deferred rent liabilities reclassified upon adoption to reduce the measurement of the lease assets. The standard does not materially impact the Company's unaudited condensed consolidated statements of income.

Recent Accounting Pronouncements - ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). The amendments in this update require an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. Organizations will continue to use judgment to determine which loss estimation method is appropriate for their circumstances. Additionally, the amendments in this update amend the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For certain public companies, this update was effective for interim and annual periods beginning after December 15, 2019. The implementation deadline of ASU 2016-13 was extended for smaller reporting and other companies until the fiscal year and interim periods beginning after December 15, 2022. The Company will implement ASU 2016-13 effective January 1, 2023.

ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates ("ASU 2019-10"), extended the implementation deadline of ASU 2016-13 for smaller reporting and other companies until the fiscal year and interim periods beginning after December 15, 2022. The Company meets the requirements to be considered a smaller reporting company under SEC Regulation S-K and SEC Rule 405, and will adopt ASU 2016-13 effective January 1, 2023. The Company is evaluating the impact of the adoption of ASU 2016-13, and is working with a third-party vendor solution to assist with the application of ASU 2016-13 and finalizing the loss estimation models to be used. Once management determines which methods will be utilized, another third party vendor will be contracted to perform a model validation prior to adoption. The Company expects to recognize a one-time cumulative-effect adjustment to the

11

allowance for credit losses as of the date of adoption of the new standard. While the Company anticipates the allowance for loan losses will increase under its current assumptions, it expects the impact of adopting ASU 2016-13 will be influenced by the composition, characteristics and quality of its loan and investment securities portfolios, as well as general economic conditions and forecasts at the adoption date. The other provisions of ASU 2019-10 were not applicable to the Company.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"). ASU 2020-04 contains optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The optional expedients apply consistently to all contracts or transactions within the scope of this topic, while the optional expedients for hedging relationships can be elected on an individual basis. The Company has formed a cross-functional working group to lead the transition from LIBOR to a planned adoption of an alternate index. The Company currently plans to replace LIBOR with the 30-Day Average SOFR or Term SOFR in its loan agreements. The Company implemented fallback language for loans with maturities after 2021. The Company expects to adopt the LIBOR transition relief allowed under this standard, and is currently evaluating the potential impact of this guidance on its financial statements.

In March 2022, the FASB issued ASU No. 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (“ASU 2022-02”). ASU 2022-02 eliminates the troubled debt restructuring accounting model. This change will require all loan modifications to be accounted for under the general loan modification guidance in Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs, and subject entities to new disclosure requirements on loan modifications to borrowers experiencing financial difficulty. For entities that have adopted Topic 326, ASU 2022-02 is effective for periods beginning after December 15, 2022. For entities adopting Topic 326 in periods after December 15, 2022, ASU 2022-02 is effective when the company adopts Topic 326. The Company will implement ASU 2022-02 effective January 1, 2023, and is evaluating the impact.

NOTE 2. INVESTMENT SECURITIES

At March 31, 2022 and December 31, 2021, all investment securities were classified as AFS. The following table summarizes amortized cost and fair value of investment securities, and the corresponding amounts of gross unrealized gains and losses recognized in AOCI, at March 31, 2022 and December 31, 2021:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
March 31, 2022
U.S. Treasury securities	$	20,081	$	—	$	1,543	$	18,538
States and political subdivisions	244,922		1,984		9,346		237,560
GSE residential MBSs	61,239		—		2,010		59,229
GSE residential CMOs	74,023		48		3,044		71,027
Non-agency CMOs	29,832		3		2,832		27,003
Asset-backed	117,805		—		1,835		115,970
Other	403		—		—		403
Totals	$	548,305	$	2,035	$	20,610	$	529,730
December 31, 2021
U.S. Treasury securities	$	20,084	$	—	$	382	$	19,702
States and political subdivisions	185,437		8,606		673		193,370
GSE residential MBSs	41,260		44		578		40,726
GSE residential CMOs	66,430		436		944		65,922
Non-agency CMOs	30,676		—		978		29,698
Asset-backed	122,520		401		300		122,621
Other	399		—		—		399
Totals	$	466,806	$	9,487	$	3,855	$	472,438

12

The following table summarizes investment securities with unrealized losses at March 31, 2022 and December 31, 2021, aggregated by major investment security type and the length of time in a continuous unrealized loss position.

	Less Than 12 Months					12 Months or More					Total
	# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses
March 31, 2022
U.S. Treasury securities	3	$	18,538	$	1,543	—	$	—	$	—	3	$	18,538	$	1,543
States and political subdivisions	30	166,305		9,346		—	—		—		30	166,305		9,346
GSE residential MBSs	14	59,229		2,010		—	—		—		14	59,229		2,010
GSE residential CMOs	12	66,516		2,782		1	3,501		262		13	70,017		3,044
Non-agency CMOs	3	22,303		2,832		—	—		—		3	22,303		2,832
Asset-backed	12	83,667		1,352		3	31,910		483		15	115,577		1,835
Totals	74	$	416,558	$	19,865	4	$	35,411	$	745	78	$	451,969	$	20,610
December 31, 2021
U.S. Treasury securities	3	$	19,702	$	382	—	$	—	$	—	3	$	19,702	$	382
States and political subdivisions	12	45,522		673		—	—		—		12	45,522		673
GSE residential MBSs	9	37,899		578		—	—		—		9	37,899		578
GSE residential CMOs	7	41,163		944		—	—		—		7	41,163		944
Non-agency CMOs	3	24,661		978		—	—		—		3	24,661		978
Asset-backed	3	21,245		138		3	34,180		162		6	55,425		300
Totals	37	$	190,192	$	3,693	3	$	34,180	$	162	40	$	224,372	$	3,855

The Company determines whether unrealized losses are temporary in nature in accordance with FASB ASC 320-10, Investments - Overall, (“FASB ASC 320-10”) and FASB ASC 325-40, Investments – Beneficial Interests in Securitized Financial Assets, when applicable. The evaluation is based upon factors such as the creditworthiness of the underlying borrowers, performance of the underlying collateral, if applicable, and the level of credit support in the security structure. Management also evaluates other factors and circumstances that may be indicative of an OTTI condition. This includes, but is not limited to, an evaluation of the type of security, length of time and extent to which the fair value has been less than cost and near-term prospects of the issuer.

FASB ASC 320-10 requires the Company to assess if an OTTI exists by considering whether the Company has the intent to sell the security or it is more likely than not that it will be required to sell the security before recovery. If either of these situations applies, the guidance requires the Company to record an OTTI charge to earnings on debt securities for the difference between the amortized cost basis of the security and the fair value of the security. If neither of these situations applies, the Company is required to assess whether it is expected to recover the entire amortized cost basis of the security. If the Company is not expected to recover the entire amortized cost basis of the security, the guidance requires the Company to bifurcate the identified OTTI into a credit loss component and a component representing loss related to other factors. A discount rate is applied which equals the effective yield of the security. The difference between the present value of the expected flows and the amortized book value is considered a credit loss, which would be recorded through earnings as an OTTI charge. When a market price is not readily available, the market value of the security is determined using the same expected cash flows; the discount rate is a rate the Company determines from the open market and other sources as appropriate for the security. The difference between the market value and the present value of cash flows expected to be collected is recognized in AOCI on the unaudited condensed consolidated statements of financial condition.

U.S. Treasury Securities. The unrealized losses presented in the table above have been caused by an increase in rates from the time these securities were purchased. Management considers the full faith and credit of the U.S. government in determining whether a security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at March 31, 2022 or December 31, 2021.

States and Political Subdivisions. The unrealized losses presented in the table above have been caused by a rise in interest rates from the time these securities were purchased. Management considers the investment rating, the state of the issuer of the security and other credit support in determining whether the security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at March 31, 2022 or December 31, 2021.

13

GSE Residential CMOs and GSE Residential MBS. The unrealized losses presented in the table above have been caused by a widening of spreads and a rise in interest rates from the time these securities were purchased. The contractual terms of these securities do not permit the issuer to settle the securities at a price less than its par value basis. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at March 31, 2022 or December 31, 2021.

Non-Agency CMOs. The unrealized losses presented in the table above were caused by a widening of spreads and a rise in interest rates from the time the securities were purchased. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at March 31, 2022 or December 31, 2021, except for one $14.7 million par value non-agency CMO security. For the three months ended March 31, 2022, the Company had $171 thousand in cumulative OTTI on this non-agency CMO security, which was included in securities gains and losses in the unaudited condensed consolidated statements of income. This security is expected to be called by the issuer in the second quarter of 2022 due to an anticipated default caused by increased prepayment speeds on the underlying collateral.

Asset-backed. The unrealized losses presented in the table above were caused by a widening of spreads from the time the securities were purchased. Management considers the investment rating and other credit support in determining whether a security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at March 31, 2022 or December 31, 2021.

The following table summarizes amortized cost and fair value of investment securities by contractual maturity at March 31, 2022. Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity date are shown separately.

	Amortized Cost		Fair Value
Due in one year or less	$	—	$	—
Due after one year through five years	3,376		3,509
Due after five years through ten years	79,079		75,367
Due after ten years	182,951		177,625
CMOs and MBSs	165,094		157,259
Asset-backed	117,805		115,970
Totals	$	548,305	$	529,730

The following table summarizes proceeds from sales of investment securities and gross gains and gross losses for the three months ended March 31, 2022 and 2021:

	Three months ended March 31,
	2022		2021
Proceeds from sale of investment securities	$	3,075	$	75,736
Gross gains	25		1,351
Gross losses	—		1,206

During the three months ended March 31, 2022, net investment security gains, excluding the OTTI charge noted above, of $25 thousand were recorded, compared to net gains of $145 thousand for the three months ended March 31, 2021. During the three months ended March 31, 2022, a partial sale of one security with a principal balance of $3.1 million was sold for proceeds of $3.1 million compared to 14 securities with a principal balance of $75.6 million were sold for proceeds of $75.7 million during the three months ended March 31, 2021. Investment securities with a fair value of $291.0 million and $295.6 million at March 31, 2022 and December 31, 2021, respectively, were pledged to secure public funds and for other purposes as required or permitted by law.

14

NOTE 3. LOANS AND ALLOWANCE FOR LOAN LOSSES

Consistent with ASU 2010-20, Disclosures about the Credit Quality of Financing Receivables and the Allowance for Loan Losses, the Company’s loan portfolio is grouped into segments which are further broken down into classes to allow management to monitor the performance by the borrower and to monitor the yield on the portfolio.

The risks associated with lending activities differ among the various loan classes and are subject to the impact of changes in interest rates, market conditions of collateral securing the loans, and general economic conditions. All of these factors may adversely impact both the borrower’s ability to repay its loans and associated collateral.

The Company has various types of commercial real estate loans, which have differing levels of credit risk. Owner occupied commercial real estate loans are generally dependent upon the successful operation of the borrower’s business, with the cash flows generated from the business being the primary source of repayment of the loan. If the business suffers a downturn in sales or profitability, the borrower’s ability to repay the loan could be in jeopardy.

Non-owner occupied and multi-family commercial real estate loans and non-owner occupied residential loans present a different credit risk to the Company than owner occupied commercial real estate loans, as the repayment of the loan is dependent upon the borrower’s ability to generate a sufficient level of occupancy to produce rental income that exceeds debt service requirements and operating expenses. Lower occupancy or lease rates may result in a reduction in cash flows, which hinders the ability of the borrower to meet debt service requirements, and may result in lower collateral values. The Company generally recognizes that greater risk is inherent in these credit relationships compared to owner occupied loans mentioned above.

Acquisition and development loans consist of 1-4 family residential construction and commercial and land development loans. The risk of loss on these loans is largely dependent on the Company’s ability to assess the property’s value at the completion of the project, which should exceed the property’s construction costs. During the construction phase, a number of factors could potentially negatively impact the collateral value, including cost overruns, delays in completing the project, competition, and real estate market conditions, which may change based on the supply of similar properties in the area. In the event the collateral value at the completion of the project is not sufficient to cover the outstanding loan balance, the Company must rely upon other repayment sources, if any, including the guarantors of the project or other collateral securing the loan.

On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act was enacted. The CARES Act established the SBA PPP. The SBA PPP is intended to provide economic relief to small businesses nationwide adversely impacted under the COVID-19 Emergency Declaration issued on March 13, 2020. The SBA PPP, which began on April 3, 2020, provided small businesses with funds to cover up to 24 weeks of payroll costs and other expenses, including benefits. It also provides for forgiveness of up to the full principal amount of qualifying loans. In total, the Bank closed and funded almost 6,500 loans for a total gross loan amount of $699.4 million through December 31, 2021.

Commercial and industrial loans include advances to local and regional businesses for general commercial purposes and include permanent and short-term working capital, machinery and equipment financing, and may be either in the form of lines of credit or term loans. Although commercial and industrial loans may be unsecured to our highest-rated borrowers, the majority of these loans are secured by the borrower’s accounts receivable, inventory and machinery and equipment. In a significant number of these loans, the collateral also includes the business real estate or the business owner’s personal real estate or assets. Commercial and industrial loans present credit exposure to the Company, as they are more susceptible to risk of loss during a downturn in the economy as borrowers may have greater difficulty in meeting their debt service requirements and the value of the collateral may decline. The Company attempts to mitigate this risk through its underwriting standards, including evaluating the creditworthiness of the borrower and, to the extent available, credit ratings on the business. Additionally, monitoring of the loans through annual renewals and meetings with the borrowers are typical. However, these procedures cannot eliminate the risk of loss associated with commercial and industrial lending. At March 31, 2022 and December 31, 2021, commercial and industrial loans include $122.5 million and $189.9 million, respectively, of loans, net of deferred fees and costs, originated through the SBA PPP. At March 31, 2022, the Bank has $2.4 million of net deferred SBA PPP fees remaining to be recognized through net interest income over the life of the loans, which is between two and five years. The timing of the recognition of these fees is dependent upon the loan forgiveness process established by the SBA. As these loans are 100% guaranteed by the SBA, there is no associated ALL at March 31, 2022.

Municipal loans consist of extensions of credit to municipalities and school districts within the Company’s market area. These loans generally present a lower risk than commercial and industrial loans, as they are generally secured by the municipality’s full taxing authority, by revenue obligations, or by its ability to raise assessments on its clients for a specific utility.

15

The Company originates loans to its retail clients, including fixed-rate and adjustable first lien mortgage loans, with the underlying 1-4 family owner occupied residential property securing the loan. The Company’s risk exposure is minimized in these types of loans through the evaluation of the creditworthiness of the borrower, including credit scores and debt-to-income ratios, and underwriting standards, which limit the loan-to-value ratio to generally no more than 80% upon loan origination, unless the borrower obtains private mortgage insurance.

Home equity loans, including term loans and lines of credit, present a slightly higher risk to the Company than 1-4 family first liens, as these loans can be first or second liens on 1-4 family owner occupied residential property, but can have loan-to-value ratios of no greater than 85% of the value of the real estate taken as collateral. The creditworthiness of the borrower is also considered, including credit scores and debt-to-income ratios.

Installment and other loans’ credit risk is mitigated through prudent underwriting standards, including evaluation of the creditworthiness of the borrower through credit scores and debt-to-income ratios and, if secured, the collateral value of the assets. These loans can be unsecured or secured by assets the value of which may depreciate quickly or may fluctuate, and may present a greater risk to the Company than 1-4 family residential loans.

In an effort to assist clients that were negatively impacted by the COVID-19 pandemic, the Bank offered various mitigation options, including a loan payment deferral program. Under this program, most commercial deferrals were for a 90-day period, while most consumer deferrals were for a 180-day period. In accordance with the revised Interagency Statement on Loan Modifications by Financial Institutions Working with Customers Affected by the Coronavirus issued by the federal bank regulatory agencies on April 7, 2020, these deferrals are exempt from TDR status as they meet the specified requirements. At March 31, 2022 and December 31, 2021, the remaining loan deferral balances were inconsequential.

The following table presents the loan portfolio by segment and class, excluding residential mortgage LHFS, at March 31, 2022 and December 31, 2021:

	March 31, 2022		December 31, 2021
Commercial real estate:
Owner occupied	$	256,526	$	238,668
Non-owner occupied	558,999		551,783
Multi-family	93,158		93,255
Non-owner occupied residential	102,269		106,112
Acquisition and development:
1-4 family residential construction	15,115		12,279
Commercial and land development	105,204		93,925
Commercial and industrial (1)	443,170		485,728
Municipal	14,626		14,989
Residential mortgage:
First lien	203,231		198,831
Home equity - term	5,820		6,081
Home equity - lines of credit	164,818		160,705
Installment and other loans	15,371		17,630
Total loans	$	1,978,307	$	1,979,986

(1) This balance includes $122.5 million and $189.9 million of SBA PPP loans, net of deferred fees and costs, at March 31, 2022 and December 31, 2021, respectively.

In order to monitor ongoing risk associated with its loan portfolio and specific loans within the segments, management uses an internal grading system. The first several rating categories, representing the lowest risk to the Bank, are combined and given a “Pass” rating. Management generally follows regulatory definitions in assigning criticized ratings to loans, including "Special Mention," "Substandard," "Doubtful" or "Loss." The Special Mention category includes loans that have potential weaknesses that may, if not monitored or corrected, weaken the asset or inadequately protect the Bank's position at some future date. These assets pose elevated risk, but their weakness does not yet justify a more severe, or classified rating. Substandard loans are classified as they have a well-defined weakness, or weaknesses that jeopardize liquidation of the debt. These loans are characterized by the distinct possibility that the Bank will sustain some loss if the deficiencies are not corrected. Substandard loans include loans that management has determined not to be impaired, as well as loans considered to be impaired. A Doubtful loan has a high probability of total or substantial loss, but because of specific pending events that may strengthen the asset, its

16

classification as Loss is deferred. Loss loans are considered uncollectible, as the borrowers are often in bankruptcy, have suspended debt repayments, or have ceased business operations. Once a loan is classified as Loss, there is little prospect of collecting the loan’s principal or interest and it is charged-off.

The Company has a loan review policy and program, which is designed to identify and monitor risk in the lending function. The Management ERM Committee, comprised of executive officers, senior officers and loan department personnel, is charged with the oversight of overall credit quality and risk exposure of the Company's loan portfolio. This includes the monitoring of the lending activities of all Company personnel with respect to underwriting and processing new loans and the timely follow-up and corrective action for loans showing signs of deterioration in quality. A loan review program provides the Company with an independent review of the commercial loan portfolio on an ongoing basis. Generally, consumer and residential mortgage loans are included in the Pass categories unless a specific action, such as extended delinquencies, bankruptcy, repossession or death of the borrower occurs, which heightens awareness as to a possible credit event.

Internal loan reviews are completed annually on all commercial relationships with a committed loan balance in excess of $1.0 million, which includes confirmation of risk rating by an independent credit officer. In addition, all commercial relationships greater than $500 thousand rated Substandard, Doubtful or Loss are reviewed quarterly and corresponding risk ratings are reaffirmed by the Company's Problem Loan Committee, with subsequent reporting to the Management ERM Committee and the Board of Directors.

17

The following table summarizes the Company’s loan portfolio ratings based on its internal risk rating system at March 31, 2022 and December 31, 2021:

	Pass		Special Mention		Non-Impaired Substandard		Impaired - Substandard		Doubtful		PCI Loans		Total
March 31, 2022
Commercial real estate:
Owner occupied	$	242,529	$	6,360	$	2,277	$	3,062	$	—	$	2,298	$	256,526
Non-owner occupied	537,505		18,771		2,419		—		—		304		558,999
Multi-family	84,541		8,158		459		—		—		—		93,158
Non-owner occupied residential	99,545		1,005		1,014		100		—		605		102,269
Acquisition and development:
1-4 family residential construction	15,115		—		—		—		—		—		15,115
Commercial and land development	103,486		1,236		482		—		—		—		105,204
Commercial and industrial	424,425		7,642		8,792		161		—		2,150		443,170
Municipal	14,626		—		—		—		—		—		14,626
Residential mortgage:
First lien	196,217		—		221		2,278		—		4,515		203,231
Home equity - term	5,798		—		—		6		—		16		5,820
Home equity - lines of credit	164,327		19		46		426		—		—		164,818
Installment and other loans	15,314		—		—		52		—		5		15,371
	$	1,903,428	$	43,191	$	15,710	$	6,085	$	—	$	9,893	$	1,978,307
December 31, 2021
Commercial real estate:
Owner occupied	$	219,250	$	7,239	$	6,087	$	3,763	$	—	$	2,329	$	238,668
Non-owner occupied	528,010		23,297		166		—		—		310		551,783
Multi-family	84,414		8,238		603		—		—		—		93,255
Non-owner occupied residential	102,588		1,065		1,153		122		—		1,184		106,112
Acquisition and development:
1-4 family residential construction	12,279		—		—		—		—		—		12,279
Commercial and land development	92,049		1,385		491		—		—		—		93,925
Commercial and industrial	470,579		7,917		4,720		250		—		2,262		485,728
Municipal	14,989		—		—		—		—		—		14,989
Residential mortgage:
First lien	191,386		—		225		2,635		—		4,585		198,831
Home equity - term	6,058		—		—		7		—		16		6,081
Home equity - lines of credit	160,203		20		46		436		—		—		160,705
Installment and other loans	17,584		—		—		40		—		6		17,630
	$	1,899,389	$	49,161	$	13,491	$	7,253	$	—	$	10,692	$	1,979,986

For commercial real estate, acquisition and development and commercial and industrial loans, a loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by

18

management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays and payment shortfalls generally are not classified as impaired. Generally, loans that are more than 90 days past due are deemed impaired. Management determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed to determine if the loan should be placed on nonaccrual status. Nonaccrual loans in the commercial and commercial real estate portfolios and any TDRs are, by definition, deemed to be impaired. Impairment is measured on a loan-by-loan basis for commercial, construction and restructured loans by either the present value of the expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price, or the fair value of the collateral if the loan is collateral dependent. A loan is collateral dependent if the repayment of the loan is expected to be provided solely by the underlying collateral. For loans that are deemed to be impaired for extended periods of time, periodic updates on fair values are obtained, which may include updated appraisals. Updated fair values are incorporated into the impairment analysis in the next reporting period.

Loan charge-offs, which may include partial charge-offs, are taken on an impaired loan that is collateral dependent if the loan’s carrying balance exceeds its collateral’s appraised value, the loan has been identified as uncollectible, and it is deemed to be a confirmed loss. Typically, impaired loans with a charge-off or partial charge-off will continue to be considered impaired, unless the note is split into two, and management expects the performing note to continue to perform and is adequately secured. The second, or non-performing note, would be charged-off. Generally, an impaired loan with a partial charge-off may continue to have an impairment reserve on it after the partial charge-off, if factors warrant.

At March 31, 2022 and December 31, 2021, nearly all of the Company’s loan impairments were measured based on the estimated fair value of the collateral securing the loan, except for TDRs. By definition, TDRs are considered impaired. All TDR impairment analyses are initially based on discounted cash flows for those loans. For real estate loans, collateral generally consists of commercial real estate, but in the case of commercial and industrial loans, it could also consist of accounts receivable, inventory, equipment or other business assets. Commercial and industrial loans may also have real estate collateral.

Updated appraisals are generally required every 18 months for classified commercial loans in excess of $250 thousand. The “as is" value provided in the appraisal is often used as the fair value of the collateral in determining impairment, unless circumstances, such as subsequent improvements, approvals, or other circumstances, dictate that another value than that provided by the appraiser is more appropriate.

Generally, impaired commercial loans secured by real estate, other than performing TDRs, are measured at fair value using certified real estate appraisals that had been completed within the last 18 months. Appraised values are discounted for estimated costs to sell the property and other selling considerations to arrive at the property’s fair value. In those situations in which it is determined an updated appraisal is not required for loans individually evaluated for impairment, fair values are based on either an existing appraisal or a discounted cash flow analysis as determined by management. The approaches are discussed below:

•Existing appraisal – if the existing appraisal provides a strong loan-to-value ratio (generally 70% or lower) and, after consideration of market conditions and knowledge of the property and area, it is determined by the Credit Administration staff that there has not been a significant deterioration in the collateral value, the existing certified appraised value may be used. Discounts to the appraised value, as deemed appropriate for selling costs, are factored into the fair value.

•Discounted cash flows – in limited cases, discounted cash flows may be used on projects in which the collateral is liquidated to reduce the borrowings outstanding, and is used to validate collateral values derived from other approaches.

Collateral on certain impaired loans is not limited to real estate, and may consist of accounts receivable, inventory, equipment or other business assets. Estimated fair values are determined based on borrowers’ financial statements, inventory ledgers, accounts receivable aging or appraisals from individuals with knowledge in the business. Stated balances are generally discounted for the age of the financial information or the quality of the assets. In determining fair value, liquidation discounts are applied to this collateral based on existing loan evaluation policies.

The Company distinguishes substandard loans on both an impaired and non-impaired basis, as it places less emphasis on a loan’s classification, and increased reliance on whether the loan was performing in accordance with the contractual terms. A substandard classification does not automatically meet the definition of impaired. Loss potential, while existing in the aggregate amount of substandard loans, does not have to exist in individual extensions of credit classified as substandard. As a result, the Company’s methodology includes an evaluation of certain accruing commercial real estate, acquisition and development, and commercial and industrial loans rated substandard to be collectively evaluated for impairment. Although the Company believes

19

these loans meet the definition of substandard, they are generally performing and management has concluded that it is likely the Company will be able to collect the scheduled payments of principal and interest when due according to the contractual terms of the loan agreement.

Larger groups of smaller balance homogeneous loans are collectively evaluated for impairment. Generally, the Company does not separately identify individual consumer and residential loans for impairment disclosures, unless such loans are the subject of a restructuring agreement due to financial difficulties of the borrower.

The following table, which excludes accruing PCI loans, summarizes impaired loans by segment and class, segregated by those for which a specific allowance was required and those for which a specific allowance was not required at March 31, 2022 and December 31, 2021. The recorded investment in loans excludes accrued interest receivable due to insignificance. Related allowances established generally pertain to those loans in which loan forbearance agreements were in the process of being negotiated or updated appraisals were pending, and any partial charge-off will be recorded when final information is received.

	Impaired Loans with a Specific Allowance						Impaired Loans with No Specific Allowance
	Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)		Related Allowance		Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)
March 31, 2022
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,062	$	4,840
Non-owner occupied residential	—		—		—		100		214
Commercial and industrial	—		—		—		161		447
Residential mortgage:
First lien	338		338		29		1,940		2,938
Home equity—term	—		—		—		6		9
Home equity—lines of credit	—		—		—		426		651
Installment and other loans	—		—		—		52		52
	$	338	$	338	$	29	$	5,747	$	9,151
December 31, 2021
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,763	$	4,902
Non-owner occupied residential	—		—		—		122		259
Commercial and industrial	—		—		—		250		547
Residential mortgage:
First lien	341		341		28		2,294		3,337
Home equity—term	—		—		—		7		10
Home equity—lines of credit	—		—		—		436		653
Installment and other loans	—		—		—		40		40
	$	341	$	341	$	28	$	6,912	$	9,748

20

The following table, which excludes accruing PCI loans, summarizes the average recorded investment in impaired loans and related recognized interest income for the three months ended March 31, 2022 and 2021:

	2022				2021
	Average Impaired Balance		Interest Income Recognized		Average Impaired Balance		Interest Income Recognized
Three Months Ended March 31,
Commercial real estate:
Owner occupied	$	3,422	$	—	$	3,448	$	1
Multi-family	—		—		19		—
Non-owner occupied residential	107		—		267		—
Acquisition and development:
Commercial and land development	—		—		614		—
Commercial and industrial	218		—		2,878		—
Residential mortgage:
First lien	2,406		7		2,636		11
Home equity - term	7		—		12		—
Home equity - lines of credit	432		—		616		—
Installment and other loans	45		—		15		—
	$	6,637	$	7	$	10,505	$	12

The following table presents impaired loans that are TDRs, with the recorded investment at March 31, 2022 and December 31, 2021:

	March 31, 2022			December 31, 2021
	Number of Contracts	Recorded Investment		Number of Contracts	Recorded Investment
Accruing:
Residential mortgage:
First lien	7	$	575	8	$	804
Nonaccruing:
Residential mortgage:
First lien	6	276		5	285
	13	$	851	13	$	1,089

There was one new first lien residential mortgage TDR on non-accrual status for the three months ended March 31, 2022 of $4 thousand. There were no new TDRs in 2021.

21

Management further monitors the performance and credit quality of the loan portfolio by analyzing the length of time a portfolio is past due, by aggregating loans based on its delinquencies. The following table presents the classes of loan portfolio summarized by aging categories of performing loans and nonaccrual loans at March 31, 2022 and December 31, 2021:

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
March 31, 2022
Commercial real estate:
Owner occupied	$	250,844	$	322	$	—	$	—	$	322	$	3,062	$	254,228
Non-owner occupied	558,695		—		—		—		—		—		558,695
Multi-family	93,158		—		—		—		—		—		93,158
Non-owner occupied residential	101,254		310		—		—		310		100		101,664
Acquisition and development:
1-4 family residential construction	15,115		—		—		—		—		—		15,115
Commercial and land development	105,204		—		—		—		—		—		105,204
Commercial and industrial	440,652		207		—		—		207		161		441,020
Municipal	14,626		—		—		—		—		—		14,626
Residential mortgage:
First lien	194,216		2,741		—		56		2,797		1,703		198,716
Home equity - term	5,786		12		—		—		12		6		5,804
Home equity - lines of credit	163,725		437		230		—		667		426		164,818
Installment and other loans	15,231		83		—		—		83		52		15,366
Subtotal	1,958,506		4,112		230		56		4,398		5,510		1,968,414
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,298		—		—		—		—		—		2,298
Non-owner occupied	304		—		—		—		—		—		304
Non-owner occupied residential	494		—		—		111		111		—		605
Commercial and industrial	2,150		—		—		—		—		—		2,150
Residential mortgage:
First lien	3,837		608		—		70		678		—		4,515
Home equity - term	15		—		—		1		1		—		16
Installment and other loans	2		3		—		—		3		—		5
Subtotal	9,100		611		—		182		793		—		9,893
	$	1,967,606	$	4,723	$	230	$	238	$	5,191	$	5,510	$	1,978,307

22

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
December 31, 2021
Commercial real estate:
Owner occupied	$	231,371	$	314	$	—	$	891	$	1,205	$	3,763	$	236,339
Non-owner occupied	551,473		—		—		—		—		—		551,473
Multi-family	93,255		—		—		—		—		—		93,255
Non-owner occupied residential	104,645		161		—		—		161		122		104,928
Acquisition and development:
1-4 family residential construction	12,279		—		—		—		—		—		12,279
Commercial and land development	93,793		132		—		—		132		—		93,925
Commercial and industrial	483,088		128		—		—		128		250		483,466
Municipal	14,989		—		—		—		—		—		14,989
Residential mortgage:
First lien	189,043		2,995		281		96		3,372		1,831		194,246
Home equity - term	6,042		16		—		—		16		7		6,065
Home equity - lines of credit	159,628		641		—		—		641		436		160,705
Installment and other loans	17,467		109		8		—		117		40		17,624
Subtotal	1,957,073		4,496		289		987		5,772		6,449		1,969,294
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,329		—		—		—		—		—		2,329
Non-owner occupied	310		—		—		—		—		—		310
Non-owner occupied residential	479		—		587		118		705		—		1,184
Commercial and industrial	2,262		—		—		—		—		—		2,262
Residential mortgage:
First lien	3,937		387		166		95		648		—		4,585
Home equity - term	15		—		—		1		1		—		16
Installment and other loans	6		—		—		—		—		—		6
Subtotal	9,338		387		753		214		1,354		—		10,692
	$	1,966,411	$	4,883	$	1,042	$	1,201	$	7,126	$	6,449	$	1,979,986

The Company maintains its ALL at a level management believes adequate for probable incurred credit losses. The ALL is established and maintained through a provision for loan losses charged to earnings. On a quarterly basis, management assesses the adequacy of the ALL utilizing a defined methodology, which considers specific credit evaluation of impaired loans as discussed above, historical loan loss experience, and qualitative factors. Management believes its approach properly addresses relevant accounting guidance for loans individually identified as impaired and for loans collectively evaluated for impairment, and other bank regulatory guidance.

In connection with its quarterly evaluation of the adequacy of the ALL, management reviews its methodology to determine if it properly addresses the current risk in the loan portfolio. For each loan class, general allowances based on quantitative factors, principally historical loss trends, are provided for loans that are collectively evaluated for impairment. An

23

adjustment to historical loss factors may be incorporated for delinquency and other potential risk not elsewhere defined within the ALL methodology.

In addition to this quantitative analysis, adjustments to the ALL requirements are allocated on loans collectively evaluated for impairment based on additional qualitative factors, including:

Nature and Volume of Loans – including loan growth in the current and subsequent quarters based on the Company’s targeted growth and strategic plan, coupled with the types of loans booked based on risk management and credit culture; the number of exceptions to loan policy; and supervisory loan to value exceptions.

Concentrations of Credit and Changes within Credit Concentrations – including the composition of the Company’s overall portfolio makeup and management's evaluation related to concentration risk management and the inherent risk associated with the concentrations identified.

Underwriting Standards and Recovery Practices – including changes to underwriting standards and perceived impact on anticipated losses; trends in the number of exceptions to loan policy; supervisory loan to value exceptions; and administration of loan recovery practices.

Delinquency Trends – including delinquency percentages noted in the portfolio relative to economic conditions; severity of the delinquencies; and whether the ratios are trending upwards or downwards.

Classified Loans Trends – including internal loan ratings of the portfolio; severity of the ratings; whether the loan segment’s ratings show a more favorable or less favorable trend; and underlying market conditions and impact on the collateral values securing the loans.

Experience, Ability and Depth of Management/Lending staff – including the level of experience of senior and middle management and the lending staff; turnover of the staff; and instances of repeat criticisms.

Quality of Loan Review – including the level of experience of the loan review staff; in-house versus outsourced provider of review; turnover of the staff; and instances of repeat criticisms.

National and Local Economic Conditions – including trends in the consumer price index, unemployment rates, the housing price index, housing statistics compared to the prior year, bankruptcy rates, regulatory and legal environment risks and competition.

All factors noted above were deemed appropriate at March 31, 2022 and were unchanged for the three months ended March 31, 2022, except for a reduction in the National and Local Economic Conditions. This factor had been previously increased to account for economic concerns in the commercial real estate portfolio associated with the COVID-19 pandemic. The additional allocation was removed at March 31, 2022 as these concerns have subsided.

24

The following table presents the activity in the ALL for the three months ended March 31, 2022 and 2021:

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
Three Months Ended
March 31, 2022
Balance, beginning of period	$	12,037	$	2,062	$	3,814	$	30	$	17,943	$	2,785	$	215	$	3,000	$	237	$	21,180
Provision for loan losses	(523)		258		500		(1)		234		72		(6)		66		—		300
Charge-offs	—		—		(61)		—		(61)		(10)		(13)		(23)		—		(84)
Recoveries	32		1		48		—		81		26		5		31		—		112
Balance, end of period	$	11,546	$	2,321	$	4,301	$	29	$	18,197	$	2,873	$	201	$	3,074	$	237	$	21,508
March 31, 2021
Balance, beginning of period	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151
Provision for loan losses	(494)		(69)		(54)		(2)		(619)		(289)		(106)		(395)		14		(1,000)
Charge-offs	—		—		(454)		—		(454)		(21)		(20)		(41)		—		(495)
Recoveries	14		1		280		—		295		6		10		16		—		311
Balance, end of period	$	10,671	$	1,046	$	3,714	$	38	$	15,469	$	3,058	$	208	$	3,266	$	232	$	18,967

The following table summarizes the ending loan balance individually evaluated for impairment based upon loan segment, as well as the related ALL loss allocation for each at March 31, 2022 and December 31, 2021. Accruing PCI loans are excluded from loans individually evaluated for impairment.

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
March 31, 2022
Loans allocated by:
Individually evaluated for impairment	$	3,162	$	—	$	161	$	—	$	3,323	$	2,710	$	52	$	2,762	$	—	$	6,085
Collectively evaluated for impairment	1,007,790		120,319		443,009		14,626		1,585,744		371,159		15,319		386,478		—		1,972,222
	$	1,010,952	$	120,319	$	443,170	$	14,626	$	1,589,067	$	373,869	$	15,371	$	389,240	$	—	$	1,978,307
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	29	$	—	$	29	$	—	$	29
Collectively evaluated for impairment	11,546		2,321		4,301		29		18,197		2,844		201		3,045		237		21,479
	$	11,546	$	2,321	$	4,301	$	29	$	18,197	$	2,873	$	201	$	3,074	$	237	$	21,508
December 31, 2021
Loans allocated by:
Individually evaluated for impairment	$	3,885	$	—	$	250	$	—	$	4,135	$	3,078	$	40	$	3,118	$	—	$	7,253
Collectively evaluated for impairment	985,933		106,204		485,478		14,989		1,592,604		362,539		17,590		380,129		—		1,972,733
	$	989,818	$	106,204	$	485,728	$	14,989	$	1,596,739	$	365,617	$	17,630	$	383,247	$	—	$	1,979,986
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	28	$	—	$	28	$	—	$	28
Collectively evaluated for impairment	12,037		2,062		3,814		30		17,943		2,757		215		2,972		237		21,152
	$	12,037	$	2,062	$	3,814	$	30	$	17,943	$	2,785	$	215	$	3,000	$	237	$	21,180

25

The following table provides activity for the accretable yield of purchased impaired loans for the three months ended March 31, 2022 and 2021:

	Three Months Ended
	March 31, 2022		March 31, 2021
Accretable yield, beginning of period	$	2,661	$	3,438
Accretion of income	(314)		(466)
Reclassifications from nonaccretable difference due to improvement in expected cash flows	243		44
Other changes, net	(73)		56
Accretable yield, end of period	$	2,517	$	3,072

NOTE 4. LEASES

A lease provides the lessee the right to control the use of an identified asset for a period of time in exchange for consideration. The Company has primarily entered into operating leases for branches and office space. Most of the Company's leases contain renewal options, which the Company is reasonably certain to exercise. Including renewal options, the Company's leases range from 6 to 31 years. Operating lease right-of-use assets and lease liabilities are included in other assets and accrued interest and other liabilities on the Company's unaudited condensed consolidated balance sheets.

The Company uses its incremental borrowing rate to determine the present value of the lease payments, as the rate implicit in the Company's leases is not readily determinable. Lease agreements that contain non-lease components are generally accounted for as a single lease component, while variable costs, such as common area maintenance expenses and property taxes, are expensed as incurred.

The following table summarizes the Company's operating leases at March 31, 2022 and December 31, 2021:

	March 31, 2022			December 31, 2021
Operating lease ROU assets	$	10,305		$	10,515
Operating lease ROU liabilities	10,937			11,119
Weighted-average remaining lease term (in years)	14.4			14.6
Weighted-average discount rate	4.1		%	4.1		%

The following table presents information related to the Company's operating leases for the three months ended March 31, 2022 and 2021:

	Three Months Ended
	March 31, 2022		March 31, 2021
Cash paid for operating lease liabilities	$	294	$	343
Operating lease expense	394		403

The following table presents expected future maturities of the Company's lease liabilities as of March 31, 2022:

2022	$	868
2023	1,216
2024	1,246
2025	1,269
2026	1,302
Thereafter	9,687
	15,588
Less: imputed interest	4,651
Total lease liabilities	$	10,937

26

NOTE 5. GOODWILL AND OTHER INTANGIBLE ASSETS

The following table presents changes in goodwill for the three months ended March 31, 2022 and 2021:

	March 31, 2022		March 31, 2021
Balance, beginning of year	$	18,724	$	18,724
Balance, end of period	$	18,724	$	18,724

Goodwill is not amortized but is reviewed for potential impairment on at least an annual basis, with testing between annual tests if an event occurs or circumstances change that could potentially reduce the fair value of a reporting unit.

The Company conducted its last annual goodwill impairment test as of November 30, 2021 using generally accepted valuation methods. As a result of that impairment test, no goodwill impairment was identified. No changes occurred that would impact the results of that analysis through March 31, 2022.

The following table presents changes in and components of other intangible assets for the three months ended March 31, 2022 and 2021:

	Three Months Ended March 31,
	2022		2021
Beginning of period	$	4,183	$	5,458
Amortization expense	(292)		(334)
Balance, end of period	$	3,891	$	5,124

No impairment charges were recorded in the three months ended March 31, 2022 and March 31, 2021.

The following table presents the components of other identifiable intangible assets at March 31, 2022 and December 31, 2021:

	March 31, 2022				December 31, 2021
	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
Amortized intangible assets:
Core deposit intangibles	$	8,390	$	4,500	$	8,390	$	4,208
Other customer relationship intangibles	25		24		25		24
Total	$	8,415	$	4,524	$	8,415	$	4,232

The following table presents future estimated aggregate amortization expense for intangible assets remaining at March 31, 2022:

2022	$	813
2023	935
2024	766
2025	596
2026	427
Thereafter	354
	$	3,891

27

NOTE 6. SHARE-BASED COMPENSATION PLANS

The Company maintains share-based compensation plans under the shareholder-approved 2011 Plan. The purpose of the share-based compensation plans is to provide officers, employees, and non-employee members of the Board of Directors of the Company with additional incentive to further the success of the Company. At March 31, 2022, 881,920 shares of the common stock of the Company were reserved, of which 137,443 shares are available to be issued. At the Company's 2022 Annual Meeting of Shareholders held on April 26, 2022, the Company's shareholders approved an amendment to the 2011 Plan increasing the number of shares available for issuance under the 2011 Plan by 400,000.

The 2011 Plan incentive awards may consist of grants of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, deferred stock units and performance shares. All employees and members of the Board of Directors of the Company and its subsidiaries, are eligible to participate in the 2011 Plan. The 2011 Plan allows for the Compensation Committee of the Board of Directors to determine the type of incentive to be awarded, its term, manner of exercise, vesting and restrictions on shares. Generally, awards are nonqualified under the IRC, unless the awards are deemed to be incentive awards to employees at the Compensation Committee’s discretion.

The following table presents a summary of nonvested restricted shares activity for the three months ended March 31, 2022:

	Shares	Weighted Average Grant Date Fair Value
Nonvested shares, beginning of year	274,697	$	20.05
Granted	121,949	25.02
Forfeited	(10,622)	20.02
Vested	(54,054)	19.31
Nonvested shares, at period end	331,970	$	22.00

The following table presents restricted shares compensation expense, with tax benefit information, and fair value of shares vested, for the three months ended March 31, 2022 and 2021:

	Three months ended March 31,
	2022		2021
Restricted share award expense	$	330	$	434
Restricted share award tax benefit	69		91
Fair value of shares vested	1,324		1,028

The unrecognized compensation expense related to the share awards totaled $4.6 million at March 31, 2022 and $2.3 million at December 31, 2021. The unrecognized compensation expense at March 31, 2022 is expected to be recognized over a weighted-average period of 2.3 years.

The Company maintains an employee stock purchase plan to provide its employees with an opportunity to purchase Company common stock. Eligible employees may purchase shares in an amount that does not exceed 10% of their annual salary, at the lower of 95% of the fair market value of the shares on the semi-annual offering date or related purchase date. The purchases occur in March and September of each year. The Company reserved 350,000 shares of its common stock to be issued under the employee stock purchase plan. At March 31, 2022, 147,527 shares were available to be issued under the employee stock purchase plan.

The following table presents information for the employee stock purchase plan for the three months ended March 31, 2022 and 2021:

	Three months ended March 31,
	2022		2021
Shares purchased	3,953		5,484
Weighted average price of shares purchased	$	22.46	$	13.44
Compensation expense recognized	8		33

The Company issues new shares or treasury shares, depending on market conditions, in its share-based compensation plans.

28

NOTE 7. DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used as risk management tools by the Company to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings and are not used for trading or speculative purposes.

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. The Company, however, discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in AOCI are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. At March 31, 2022 and December 31, 2021, the Company had no interest rate derivative designated as a hedging instrument.

The Company enters into interest rate swaps that allow its commercial loan customers to effectively convert a variable-rate commercial loan agreement to a fixed-rate commercial loan agreement. Under these agreements, the Company enters into a variable-rate loan agreement with a customer in addition to an interest rate swap agreement, which serves to effectively swap the customer’s variable-rate loan into a fixed-rate loan. The Company then enters into a corresponding swap agreement with a third party in order to economically hedge its exposure through the customer agreement. The interest rate swaps with both the customers and third parties are not designated as hedges and are marked through earnings. At March 31, 2022, the Company had 14 customer and 14 corresponding third-party broker interest rate derivatives not designated as a hedging instrument with an aggregate notional amount of $120.6 million. The Company had $75.8 million in notional amount of such derivative instruments at December 31, 2021. During the three months ended March 31, 2022 and 2021, the Company entered into new interest rate swaps with its commercial loan customers and recognized swap fee income of $953 thousand and zero, respectively, which is included in noninterest income in the unaudited condensed consolidated statements of income. At March 31, 2022 and December 31, 2021, the Company provided cash collateral of zero and $260 thousand to the counterparties for these derivatives, respectively. At March 31, 2022 and December 31, 2021, the Company was holding cash collateral of $2.6 million and $490 thousand from the counterparties for these derivatives, respectively.

The Company entered into a risk participation agreement with a financial institution counterparty (the “Agent Bank”) for an interest rate derivative contract related to a loan in which the Company is a participant. The risk participation agreement provides credit protection to the Agent Bank should the borrower fail to perform on its interest rate derivative contracts with the Agent Bank. The Company received an upfront fee of $53 thousand upon entry into the risk participation agreement during the three months ended March 31, 2021, and is included in noninterest income in the unaudited condensed consolidated statements of income. The Company manages its credit risk on the risk participation agreement by monitoring the creditworthiness of the borrower, which is based on the same credit review process as though the Company had entered into the derivative instruments directly with the borrower. The notional amount of such risk participation agreement reflects the Company’s pro-rata share of the derivative instrument, consistent with its share of the related participated loan. The total notional amount of the risk participation agreement was $15.9 million at both March 31, 2022 and December 31, 2021.

As a part of its normal residential mortgage operations, the Company will enter into an interest rate lock commitment with a potential borrower. The Company will enter into a corresponding commitment with an investor to sell that loan at a specific price shortly after origination. In accordance with FASB ASC 820, adjustments are recorded through earnings to account for the net change in fair value of these transactions for the held for sale pipeline.

29

The following table summarizes the fair value of the Company's derivative instruments at March 31, 2022 and December 31, 2021:

	March 31, 2022					December 31, 2021
	Notional Amount		Balance Sheet Location	Fair Value		Notional Amount		Balance Sheet Location	Fair Value
Derivatives not designated as hedging instruments:
Interest rate swaps	$	60,279	Other assets	$	3,067	$	37,915	Other assets	$	764
Interest rate swaps	60,279		Other liabilities	(3,024)		37,915		Other liabilities	(758)
Risk participation	15,855		Other liabilities	(1)		15,855		Other liabilities	(2)
Interest rate lock commitments with customers	12,302		Other assets	300		16,604		Other assets	353
Forward sale commitment	7,537		Other assets	353		8,665		Other assets	52
Total derivatives not designated as hedging instruments				$	695				$	409

The following tables summarize the effect of the Company's derivative financial instruments on OCI and net income for the three months ended March 31, 2022 and 2021:

	Amount of Gain Recognized in OCI on Derivative
	Three Months Ended March 31,
	2022		2021
Derivatives in cash flow hedging relationships:
Interest rate products	$	—	$	739
Total	$	—	$	739

	Amount of Loss Reclassified from AOCI into Income				Location of Loss Recognized from AOCI into Income
	Three Months Ended March 31,
	2022		2021
Derivatives in cash flow hedging relationships:
Interest rate products	$	—	$	(87)	Interest expense
Total	$	—	$	(87)

During the three months ended September 30, 2021, the Company terminated its interest rate swap designated as a hedging instrument of $50.0 million.

	Amount of Gain (Loss) Recognized in Income				Location of Gain (Loss) Recognized in Income
	Three Months Ended March 31,
	2022		2021
Derivatives not designated as hedging instruments:
Interest rate products	$	37	$	52	Other operating expenses
Risk participation agreement	2		4		Other operating expenses
Interest rate lock commitments with customers	(53)		(1)		Mortgage banking activities
Forward sale commitment	300		254		Mortgage banking activities
Total	$	286	$	309

NOTE 8. SHAREHOLDERS’ EQUITY AND REGULATORY CAPITAL

Banks and bank holding companies are subject to regulatory capital requirements administered by federal banking agencies. Capital adequacy guidelines and, additionally for banks, prompt corrective action regulations, involve quantitative measures of assets, liabilities and certain off-balance sheet items calculated under regulatory accounting practices. Capital

30

amounts and classifications are also subject to qualitative judgments by regulators. Failure to meet capital requirements can initiate regulatory action. Under the Basel Committee on Banking Supervision's capital guidelines for U.S. Banks ("Basel III rules"), an entity must hold a capital conservation buffer above the adequately capitalized risk-based capital ratios. The Company and the Bank have elected not to include net unrealized gains or losses included in AOCI in computing regulatory capital.

The consolidated asset limit on small bank holding companies is $3.0 billion and a company with assets under that limit is not subject to the FRB consolidated capital rules, but may file reports that include capital amounts and ratios. The Company has elected to file those reports.

Management believes that the Company and the Bank met all capital adequacy requirements to which they are subject at March 31, 2022 and December 31, 2021.

Prompt corrective action regulations provide five classifications: well capitalized, adequately capitalized, undercapitalized, significantly undercapitalized and critically undercapitalized, although these terms are not used to represent overall financial condition. If adequately capitalized, regulatory approval is required to accept brokered deposits. If undercapitalized, capital distributions are limited, as is asset growth and expansion, and capital restoration plans are required. At March 31, 2022, the most recent regulatory notifications categorized the Bank as well capitalized under the regulatory framework for prompt corrective action. There are no conditions or events since that notification that management believes have changed the Bank's classification.

31

The following table presents capital amounts and ratios at March 31, 2022 and December 31, 2021:

	Actual				For Capital Adequacy Purposes (includes applicable capital conservation buffer)				To Be Well Capitalized Under Prompt Corrective Action Provisions
	Amount		Ratio		Amount		Ratio		Amount		Ratio
March 31, 2022
Total risk-based capital:
Orrstown Financial Services, Inc.	$	300,952	14.3	%	$	220,591	10.5	%	n/a		n/a
Orrstown Bank	288,988		13.8	%	220,509		10.5	%	$	210,009	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	245,833		11.7	%	178,574		8.5	%	n/a		n/a
Orrstown Bank	265,847		12.7	%	178,508		8.5	%	168,007		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	245,833		11.7	%	147,061		7.0	%	n/a		n/a
Orrstown Bank	265,847		12.7	%	147,006		7.0	%	136,506		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	245,833		8.8	%	112,328		4.0	%	n/a		n/a
Orrstown Bank	265,847		9.5	%	112,352		4.0	%	140,440		5.0	%
December 31, 2021
Total risk-based capital:
Orrstown Financial Services, Inc.	$	297,823	15.0	%	$	208,617	10.5	%	n/a		n/a
Orrstown Bank	278,780		14.0	%	208,550		10.5	%	$	198,619	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	243,075		12.2	%	168,880		8.5	%	n/a		n/a
Orrstown Bank	255,995		12.9	%	168,826		8.5	%	158,895		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	243,075		12.2	%	139,078		7.0	%	n/a		n/a
Orrstown Bank	255,995		12.9	%	139,033		7.0	%	129,102		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	243,075		8.5	%	114,384		4.0	%	n/a		n/a
Orrstown Bank	255,995		8.9	%	114,470		4.0	%	143,087		5.0	%

In September 2015, the Board of Directors of the Company authorized a share repurchase program under which the Company may repurchase up to 5% of the Company's outstanding shares of common stock, or approximately 416,000 shares, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act of 1934, as amended. On April 19, 2021, the Board of Directors authorized the additional future repurchase of up to 562,000 shares of its outstanding common stock. When and if appropriate, repurchases may be made in the open market or privately negotiated transactions, depending on market conditions, regulatory requirements and other corporate considerations, as determined by management. Share repurchases may not occur and may be discontinued at any time. At March 31, 2022, 415,805 shares had been repurchased at a total cost of $8.9 million, or $21.35 per share. Common stock available for future repurchase totals approximately 562,195 shares, or 5% of the Company's outstanding common stock at March 31, 2022.

On April 18, 2022, the Board declared a cash dividend of $0.19 per common share, which will be paid on May 9, 2022 to shareholders of record at May 2, 2022.

32

NOTE 9. EARNINGS PER SHARE

The following table presents earnings per share for the three months ended March 31, 2022 and 2021:

	Three Months Ended March 31,
	2022		2021
Net income	$	8,368	$	10,207
Weighted average shares outstanding - basic	10,860		10,975
Dilutive effect of share-based compensation	147		99
Weighted average shares outstanding - diluted	11,007		11,074
Per share information:
Basic earnings per share	$	0.77	$	0.93
Diluted earnings per share	0.76		0.92

Average outstanding restricted award shares totaling 112,223 and 0 for the three months ended March 31, 2022 and 2021, respectively, were not included in the computation of earnings per share because the effect was antidilutive. The dilutive effect of share-based compensation in each period above relates principally to restricted stock awards.

NOTE 10. FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK

The Company is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its clients. These financial instruments include commitments to extend credit and standby letters of credit. Those instruments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the unaudited condensed consolidated balance sheets. The contract amounts of those instruments reflect the extent of involvement the Company has in particular classes of financial instruments.

The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and standby letters of credit and financial guarantees written is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet instruments. The following table presents these contractual, or notional, amounts:

	Contractual or Notional Amount
	March 31, 2022		December 31, 2021
Commitments to fund:
Home equity lines of credit	$	273,734	$	261,580
1-4 family residential construction loans	56,330		40,348
Commercial real estate, construction and land development loans	142,301		124,488
Commercial, industrial and other loans	368,199		378,996
Standby letters of credit	20,772		19,724

Commitments to extend credit are agreements to lend to a client as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The Company evaluates each client’s credit-worthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management’s credit evaluation of the client. Collateral varies but may include accounts receivable, inventory, equipment, residential real estate, and income-producing commercial properties.

Standby letters of credit and financial guarantees written are conditional commitments issued by the Company to guarantee the performance of a client to a third party. Those guarantees are primarily issued to support public and private borrowing arrangements. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loans to clients. The Company holds collateral supporting those commitments when deemed necessary by management. The liability at March 31, 2022 and December 31, 2021 for guarantees under standby letters of credit issued was not considered to be material.

33

The Company maintains a reserve, based on historical loss experience of the related loan class and utilization assumptions, for off-balance sheet credit exposures that currently are not funded, in other liabilities on the unaudited condensed consolidated balance sheets. This reserve totaled approximately $1.6 million at both March 31, 2022 and December 31, 2021.

NOTE 11. FAIR VALUE

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Certain financial instruments and all non-financial instruments are excluded from disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company.

The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market participant assumptions based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are:

Level 1 – quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access at the measurement date.

Level 2 – significant other observable inputs other than Level 1 prices such as prices for similar assets and liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 – at least one significant unobservable input that reflects a company's own assumptions about the assumptions that market participants would use in pricing an asset or liability.

In instances in which multiple levels of inputs are used to measure fair value, hierarchy classification is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

The Company used the following methods and significant assumptions to estimate fair value for instruments measured on a recurring basis:

Where quoted prices are available in an active market, investment securities are classified within Level 1 of the valuation hierarchy. Level 1 investment securities include highly liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, investment securities are classified within Level 2 and fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flow. Level 2 investment securities include U.S. agency securities, MBS, obligations of states and political subdivisions and certain corporate, asset backed and other securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, investment securities are classified within Level 3 of the valuation hierarchy. The Company’s investment securities are classified as available for sale.

The fair values of interest rate swaps and risk participation derivatives are determined using models that incorporate readily observable market data into a market standard methodology. This methodology nets the discounted future cash receipts and the discounted expected cash payments. The discounted variable cash receipts and payments are based on expectations of future interest rates derived from observable market interest rate curves. In addition, fair value is adjusted for the effect of nonperformance risk by incorporating credit valuation adjustments for the Company and its counterparties. These assets and liabilities are classified as Level 2 fair values, based upon the lowest level of input that is significant to the fair value measurements.

34

The following table summarizes assets and liabilities measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
March 31, 2022
Financial Assets
Investment securities:
U.S. Treasury securities	$	18,538	$	—	$	—	$	18,538
States and political subdivisions	—		230,539		7,021		237,560
GSE residential MBSs	—		59,229		—		59,229
GSE residential CMOs	—		71,027		—		71,027
Nonagency CMOs	—		15,390		11,613		27,003
Asset-backed	—		115,970		—		115,970
Other	403		—		—		403
Loans held for sale	—		7,403		—		7,403
Derivatives	—		3,067		300		3,367
Totals	$	18,941	$	502,625	$	18,934	$	540,500
Financial Liabilities
Derivatives	$	—	$	3,025	$	—	$	3,025
December 31, 2021
Financial Assets
Investment securities:
U.S. Treasury securities	$	19,702	$	—	$	—	$	19,702
States and political subdivisions	—		183,171		10,199		193,370
GSE residential MBSs	—		40,726		—		40,726
GSE residential CMOs	—		65,922		—		65,922
Nonagency CMOs	—		16,750		12,948		29,698
Asset-backed	—		122,621		—		122,621
Other	399		—		—		399
Loans held for sale	—		8,868		—		8,868
Derivatives	—		764		353		1,117
Totals	$	20,101	$	438,822	$	23,500	$	482,423
Financial Liabilities
Derivatives	$	—	$	760	$	—	$	760

The Company had one municipal bond and one CMO measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at both March 31, 2022 and December 31, 2021. The Level 3 valuation is based on a non-executable broker quote, which is considered a significant unobservable input. Such quotes are updated as available and may remain constant for a period of time for certain broker-quoted securities that do not move with the market or that are not interest rate sensitive as a result of their structure or overall attributes.

The Company’s residential mortgage LHFS are recorded at fair value utilizing Level 2 measurements. This fair value measurement is determined based upon third party quotes obtained on similar loans. For LHFS, for which the fair value option has been elected, the aggregate fair value declined below the aggregate principal balance by $195 thousand as of March 31, 2022, and exceeded the aggregate principal balance by $150 thousand as of December 31, 2021.

The determination of the fair value of interest rate lock commitments on residential mortgages is based on agreed upon pricing with the respective investor on each loan and includes a pull through percentage. The pull through percentage represents an estimate of loans in the pipeline to be delivered to an investor versus the total loans committed for delivery. Significant changes in this input could result in a significantly higher or lower fair value measurement. As the pull through percentage is a significant unobservable input, this is deemed a Level 3 valuation input. The average pull through percentage, which is based

35

upon historical experience, was 93% as of March 31, 2022. An increase or decrease of 5% in the pull through assumption would result in a positive or negative change of $6 thousand in the fair value of interest rate lock commitments at March 31, 2022.

The following provides details of the Level 3 fair value measurement activity for the periods ended March 31, 2022 and 2021:

Investment securities:

	Three Months Ended March 31,
	2022		2021
Balance, beginning of period	$	23,147	$	31,503
Unrealized loss included in OCI	(1,360)		(665)
Net discount accretion	71		129
Principal payments and other	—		(1,858)
Sales	(3,053)		(3,545)
OTTI	(171)		—
Balance, end of period	$	18,634	$	25,564

Interest rate lock commitments on residential mortgages:

	Three Months Ended March 31,
	2022		2021
Balance, beginning of period	$	353	$	673
Total losses
Included in earnings	(53)		(1)
Balance, end of period	$	300	$	672

Certain financial assets are measured at fair value on a nonrecurring basis. Adjustments to the fair value of these assets usually results from the application of lower of cost or market accounting or write-downs of individual assets. The Company used the following methods and significant assumptions to estimate fair value for these financial assets.

Impaired Loans

Loans are designated as impaired when, in the judgment of management and based on current information and events, it is probable that all amounts due, according to the contractual terms of the loan agreement, will not be collected. The measurement of loss associated with impaired loans for all loan classes can be based on either the observable market price of the loan, the fair value of the collateral, or discounted cash flows using the rate of return implicit in the original loan for TDRs. For collateral-dependent loans, fair value is measured based on the value of the collateral securing the loan, less estimated costs to sell. Collateral may be in the form of real estate or business assets including equipment, inventory, and accounts receivable. The value of the real estate collateral is determined utilizing an income or market valuation approach based on an appraisal conducted by an independent, licensed appraiser outside of the Company using observable market data (Level 2). However, if the collateral is a house or building in the process of construction, or if management adjusts the appraisal value, then the fair value is considered Level 3. The value of business equipment is based upon an outside appraisal, if deemed significant, or the net book value on the applicable business’ financial statements if not considered significant using observable market data. Likewise, values for inventory and accounts receivable collateral are based on financial statement balances or aging reports (Level 3). Impaired loans with an allocation to the ALL are measured at fair value on a nonrecurring basis. Any fair value adjustments are recorded in the period incurred as provision for loan losses on the unaudited condensed consolidated statements of income.

Any changes in the fair value of impaired loans still held were not material for the three months ended March 31, 2022 and 2021.

36

Foreclosed Real Estate

OREO property acquired through foreclosure is initially recorded at the fair value of the property at the transfer date less estimated selling cost. Subsequently, OREO is carried at the lower of its carrying value or the fair value less estimated selling cost. Fair value is usually determined based upon an independent third-party appraisal of the property or occasionally upon a recent sales offer. The Company had no OREO balances at March 31, 2022 and December 31, 2021.

Mortgage Servicing Rights

The MSR fair value is estimated to be equal to its carrying value, unless the quarterly valuation model calculates the present value of the estimated net servicing income is less than its carrying value, in which case an impairment charge is taken. At March 31, 2022 and December 31, 2021, an impairment reserve of $47 thousand and $79 thousand, respectively, existed on the MSR portfolio. For the three months ended March 31, 2022 and 2021, impairment valuation allowance reversals of $32 thousand and $606 thousand were included, respectively, in mortgage banking activities on the unaudited condensed consolidated statements of income. The reversals in the three months ended March 31, 2022 and 2021 were due to subsequent increases in market rates.

The following table summarizes assets measured at fair value on a nonrecurring basis at March 31, 2022 and December 31, 2021:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
March 31, 2022
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	144	$	144
Non-owner occupied residential	—		—		18		18
Residential mortgage:
First lien	—		—		491		491
Home equity - lines of credit	—		—		69		69
Total impaired loans	$	—	$	—	$	722	$	722
Mortgage servicing rights	$	—	$	—	$	322	$	322
December 31, 2021
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	751	$	751
Non-owner occupied residential	—		—		24		24
Residential mortgage:
First lien	—		—		545		545
Home equity - lines of credit	—		—		72		72
Total impaired loans	$	—	$	—	$	1,392	$	1,392
Mortgage servicing rights	$	—	$	—	$	322	$	322

37

The following table presents additional qualitative information about assets measured on a nonrecurring basis and for which the Company has utilized Level 3 inputs to determine fair value:

	Fair Value Estimate		Valuation Techniques	Unobservable Input	Range
March 31, 2022
Impaired loans	$	722	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	0% - 25% discount
				- Management adjustments for liquidation expenses	4.73% - 17.93% discount
Mortgage servicing rights	$	322	Discounted cash flows	Weighted average CPR	8.23%
				- Weighted average discount rate	9.03%
December 31, 2021
Impaired loans	$	1,392	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	10% - 25% discount
				- Management adjustments for liquidation expenses	6.08% - 17.93% discount
Mortgage servicing rights	$	322	Discounted cash flows	Weighted average CPR	12.60%
				- Weighted average discount rate	9.03%

38

Fair values of financial instruments

GAAP requires disclosure of the fair value of financial assets and liabilities, including those that are not measured and reported at fair value on a recurring or nonrecurring basis. The following table presents carrying amounts and estimated fair values of the financial assets and liabilities at March 31, 2022 and December 31, 2021:

	Carrying Amount		Fair Value		Level 1		Level 2		Level 3
March 31, 2022
Financial Assets
Cash and due from banks	$	26,446	$	26,446	$	26,446	$	—	$	—
Interest-bearing deposits with banks	187,792		187,792		187,792		—		—
Restricted investments in bank stock	6,791		n/a		n/a		n/a		n/a
Investment securities	529,730		529,730		18,941		492,155		18,634
Loans held for sale	7,403		7,403		—		7,403		—
Loans, net of allowance for loan losses	1,956,799		1,906,140		—		—		1,906,140
Derivatives	3,367		3,367		—		3,067		300
Accrued interest receivable	8,642		8,642		—		2,940		5,702
Financial Liabilities
Deposits	2,545,992		2,545,739		—		2,545,739		—
Securities sold under agreements to repurchase	24,624		24,624		—		24,624		—
FHLB advances and other borrowings	1,788		1,865		—		1,865		—
Subordinated notes	31,978		33,094		—		33,094		—
Derivatives	3,025		3,025		—		3,025		—
Accrued interest payable	661		661		—		661		—
Off-balance sheet instruments	—		—		—		—		—
December 31, 2021
Financial Assets
Cash and due from banks	$	21,217	$	21,217	$	21,217	$	—	$	—
Interest-bearing deposits with banks	187,493		187,493		187,493		—		—
Restricted investments in bank stock	7,252		n/a		n/a		n/a		n/a
Investment securities	472,438		472,438		20,101		429,190		23,147
Loans held for sale	8,868		8,868		—		8,868		—
Loans, net of allowance for loan losses	1,958,806		1,946,365		—		—		1,946,365
Derivatives	1,117		1,117		—		764		353
Accrued interest receivable	8,234		8,235		—		2,203		6,032
Financial Liabilities
Deposits	2,464,929		2,466,191		—		2,466,191		—
Securities sold under agreements to repurchase	23,301		23,301		—		23,301		—
FHLB advances and other borrowings	1,896		2,035		—		2,035		—
Subordinated notes	31,963		31,815		—		31,815		—
Derivatives	760		760		—		760		—
Accrued interest payable	154		154		—		154		—
Off-balance sheet instruments	—		—		—		—		—

In accordance with the Company's adoption of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, the methods utilized to measure the fair value of financial instruments at March 31, 2022 and December 31, 2021 represent an approximation of exit price; however, an actual exit price may differ.

39

NOTE 12. CONTINGENCIES

The nature of the Company’s business generates a certain amount of litigation involving matters arising out of the ordinary course of business. Except as described below, in the opinion of management, there are no legal proceedings that might have a material effect on the results of operations, liquidity, or the financial position of the Company at this time.

On May 25, 2012, SEPTA filed a putative class action complaint in the U.S. District Court for the Middle District of Pennsylvania against the Company, the Bank and certain current and former directors and officers (collectively, the “Orrstown Defendants”). The complaint alleged, among other things, that (i) in connection with the Company’s Registration Statement on Form S-3 dated February 23, 2010 and its Prospectus Supplement dated March 23, 2010, and (ii) during the purported class period of March 24, 2010 through October 27, 2011, the Company issued materially false and misleading statements regarding the Company’s lending practices and financial results, including misleading statements concerning the stringent nature of the Bank’s credit practices and underwriting standards, the quality of its loan portfolio, and the intended use of the proceeds from the Company’s March 2010 public offering of common stock. The complaint asserted claims under Sections 11, 12(a) and 15 of the Securities Act of 1933, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, and sought class certification, unspecified money damages, interest, costs, fees and equitable or injunctive relief. Under the Private Securities Litigation Reform Act of 1995 (“PSLRA”), the Court appointed SEPTA Lead Plaintiff on August 20, 2012.

On March 4, 2013, SEPTA filed an amended complaint. The amended complaint expanded the list of defendants in the action to include the Company’s former independent registered public accounting firm, Smith Elliott Kearns & Company, LLC (“SEK”), and the underwriters of the Company’s March 2010 public offering of common stock. In addition, among other things, the amended complaint extended the purported 1934 Exchange Act class period from March 15, 2010 through April 5, 2012.

On June 22, 2015, in a 96-page Memorandum, the Court dismissed without prejudice SEPTA’s amended complaint against all defendants, finding that SEPTA failed to state a claim under either the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. On February 8, 2016, the Court granted SEPTA’s motion for leave to amend again and SEPTA filed its second amended complaint that same day.

On December 7, 2016, the Court issued an Order and Memorandum granting in part and denying in part defendants’ motions to dismiss SEPTA’s second amended complaint. The Court granted the motions to dismiss the Securities Act claims against all defendants, and granted the motions to dismiss the Exchange Act Section 10(b) and Rule 10b-5 claims against all defendants except Orrstown Financial Services, Inc., Orrstown Bank, Thomas R. Quinn, Jr., Bradley S. Everly, and Jeffrey W. Embly. The Court also denied the motions to dismiss the Exchange Act Section 20(a) claims against Quinn, Everly, and Embly.

On December 15, 2017, the Orrstown Defendants and SEPTA exchanged expert reports in opposition to and in support of class certification, respectively. On January 15, 2018, the parties exchanged expert rebuttal reports. SEPTA has not yet filed a motion for class certification.

On August 9, 2018, SEPTA filed a motion to compel the production of Confidential Supervisory Information (CSI) of non-parties the Board of Governors of the FRB and the Pennsylvania Department of Banking and Securities, in the possession of Orrstown and third parties. On August 30, 2018, the FRB filed an unopposed motion to intervene in the Action for the purpose of opposing SEPTA’s motion to compel. On February 12, 2019, the Court denied SEPTA’s motion to compel the production of CSI on the ground that SEPTA had failed to exhaust its administrative remedies.

On April 11, 2019, SEPTA filed a motion for leave to file a third amended complaint. The proposed third amended complaint seeks to reassert the Securities Act claims that the Court dismissed as to all defendants on December 7, 2016, when the Court granted in part and denied in part defendants’ motions to dismiss SEPTA’s second amended complaint. The proposed third amended complaint also seeks to reassert the Exchange Act claims against those defendants that the Court dismissed from the case on December 7, 2016.

On June 13, 2019, Orrstown filed a motion for protective order to stay discovery pending resolution of SEPTA’s motion for leave to file a third amended complaint. On July 17, 2019, the Court entered an Order partially granting Orrstown’s motion for protective order, ruling that all deposition discovery in the case was stayed pending a decision on SEPTA’s motion for leave to file a third amended complaint. Party and non-party document discovery in the case has largely been completed.

On February 14, 2020, the Court issued an Order and Memorandum granting SEPTA’s motion for leave to file a third amended complaint. The third amended complaint is now the operative complaint. It reinstates the Orrstown Defendants, as well as SEK and the underwriter defendants, previously dismissed from the case on December 7, 2016. The third amended complaint also revives the previously dismissed Securities Act claim against the Orrstown Defendants, SEK, and the

40

underwriter defendants. Defendants filed their motions to dismiss the third amended complaint on April 24, 2020. SEPTA’s opposition was filed on July 8, 2020, and Orrstown’s reply brief was filed on August 12, 2020.

Additionally, on February 24, 2020, the Orrstown Defendants, and the underwriter defendants and SEK, separately filed motions under 28 U.S.C. § 1292(b) asking the District Court to certify its February 14, 2020 Order granting leave to file the third amended complaint for interlocutory appeal to the Third Circuit Court of Appeals. The District Court granted those motions on July 17, 2020, and defendants filed their Petition for Permission to Appeal with the Third Circuit on July 27, 2020. The Third Circuit granted permission to appeal the Order pursuant to 28 U.S.C. § 1292(b) on August 13, 2020. Defendants filed their joint Opening Brief in the Third Circuit on November 2, 2020, asking the Court to reverse the district court’s Order. SEPTA filed its responsive brief on December 2, 2020 and defendants filed their reply brief on December 23, 2020. Oral argument was held on February 10, 2021. On September 2, 2021, the Third Circuit affirmed the District Court's February 14, 2020 Order granting SEPTA leave to file a third amended complaint. Defendants' motions to dismiss the third amended complaint are still pending in the District Court.

The Company believes that SEPTA’s allegations and claims against the defendants are without merit, and the Company intends to defend itself vigorously against those claims. It is not possible at this time to reasonably estimate possible losses, or even a range of reasonably possible losses, in connection with the litigation.

On March 25, 2022, a customer of the Bank filed a putative class action complaint against the Bank in the Court of Common Pleas of Cumberland County, Pennsylvania in a case captioned Alleman, on behalf of himself and all others similarly situated, v. Orrstown Bank. The complaint alleges, among other things, that the Bank breached its account agreements by charging certain overdraft fees. The complaint seeks a refund of all allegedly improper fees, damages in an amount to be proven at trial, attorneys’ fees and costs, and an injunction against the Bank’s allegedly improper overdraft practices. This lawsuit is similar to lawsuits recently filed against other financial institutions pertaining to overdraft fee disclosures. Based on information available at present, it is not possible at this time to reasonably estimate possible losses, or even a range of reasonably possible losses, in connection with the litigation. Accordingly, the Company has not recognized any liability associated with this action. The Bank believes that the allegations and claims against the Bank are without merit, and intends to defend itself vigorously against those claims.

41

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis is intended to assist readers in understanding the consolidated financial condition and results of operations of Orrstown and should be read in conjunction with the preceding unaudited condensed consolidated financial statements and notes thereto included in this Quarterly Report on Form 10-Q, as well as with the audited consolidated financial statements and notes thereto for the year ended December 31, 2021, included in our Annual Report on Form 10-K. Throughout this discussion, the yield on earning assets is stated on a fully taxable-equivalent basis and balances represent average daily balances unless otherwise stated. Certain prior period amounts presented in this discussion and analysis have been reclassified to conform to current period classifications.

Overview

The Company, headquartered in Shippensburg, Pennsylvania, is a one-bank holding company that has elected status as a financial holding company. The consolidated financial information presented herein reflects the Company and its wholly-owned subsidiary, the Bank. At March 31, 2022, the Company had total assets of $2.9 billion, total liabilities of $2.6 billion and total shareholders’ equity of $254.8 million.

Cautionary Note About Forward-Looking Statements

Certain statements appearing herein, which are not historical in nature, are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, and are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition, we may make other written and oral communications, from time to time, that contain such statements. Such forward-looking statements reflect the current views of the Company's management with respect to, among other things, future events and the Company's financial performance. These statements are often, but not always, made through the use of words or phrases such as “may,” “will,” “expect,” “estimate,” “anticipate” or similar terms, or the negative variations of those words or other comparable words of a future or forward-looking nature. Forward-looking statements are statements that include projections, predictions, expectations, estimates or beliefs about events or results or otherwise are not statements of historical facts, many of which, by their nature, are inherently uncertain and beyond the Company's control, and include, but are not limited to, statements related to new business development, new loan opportunities, growth in the balance sheet and fee-based revenue lines of business, merger and acquisition activity, reducing risk assets, and mitigating losses in the future. Accordingly, the Company cautions you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements and there can be no assurances that the Company will achieve the desired level of new business development and new loans, growth in the balance sheet and fee-based revenue lines of business, successful merger and acquisition activity, continue to reduce risk assets or mitigate losses in the future. In addition to risks and uncertainties related to the COVID-19 pandemic (including those related to variants) and resulting governmental and societal responses, factors that could cause actual results to differ from those expressed or implied by the forward-looking statements include, but are not limited to, the following: ineffectiveness of the Company’s strategic growth plan due to changes in current or future market conditions; the effects of competition and how it may impact our community banking model, including industry consolidation and development of competing financial products and services; the integration of the Company's strategic acquisitions; the inability to fully achieve expected savings, efficiencies or synergies from mergers and acquisitions, or taking longer than estimated for such savings, efficiencies and synergies to be realized; changes in laws and regulations; interest rate movements; changes in credit quality; inability to raise capital, if necessary, under favorable conditions; volatility in the securities markets; the demand for our products and services; deteriorating economic conditions; geopolitical tensions; operational risks including, but not limited to, cybersecurity incidents, fraud, natural disasters and future pandemics; expenses associated with pending litigation and legal proceedings; the failure of the SBA to honor its guarantee of loans issued under the SBA PPP; the timing of the repayment of SBA PPP loans and the impact it has on fee recognition; our ability to convert new relationships gained through the SBA PPP efforts to full banking relationships; and other risks and uncertainties, including those detailed in our Annual Report on Form 10-K for the year ended December 31, 2021, and our Quarterly Reports on Form 10-Q under the sections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in other filings made with the SEC. The statements are valid only as of the date hereof and we disclaim any obligation to update this information.

Economic Climate, Inflation and Interest Rates

Preliminary real GDP for the first quarter of 2022 reflected an annualized decrease of 1.4%. This is a decrease from the fourth quarter 2021 growth rate of 6.9% and annualized growth of 6.3% for the first quarter of 2021. The decrease in the first quarter of 2022 was driven by decreases in private inventory investment which includes wholesale and retail trade on motor

42

vehicles, exports of nondurable goods, and government spending as several federal programs have expired or tapered off partially offset by increases in personal consumption primarily within healthcare and residential and nonresidential fixed investments. Personal consumption expenditures however declined from the fourth quarter of 2022 within the energy sector of nondurable goods. Restrictions and disruptions continued due to new COVID-19 cases related to the Omicron variant throughout the country. The personal consumption expenditures ("PCE") price index increased 7.0% in the first quarter of 2022, compared with an increase of 6.4% in the fourth quarter of 2021. The national unemployment rate declined to 3.6% in March 2022, down from 3.9% in December 2021 and from 6.1% in April 2021. There continued to be notable job gains in leisure and hospitality and professional and business services, retail trade and manufacturing during the first quarter of 2022. Although there was strong economic recovery in 2021 from the pandemic, the decrease in GDP during the first quarter of 2022 is indicative of the supply chain challenges, labor shortages and inflation.

Due to the COVID-19 pandemic, market interest rates had declined significantly, with the 10-year Treasury bond falling for the first time below 1.00% on March 3, 2020, but recovering to 1.51% as of December 31, 2021. At March 31, 2022, the 10-year Treasury bond reached 2.34% as it continued to rise due to stock market volatility and inflationary pressures. In 2020, in reaction to the increase in market uncertainty, the FRB cut the Fed Funds rates by 150 basis points to 0.25%. In March 2022, the Federal Reserve Open Markets Committee approved an increase to the Fed Funds rate of 25 basis points due to inflation, elevating geopolitical tensions and the state of the labor market recovery. The Committee forecasted at least three 25 basis point rate increases in 2022 and noted that it expected to conclude its asset purchase program, which tapering occurred during the first quarter of 2022 to maintain the size of the balance sheet. The Federal Reserve Open Markets Committee will meet next on May 3, 2022.

The majority of the assets and liabilities of a financial institution are monetary in nature, and therefore, differ greatly from most commercial and industrial companies that have significant investments in fixed assets or inventories. However, inflation does have an impact on the Company, particularly with respect to the growth of total assets and noninterest expenses, which tend to rise during periods of general inflation. Risks also exist due to supply and demand imbalances, employment shortages, the interest rate environment, and geopolitical tensions. It is reasonably foreseeable that estimates made in the financial statements could be materially and adversely impacted in the near term as a result of these conditions, including expected credit losses on loans and the fair value of financial instruments that are carried at fair value.

Critical Accounting Estimates

The Company’s accounting and reporting policies are in accordance with GAAP and follow accounting and reporting guidelines prescribed by bank regulatory authorities and general practices within the financial services industry in which it operates. Our financial position and results of operations are affected by management's application of accounting policies, including estimates, and assumptions and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates, assumptions, and judgments are based on information available as of the balance sheet date and through the date the financial statements are filed with the SEC. Different assumptions in the application of these policies could result in material changes in the consolidated financial position and/or consolidated results of operations and related disclosures. The more critical accounting estimates include accounting for credit losses and valuation methodologies. Accordingly, these critical accounting estimates are discussed in detail in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2021. Significant accounting policies and any changes in accounting principles and effects of new accounting pronouncements are discussed in Note 1, Summary of Significant Accounting Policies, to the Consolidated Financial Statements under Part II, Item 8, "Financial Statements and Supplementary Data," in our Annual Report on Form 10-K for the year ended December 31, 2021. Additional disclosures regarding the effects of new accounting pronouncements are included in this report in Note 1, Summary of Significant Accounting Policies, to the unaudited condensed consolidated financial statements under Part I, Item 1, "Financial Information."

43

RESULTS OF OPERATIONS

Three months ended March 31, 2022 compared with three months ended March 31, 2021

Summary

Net income totaled $8.4 million for the three months ended March 31, 2022 compared with net income of $10.2 million for the same period in 2021. Diluted earnings per share for the three months ended March 31, 2022 totaled $0.76, compared with $0.92 for the three months ended March 31, 2021. Net interest income positively influenced results of operations, and totaled $22.6 million for the three months ended March 31, 2022, compared to $21.9 million in the three months ended March 31, 2021. Noninterest income totaled approximately $7.5 million for both the three months ended March 31, 2022 and 2021. Noninterest expenses totaled $19.4 million for the three months ended March 31, 2022 compared to $17.8 million for the three months ended March 31, 2021.

The comparison of operating results for 2022 with 2021 reflects the impact of commercial loan growth and reductions in the cost of funds partially offset by increases in the provision for loan loss expense and salaries and employee benefits expense.

44

Net Interest Income

Net interest income increased by $718 thousand, from $21.9 million to $22.6 million, for the three months ended March 31, 2022 compared with the three months ended March 31, 2021. Total interest expense decreased from $2.1 million to $1.2 million, in comparing the three months ended March 31, 2022 with the three months ended March 31, 2021. Interest income on loans decreased by $142 thousand, from $21.5 million to $21.4 million, and investment securities interest income decreased by $59 thousand, from $2.4 million to $2.3 million, for the same period.

The following table presents net interest income, net interest spread and net interest margin for the three months ended March 31, 2022 and 2021 on a taxable-equivalent basis:

	Three Months Ended March 31, 2022						Three Months Ended March 31, 2021
	Average Balance		Taxable- Equivalent Interest		Taxable- Equivalent Rate		Average Balance		Taxable- Equivalent Interest		Taxable- Equivalent Rate
Assets
Federal funds sold & interest-bearing bank balances	$	199,788	$	101	0.20	%	$	145,595	$	39	0.11	%
Investment securities (1)	472,195		2,512		2.13		468,273		2,512		2.18
Loans (1)(2)(3)	1,974,804		21,429		4.39		2,033,219		21,574		4.30
Total interest-earning assets	2,646,787		24,042		3.67		2,647,087		24,125		3.70
Other assets	184,300						182,737
Total	$	2,831,087					$	2,829,824
Liabilities and Shareholders’ Equity
Interest-bearing demand deposits	$	1,398,182	256		0.07		$	1,334,219	438		0.13
Savings deposits	227,676		57		0.10		183,576		45		0.10
Time deposits	298,618		372		0.51		397,271		909		0.93
Total interest-bearing deposits	1,924,476		685		0.14		1,915,066		1,392		0.29
Securities sold under agreements to repurchase	23,530		7		0.12		21,452		9		0.17
FHLB Advances and other borrowings	1,850		22		4.74		58,000		171		1.20
Subordinated notes	31,969		503		6.29		31,909		502		6.29
Total interest-bearing liabilities	1,981,825		1,217		0.25		2,026,427		2,074		0.42
Noninterest-bearing demand deposits	540,139						516,849
Other	40,919						36,244
Total liabilities	2,562,883						2,579,520
Shareholders’ equity	268,204						250,304
Total	$	2,831,087					$	2,829,824
Taxable-equivalent net interest income /net interest spread			22,825		3.42	%			22,051		3.28	%
Taxable-equivalent net interest margin					3.49	%					3.38	%
Taxable-equivalent adjustment			(252)						(196)
Net interest income			$	22,573					$	21,855

NOTES TO ANALYSIS OF NET INTEREST INCOME:
(1)	Yields and interest income on tax-exempt assets have been computed on a taxable-equivalent basis assuming a 21% tax rate.
(2)	Average balances include nonaccrual loans.
(3)	Interest income on loans includes prepayment and late fees, where applicable.

45

For the three months ended March 31, 2022, net interest income on a taxable-equivalent basis increased by $774 thousand to $22.8 million from $22.1 million for the three months ended March 31, 2021. The Company's net interest spread increased by 14 basis points to 3.42% for the three months ended March 31, 2022 compared to the three months ended March 31, 2021.

Taxable-equivalent net interest margin was 3.49% for the three months ended March 31, 2022, which was 11 basis points higher than 3.38% for the three months ended March 31, 2021. The taxable-equivalent yield on interest-earning assets and cost of interest-bearing liabilities both decreased from the three months ended March 31, 2021 to the three months ended March 31, 2022, reflecting a lower interest rate environment and the decrease in time deposit balances. Average loans remained approximately $2.0 billion, during both the three months ended March 31, 2022 and 2021, as the impact of commercial loan growth in three months ended March 31, 2022 was offset by SBA PPP loan forgiveness. Average interest-bearing liabilities declined slightly below $2.0 billion for the 2022 period from the 2021 period due to decreased average balances in time deposits and overnight borrowings.

The yield on loans was 4.39% for the three months ended March 31, 2022 compared to 4.30% for the three months ended March 31, 2021. Taxable-equivalent interest income earned on loans decreased by $145 thousand year-over-year partially due to a decrease in the average balance of loans. The increase in the yield on total loans primarily reflects interest income from SBA PPP loans. This increase is due to accretion and forgiveness of SBA PPP loans recognized as a percent of the lower average balance during the three months ended March 31, 2022 compared to the three months ended March 31, 2021.

SBA PPP loans, net of deferred fees and costs, averaged $155.3 million during the three months ended March 31, 2022 compared to $463.9 million during the three months ended March 31, 2021. This decrease was primarily due to the forgiveness of SBA PPP loans and was partially offset by commercial loan production. The average balance of commercial loans, excluding SBA PPP loans, increased by $295.8 million from $1.1 billion in the three months ended March 31, 2021 to $1.4 billion during the three months ended March 31, 2022. Average consumer loans decreased by $17.2 million from $46.5 million for the three months ended March 31, 2021 to $29.3 million for the three months ended March 31, 2022. Average residential mortgage loans decreased from $232.6 million during the three months ended March 31, 2021 to $195.7 million during the three months ended March 31, 2022 due to lower housing inventory and runoff.

For the three months ended March 31, 2022, interest income on loans includes $3.5 million of interest and net deferred fee income recognized associated with the SBA PPP loans compared to $4.5 million of such interest and fee income for the three months ended March 31, 2021. Net deferred fees on SBA PPP loans were $2.4 million at March 31, 2022, which will be recognized over the remaining life of the loans. Accretion of purchase accounting adjustments included in interest income was $598 thousand and $926 thousand for the three months ended March 31, 2022 and 2021, respectively. The three months ended March 31, 2022 and 2021 included $260 thousand and $416 thousand, respectively, of accelerated accretion related to the payoff of acquired loans.

Interest income on investment securities on a tax-equivalent basis remained at approximately $2.5 million year-over-year, with the taxable equivalent yield decreasing from 2.18% for the three months ended March 31, 2021 to 2.13% for the three months ended March 31, 2022. The five basis point decrease reflected the increased interest rate environment between years impacting our fixed rate securities and certain repositioning within the portfolio under the Company's asset/liability management strategies.

Interest expense on deposits and borrowings decreased by $857 thousand year-over-year, despite an increase in the average balance of interest-bearing deposits of $9.4 million due primarily to continued high levels of excess liquidity in the system, as well as seasonal increases from public fund clients. The cost of interest-bearing liabilities declined 17 basis points from 0.42% for the three months ended March 31, 2021 to 0.25% for the three months ended March 31, 2022 due to the timing of deposit rate reductions in 2021 combined with the continued maturity of higher yielding certificates of deposits and the repayment and maturities of overnight borrowings in the third quarter of 2021.

Provision for Loan Losses

The Company recorded a provision for loan losses of $300 thousand for the three months ended March 31, 2022 compared to negative provision expense of $1.0 million for the same period in 2021. In calculating the provision for loan losses, both quantitative and qualitative factors, including the Company's historical charge-off data and economic and market conditions, were considered. For the three months ended March 31, 2022, the provision for loan losses was driven primarily by an increase in commercial loan production, but was partially offset by the impact of a reduction in qualitative factors to unwind an increase from 2020 applied to the commercial real estate portfolio due to concerns about the economic impact of the COVID-19 pandemic. The negative provision expense recorded in the three months ended March 31, 2021 was due to the release of a portion of the Company's COVID-19 related reserve and a reduction in outstanding loan balances on non-guaranteed loans. Net recoveries in the three months ended March 31, 2022 totaled $28 thousand, compared to net charge-offs of $184 thousand in the comparable prior year period. Nonaccrual loans were 0.28% of gross loans at March 31, 2022,

46

compared with 0.48% of gross loans at March 31, 2021. Nonaccrual loans decreased by $4.4 million from March 31, 2021 to March 31, 2022 and classified loans decreased by $9.0 million to $23.4 million from March 31, 2021 to March 31, 2022. The decrease in non-accrual loans includes the payoff of one loan of $2.6 million and loans returning to accrual status of $591 thousand, with the remaining decrease due to paydowns. The decrease in classified loans reflects upgrades to commercial loans that were previously downgraded due to the impact of the COVID-19 pandemic.

Additional information is included in the "Credit Risk Management" section herein.

Noninterest Income

The following table compares noninterest income for the three months ended March 31, 2022 and 2021:

	Three Months Ended March 31,				$ Change		% Change
	2022		2021		2022-2021		2022-2021
Service charges on deposit accounts	$	920	$	737	$	183	25	%
Interchange income	981		955		26		3	%
Other service charges and fees	153		148		5		3	%
Swap fee income	953		53		900		1,698	%
Trust and investment management income	1,941		1,912		29		2	%
Brokerage income	928		811		117		14	%
Mortgage banking activities	721		2,189		(1,468)		(67)	%
Income from life insurance	566		557		9		2	%
Other income	457		37		420		1,135	%
Investment securities (losses) gains	(146)		145		(291)		(201)	%
Total noninterest income	$	7,474	$	7,544	$	(70)	(1)	%

The following factors contributed to the more significant changes in noninterest income between the three months ended March 31, 2022 and 2021:

•Service charges on deposit accounts increased by $183 thousand due to increased deposit account activity as the economy continued to recover from the COVID-19 pandemic.

•Swap fee income increased by $900 thousand due to increased client interest in locking in rates in the rising interest rate environment.

•Mortgage banking income decreased by $1.5 million due to current market conditions, including low housing inventory and a rising interest rate environment, which caused declines in residential mortgage loan production, the residential mortgage loan pipeline and secondary market sales during the first quarter of 2022, compared to strong refinancing activity in the same period in 2021 that resulted in an increase in the gain on sale margin. These changes resulted in a decrease in the gain on sale of residential mortgage loans of $1.1 million for the three months ended March 31, 2022 compared to the first quarter of 2021. In addition, the Company recorded an MSR valuation reserve reversal of $47 thousand in the three months ended March 31, 2022 compared to $460 thousand in the three months ended March 31, 2021, which was driven by significant market interest rate reductions caused by the COVID-19 pandemic earlier in 2021. Mortgage loans sold totaled $31.9 million in the first quarter of 2022 compared with $57.3 million in the first quarter of 2021.

•Other income increased by $420 thousand due primarily to the gain on sale of an SBA loan of $271 thousand during the three months ended March 31, 2022.

•During the three months ended March 31, 2022, the Company recorded net investment securities losses of $146 thousand due to an OTTI charge of $171 thousand on one non-agency CMO security that is expected to be called by the issuer in the second quarter of 2022 due to an anticipated default caused by increased prepayment speeds on underlying collateral. The impairment charge was partially offset by a gain of $25 thousand, primarily from the partial sale of $3.1 million of one municipal security. During the three months ended March 31, 2021, the Company sold 14 securities with a principal balance of $75.6 million for a gain of $128 thousand.

•Other line items within noninterest income showed fluctuations between 2022 and 2021 attributable to normal business operations.

47

Noninterest Expenses

The following table compares noninterest expenses for the three months ended March 31, 2022 and 2021:

	Three Months Ended March 31,				$ Change		% Change
	2022		2021		2022-2021		2022-2021
Salaries and employee benefits	$	11,337	$	10,197	$	1,140	11.2	%
Occupancy	1,288		1,240		48		3.9	%
Furniture and equipment	1,279		1,278		1		0.1	%
Data processing	1,053		1,019		34		3.3	%
Automated teller machine and interchange fees	305		249		56		22.5	%
Advertising and bank promotions	355		425		(70)		(16.5)	%
FDIC insurance	283		194		89		45.9	%
Professional services	808		721		87		12.1	%
Directors' compensation	231		234		(3)		(1.3)	%
Taxes other than income	564		451		113		25.1	%
Intangible asset amortization	292		334		(42)		(12.6)	%
Other operating expenses	1,569		1,441		128		8.9	%
Total noninterest expenses	$	19,364	$	17,783	$	1,581	8.9	%

The following factors contributed to the more significant changes in noninterest expenses between the three months ended March 31, 2022 and 2021:

•Salaries and employee benefits expense increased by $1.1 million due primarily to additions to staff to maintain a strong growth trajectory.

•Automated teller machine and interchange fees increased by $56 thousand due to primarily to an increase in card processing rates from a third party vendor.

•FDIC insurance expense increased by $89 thousand due to an increase in the assessment rate driven by commercial loan growth.

•Professional services increased by $87 thousand due to an increase in compliance and technology consulting during the first quarter of 2022 compared to the same period of 2021, partially offset by increased legal costs incurred in the three months ended March 31, 2021 in connection with the SEPTA litigation.

•Taxes other than income increased by $113 thousand due to the increase in the Pennsylvania Bank Shares Tax expense, which is based on the Bank's total equity balance, and an increase in state personal property taxes for the three months ended March 31, 2022 compared to the three months ended March 31, 2021.

•Other operating expenses increased by $128 thousand primarily due to an increase in loan-related costs of $186 thousand from commercial loan production, increases of $83 thousand in employee-related costs and $53 thousand in postage, printing and supplies as employees returned from the work-from-home environment resulting from the COVID-19 pandemic and travel increased as the economy and businesses recover. These increases were partially offset by a reduction in the reserve for unfunded commitments of $238 thousand from $266 thousand during the three months ended March 31, 2021 to $28 thousand for the three months ended March 31, 2022. The reserve for unfunded commitments during the three months ended March 31, 2021 was elevated due to the COVID-19 pandemic.

•Other line items within noninterest expenses showed fluctuations between 2022 and 2021 attributable to normal business operations.

48

Income Tax Expense

Income tax expense totaled $2.0 million, an effective tax rate of 19.4%, for the three months ended March 31, 2022 compared with $2.4 million, an effective tax rate of 19.1%, for the three months ended March 31, 2021. The Company’s effective tax rate is less than the 21% federal statutory rate, principally due to tax-free income, which includes interest income on tax-free loans and investment securities and income from life insurance policies, federal income tax credits, and the impact of non-tax deductible expenses. The increase in the effective tax rate from the three months ended March 31, 2021 to the three months ended March 31, 2022 was due partially due to lower estimated federal tax credits for the 2022 fiscal year and a lower pre-tax income projection in the 2021.

FINANCIAL CONDITION

Management devotes substantial time to overseeing the investment of funds in loans and investment securities and the formulation of policies directed toward the profitability and management of the risks associated with these investments.

Investment Securities

The Company utilizes investment securities to manage interest rate risk, to enhance income through interest and dividend income, to provide liquidity and to provide collateral for certain deposits and borrowings. At March 31, 2022, AFS securities totaled $529.7 million, an increase of $57.3 million, from $472.4 million at December 31, 2021. During the three months ended March 31, 2022, the Company purchased $62.9 million and $32.0 million of municipal securities and agency MBS and partially sold $3.1 million of a municipal security for a gain of $22 thousand. During the first quarter of 2022, the Company recorded an OTTI charge of $171 thousand on one $14.7 million par value non-agency CMO, which is expected to be called by the issuer in the second quarter of 2022 due to an anticipated default. The balance of investment securities included net unrealized losses of $18.6 million at March 31, 2022 compared to net unrealized gains of $5.6 million at December 31, 2021 due to market interest rate increases.

49

The following table summarizes the credit ratings and collateral associated with the Company's investment portfolio, excluding equity securities, at March 31, 2022:

Sector	Portfolio Mix		Amortized Book		Fair Value		Credit Enhancement		AAA		AA		A		BBB		NR		Collateral Type
Unsecured ABS	1	%	$	6,548	$	6,549	33	%	—	%	—	%	—	%	—	%	100	%	Unsecured Consumer Debt
Student Loan ABS	1		8,228		8,124		26		—		—		—		—		100		Seasoned Student Loans
Federal Family Education Loan ABS	18		97,140		95,572		6		85		15		—		—		—		Federal Family Education Loan (1)
PACE Loan ABS	1		3,350		3,267		5		100		—		—		—		—		PACE Loans
Non-Agency RMBS	5		25,135		22,303		31		44		—		—		—		56		Reverse Mortgages (2)
Municipal - General Obligation	20		112,387		109,100				6		88		6		—		—
Municipal - Revenue	24		132,534		128,460				—		83		12		—		5
SBA ReRemic	1		7,237		7,157				—		100		—		—		—		SBA Guarantee (3)
Agency MBS	25		135,262		130,257				—		100		—		—		—		Residential Mortgages (3)
U.S. Treasury securities	4		20,081		18,538				—		100		—		—		—
Bank CDs	—		249		249				—		—		—		—		100		FDIC Insured CD
	100	%	$	548,151	$	529,576			19	%	70	%	4	%	—	%	7	%
(1) Minimum of 18% guaranteed by U.S. government
(2) Reverse mortgages fund over time, credit enhancement is estimated based on prior experience
(3) 74% guaranteed by U.S. government agencies
Note : Ratings in table are the lowest of the six rating agencies (Standard & Poor's, Moody's, Morningstar, DBRS, KBRA and Fitch). Standard & Poor's rates U.S. government obligations at AA+

Loan Portfolio

The Company offers a variety of products to meet the credit needs of its borrowers, principally commercial real estate loans, commercial and industrial loans, retail loans secured by residential properties, and to a lesser extent, installment loans. No loans are extended to non-domestic borrowers or governments.

The risks associated with lending activities differ among loan classes and are subject to the impact of changes in interest rates, market conditions of collateral securing the loans and general economic conditions. Any of these factors may adversely impact a borrower’s ability to repay loans, and also impact the associated collateral. See Note 3, Loans and Allowance for Loan Losses, to the unaudited condensed consolidated financial statements under Part I, Item 1, "Financial Information," for a description of the Company’s loan classes and differing levels of associated credit risk.

50

The following table presents the loan portfolio, excluding residential LHFS, by segment and class at March 31, 2022 and December 31, 2021:

	March 31, 2022		December 31, 2021
Commercial real estate:
Owner occupied	$	256,526	$	238,668
Non-owner occupied	558,999		551,783
Multi-family	93,158		93,255
Non-owner occupied residential	102,269		106,112
Acquisition and development:
1-4 family residential construction	15,115		12,279
Commercial and land development	105,204		93,925
Commercial and industrial (1)	443,170		485,728
Municipal	14,626		14,989
Residential mortgage:
First lien	203,231		198,831
Home equity - term	5,820		6,081
Home equity - lines of credit	164,818		160,705
Installment and other loans	15,371		17,630
	$	1,978,307	$	1,979,986

(1) This balance includes $122.5 million and $189.9 million of SBA PPP loans at March 31, 2022 and December 31, 2021, respectively.

Total loans declined by $1.7 million from December 31, 2021 to March 31, 2022. This decrease is due to SBA PPP loan forgiveness of $67.4 million and a decrease of $2.3 million in installment and other loan portfolios due to payoffs, offset by commercial loan production, excluding SBA PPP loans, of $59.7 million, and increases in residential mortgage loans and home equity lines of credit of $4.4 million and $4.1 million, respectively, during the three months ended March 31, 2022. Overall loan growth, excluding SBA PPP loans, was 4% for the three months ended March 31, 2022.

Asset Quality

Risk Elements

The Company’s loan portfolio is subject to varying degrees of credit risk. Credit risk is managed through the Company's underwriting standards, on-going credit reviews, and monitoring of asset quality measures. Additionally, loan portfolio diversification, which limits exposure to a single industry or borrower, and collateral requirements also mitigate the Company's risk of credit loss.

The loan portfolio consists principally of loans to borrowers in south central Pennsylvania and the greater Baltimore, Maryland region. As the majority of loans are concentrated in these geographic regions, a substantial portion of the borrowers' ability to honor their obligations may be affected by the level of economic activity in the market areas.

Nonperforming assets include nonaccrual loans and foreclosed real estate. In addition, restructured loans still accruing and loans past due 90 days or more and still accruing are also deemed to be risk assets. For all loan classes, the accrual of interest income generally ceases when principal or interest is past due 90 days or more and collateral is inadequate to cover principal and interest or immediately if, in the opinion of management, full collection is unlikely. Interest will continue to accrue on loans past due 90 days or more if the collateral is adequate to cover principal and interest, and the loan is in the process of collection. Interest accrued, but not collected, as of the date of placement on nonaccrual status, is generally reversed and charged against interest income, unless fully collateralized. Subsequent payments received are either applied to the outstanding principal balance or recorded as interest income, depending on management’s assessment of the ultimate collectability of principal. Loans are returned to accrual status, for all loan classes, when all the principal and interest amounts contractually due are brought current, the loans have performed in accordance with the contractual terms of the note for a reasonable period of time, generally six months, and the ultimate collectability of the total contractual principal and interest is reasonably assured. Past due status is based on contract terms of the loan.

Loans, the terms of which are modified, are classified as TDRs if a concession was granted for legal or economic reasons related to a borrower’s financial difficulties. Concessions granted under a TDR typically involve a temporary deferral of scheduled loan payments, an extension of a loan’s stated maturity date, temporary reduction in interest rates, or below market

51

rates. If a modification occurs while the loan is on accruing status, it will continue to accrue interest under the modified terms. Nonaccrual TDRs are restored to accrual status if scheduled principal and interest payments, under the modified terms, are current for six months after modification, and the borrower continues to demonstrate its ability to meet the modified terms. TDRs are evaluated individually for impairment if they have been restructured during the most recent calendar year, or if they are not performing according to their modified terms.

The following table presents the Company’s total nonperforming and other risk assets, including the aggregate balances of nonaccrual loans, restructured loans still accruing, loans past due 90 days or more, and OREO as of March 31, 2022 and December 31, 2021. Loans 30-89 days past due and relevant asset quality ratios as of March 31, 2022 and December 31, 2021 are also presented.

	March 31, 2022			December 31, 2021
Nonaccrual loans	$	5,510		$	6,449
OREO	—			—
Total nonperforming assets	5,510			6,449
Restructured loans still accruing	575			804
Loans past due 90 days or more and still accruing	238			1,201
Total nonperforming and other risk assets (total risk assets)	$	6,323		$	8,454
Loans 30-89 days past due	$	4,953		$	5,925
Asset quality ratios:
Total nonperforming loans to total loans	0.28		%	0.33		%
Total nonperforming assets to total assets	0.19		%	0.23		%
Total nonperforming assets to total loans and OREO	0.28		%	0.33		%
Total risk assets to total loans and OREO	0.32		%	0.43		%
Total risk assets to total assets	0.22		%	0.30		%
ALL to total loans	1.09		%	1.07		%
ALL to nonperforming loans	390.34		%	328.42		%
ALL to nonperforming loans and restructured loans still accruing	353.46		%	292.02		%

Total nonperforming and other risk assets decreased by $2.1 million, or 25%, from December 31, 2021 to March 31, 2022. There was a reduction of $939 thousand in non-accrual loans from December 31, 2021 to March 31, 2022 due to $591 thousand of loans returning to accrual status and payoffs of $376 thousand. Loans past 90 days and still accruing decreased by $963 thousand from December 31, 2021 to March 31, 2022 due to the collection on a loan guaranteed by the SBA.

The following table presents detail of impaired loans at March 31, 2022 and December 31, 2021:

	March 31, 2022						December 31, 2021
	Nonaccrual Loans		Restructured Loans Still Accruing		Total		Nonaccrual Loans		Restructured Loans Still Accruing		Total
Commercial real estate:
Owner occupied	$	3,062	$	—	$	3,062	$	3,763	$	—	$	3,763
Non-owner occupied residential	100		—		100		122		—		122
Commercial and industrial	161		—		161		250		—		250
Residential mortgage:
First lien	1,703		575		2,278		1,831		804		2,635
Home equity - term	6		—		6		7		—		7
Home equity - lines of credit	426		—		426		436		—		436
Installment and other loans	52		—		52		40		—		40
	$	5,510	$	575	$	6,085	$	6,449	$	804	$	7,253

52

The following table presents our exposure to relationships with an impaired balance, which excludes accruing PCI loans, and the partial charge-offs taken to date and specific reserves established on those relationships at March 31, 2022 and December 31, 2021. Of the relationships deemed to be impaired at March 31, 2022, one had a recorded balance in excess of $1.0 million, and 59 relationships, which represents 49% of total impaired loans, had recorded balances of less than $250 thousand.

	# of Relationships	Recorded Investment		Partial Charge-offs to Date		Specific Reserves
March 31, 2022
Relationships greater than $1,000,000	1	$	2,492	$	—	$	—
Relationships greater than $500,000 but less than $1,000,000	—	—		—		—
Relationships greater than $250,000 but less than $500,000	2	595		—		—
Relationships less than $250,000	59	2,998		280		29
	62	$	6,085	$	280	$	29
December 31, 2021
Relationships greater than $1,000,000	1	$	2,535	$	—	$	—
Relationships greater than $500,000 but less than $1,000,000	1	602		17		—
Relationships greater than $250,000 but less than $500,000	2	601		—		—
Relationships less than $250,000	63	3,515		303		28
	67	$	7,253	$	320	$	28

The Company takes partial charge-offs on collateral-dependent loans when carrying value exceeds estimated fair value, as determined by the most recent appraisal adjusted for current (within the quarter) conditions, less costs to dispose. Impairment reserves remain in place if updated appraisals are pending, and represent management’s estimate of potential loss.

Internal loan reviews are completed annually on all commercial relationships with a committed loan balance in excess of $1.0 million, which includes confirmation of risk rating by an independent credit officer. In addition, all commercial relationships greater than $500 thousand rated Substandard, Doubtful or Loss are reviewed and corresponding risk ratings are reaffirmed by the Bank's Problem Loan Committee, with subsequent reporting to the Management ERM Committee.

In its individual loan impairment analysis, the Company determines the extent of any full or partial charge-offs that may be required, or any reserves that may be needed. The determination of the Company’s charge-offs or impairment reserve include an evaluation of the outstanding loan balance and the related collateral securing the credit. Through a combination of collateral securing the loans and partial charge-offs taken to date, the Company believes that it has adequately provided for the potential losses that it may incur on these relationships at March 31, 2022. However, over time, additional information may result in increased reserve allocations or, alternatively, it may be deemed that the reserve allocations exceed those that are needed.

In an effort to assist clients that were negatively impacted by the COVID-19 pandemic, the Bank offered various mitigation options, including a loan payment deferral program. Under this program, most commercial deferrals were for a 90-day period, while most consumer deferrals were for a 180-day period. In accordance with the revised Interagency Statement on Loan Modifications by Financial Institutions Working with Customers Affected by the Coronavirus issued on April 7, 2020, these deferrals are exempt from TDR status as they meet the specified requirements. At March 31, 2022 and December 31, 2021, the remaining loan deferral balances were inconsequential.

53

Credit Risk Management

Allowance for Loan Losses

The Company maintains the ALL at a level deemed adequate by management for probable incurred credit losses. The ALL is established and maintained through a provision for loan losses, which is charged to earnings. On a quarterly basis, management assesses the adequacy of the ALL using a defined methodology which considers specific credit evaluation of impaired loans, historical loss experience and qualitative factors. Management addresses the requirements for loans individually identified as impaired, loans collectively evaluated for impairment, and other bank regulatory guidance in its assessment.

The ALL is evaluated based on review of the collectability of loans in light of historical experience; the nature and volume of the loan portfolio; adverse situations that may affect a borrower’s ability to repay; estimated value of any underlying collateral; and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as more information becomes available. A description of the methodology for establishing the allowance and provision for loan losses and related procedures in establishing the appropriate level of reserve is included in Note 3, Loans and Allowance for Loan Losses, to the unaudited condensed consolidated financial statements under Part I, Item 1, "Financial Information."

54

The following table summarizes the Company’s internal risk ratings at March 31, 2022 and December 31, 2021:

	Pass		Special Mention		Non-Impaired Substandard		Impaired - Substandard		Doubtful		PCI Loans		Total
March 31, 2022
Commercial real estate:
Owner occupied	$	242,529	$	6,360	$	2,277	$	3,062	$	—	$	2,298	$	256,526
Non-owner occupied	537,505		18,771		2,419		—		—		304		558,999
Multi-family	84,541		8,158		459		—		—		—		93,158
Non-owner occupied residential	99,545		1,005		1,014		100		—		605		102,269
Acquisition and development:
1-4 family residential construction	15,115		—		—		—		—		—		15,115
Commercial and land development	103,486		1,236		482		—		—		—		105,204
Commercial and industrial	424,425		7,642		8,792		161		—		2,150		443,170
Municipal	14,626		—		—		—		—		—		14,626
Residential mortgage:
First lien	196,217		—		221		2,278		—		4,515		203,231
Home equity - term	5,798		—		—		6		—		16		5,820
Home equity - lines of credit	164,327		19		46		426		—		—		164,818
Installment and other loans	15,314		—		—		52		—		5		15,371
	$	1,903,428	$	43,191	$	15,710	$	6,085	$	—	$	9,893	$	1,978,307
December 31, 2021
Commercial real estate:
Owner occupied	$	219,250	$	7,239	$	6,087	$	3,763	$	—	$	2,329	$	238,668
Non-owner occupied	528,010		23,297		166		—		—		310		551,783
Multi-family	84,414		8,238		603		—		—		—		93,255
Non-owner occupied residential	102,588		1,065		1,153		122		—		1,184		106,112
Acquisition and development:
1-4 family residential construction	12,279		—		—		—		—		—		12,279
Commercial and land development	92,049		1,385		491		—		—		—		93,925
Commercial and industrial	470,579		7,917		4,720		250		—		2,262		485,728
Municipal	14,989		—		—		—		—		—		14,989
Residential mortgage:
First lien	191,386		—		225		2,635		—		4,585		198,831
Home equity - term	6,058		—		—		7		—		16		6,081
Home equity - lines of credit	160,203		20		46		436		—		—		160,705
Installment and other loans	17,584		—		—		40		—		6		17,630
	$	1,899,389	$	49,161	$	13,491	$	7,253	$	—	$	10,692	$	1,979,986

Potential problem loans are defined as performing loans which have characteristics that cause management concern over the ability of the borrower to perform under present loan repayment terms and which may result in the reporting of these loans as nonperforming loans in the future. Generally, management feels that Substandard loans that are currently performing and not

55

considered impaired result in some doubt as to the borrower’s ability to continue to perform under the terms of the loan, and represent potential problem loans. Non-impaired Substandard loans totaled $15.7 million at March 31, 2022.

Additionally, the Special Mention classification is intended to be a temporary classification reflective of loans that have potential weaknesses that may, if not monitored or corrected, weaken the asset or inadequately protect the Company’s position at some future date. Special Mention loans represent an elevated risk, but their weakness does not yet justify a more severe, or classified, rating. These loans require inquiry by lenders on the cause of the potential weakness and, once analyzed, the loan classification may be downgraded to Substandard or, alternatively, could be upgraded to Pass. Special Mention loans decreased by $6.0 million from December 31, 2021 to March 31, 2022 due to continued improvements in economic conditions resulting in upgrades to commercial loans that were previously downgraded due to the impact of the COVID-19 pandemic.

The following table summarizes activity in the ALL for the three months ended March 31, 2022 and 2021:

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
Three Months Ended
March 31, 2022
Balance, beginning of period	$	12,037	$	2,062	$	3,814	$	30	$	17,943	$	2,785	$	215	$	3,000	$	237	$	21,180
Provision for loan losses	(523)		258		500		(1)		234		72		(6)		66		—		300
Charge-offs	—		—		(61)		—		(61)		(10)		(13)		(23)		—		(84)
Recoveries	32		1		48		—		81		26		5		31		—		112
Balance, end of period	$	11,546	$	2,321	$	4,301	$	29	$	18,197	$	2,873	$	201	$	3,074	$	237	$	21,508
March 31, 2021
Balance, beginning of period	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151
Provision for loan losses	(494)		(69)		(54)		(2)		(619)		(289)		(106)		(395)		14		(1,000)
Charge-offs	—		—		(454)		—		(454)		(21)		(20)		(41)		—		(495)
Recoveries	14		1		280		—		295		6		10		16		—		311
Balance, end of period	$	10,671	$	1,046	$	3,714	$	38	$	15,469	$	3,058	$	208	$	3,266	$	232	$	18,967

The ALL totaled $21.5 million at March 31, 2022, an increase of $328 thousand from December 31, 2021, resulting from a provision for loan losses of $300 thousand and net recoveries of $28 thousand during the three months ended March 31, 2022. At March 31, 2022, the ALL is higher as a percentage of the total loan portfolio at 1.09% compared to 1.07% at March 31, 2021. The ALL increased in the three months ended March 31, 2022 primarily as a result of commercial loan production; however, this was partially offset by the impact of a reduction in qualitative factors to unwind an increase from 2020 applied to the commercial real estate portfolio due to concerns about the economic impact of the COVID-19 pandemic. Excluding SBA loans, which are 100% guaranteed, the ALL to total loans remained at 1.2% at both March 31, 2022 and December 31, 2021. Despite generally favorable historical charge-off data, the impact of current economic conditions may result in the need for additional provisions for loan losses in future quarters.

Classified loans totaled $23.4 million at March 31, 2022, or 1.2% of total loans outstanding, reflecting an increase from $23.1 million, or also 1.2% of loans outstanding, at December 31, 2021. The asset quality ratios previously noted are indicative of the continued benefit the Company has received from favorable historical charge-off statistics and generally stable economic and market conditions for the last few years, even while the commercial loan portfolio has been growing.

56

The following table summarizes the ending loan balances individually or collectively evaluated for impairment based on loan type, as well as the ALL allocation for each, at March 31, 2022 and December 31, 2021, including PCI loans:

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
March 31, 2022
Loans allocated by:
Individually evaluated for impairment	$	3,162	$	—	$	161	$	—	$	3,323	$	2,710	$	52	$	2,762	$	—	$	6,085
Collectively evaluated for impairment	1,007,790		120,319		443,009		14,626		1,585,744		371,159		15,319		386,478		—		1,972,222
	$	1,010,952	$	120,319	$	443,170	$	14,626	$	1,589,067	$	373,869	$	15,371	$	389,240	$	—	$	1,978,307
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	29	$	—	$	29	$	—	$	29
Collectively evaluated for impairment	11,546		2,321		4,301		29		18,197		2,844		201		3,045		237		21,479
	$	11,546	$	2,321	$	4,301	$	29	$	18,197	$	2,873	$	201	$	3,074	$	237	$	21,508
December 31, 2021
Loans allocated by:
Individually evaluated for impairment	$	3,885	$	—	$	250	$	—	$	4,135	$	3,078	$	40	$	3,118	$	—	$	7,253
Collectively evaluated for impairment	985,933		106,204		485,478		14,989		1,592,604		362,539		17,590		380,129		—		1,972,733
	$	989,818	$	106,204	$	485,728	$	14,989	$	1,596,739	$	365,617	$	17,630	$	383,247	$	—	$	1,979,986
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	28	$	—	$	28	$	—	$	28
Collectively evaluated for impairment	12,037		2,062		3,814		30		17,943		2,757		215		2,972		237		21,152
	$	12,037	$	2,062	$	3,814	$	30	$	17,943	$	2,785	$	215	$	3,000	$	237	$	21,180

In addition to the specific reserve allocations on impaired loans noted previously, eight loans, with aggregate outstanding principal balances of $413 thousand, have had cumulative partial charge-offs to the ALL totaling $280 thousand at March 31, 2022. As updated appraisals are received on collateral-dependent loans, partial charge-offs are taken to the extent the loans’ principal balance exceeds their fair value.

Management believes the allocation of the ALL among the various loan classes adequately reflects the probable incurred credit losses in each portfolio and is based on the methodology outlined in Note 3, Loans and Allowance for Loan Losses, to the Consolidated Financial Statements under Part I, Item 1, "Financial Information." Management re-evaluates and makes enhancements to its reserve methodology to better reflect the risks inherent in the different segments of the portfolio, particularly in light of increased charge-offs, with noticeable differences between the different loan classes. Management believes these enhancements to the ALL methodology improve the accuracy of quantifying probable incurred credit losses inherent in the portfolio. Management charges actual loan losses to the reserve and bases the provision for loan losses on its overall analysis.

The unallocated portion of the ALL reflects estimated inherent losses within the portfolio that have not been detected, as well as the risk of error in the specific and general reserve allocation, other potential exposure in the loan portfolio, variances in management’s assessment of national and local economic conditions and other factors management believes appropriate at the time. The unallocated portion of the ALL was 1.1% of the ALL balance at both March 31, 2022 and December 31, 2021. The Company monitors the unallocated portion of the ALL and, by policy, has determined it should not exceed 3% of the total reserve. Future negative provisions for loan losses may result if the unallocated portion was to increase, and management determined the reserves were not required for the anticipated risk in the portfolio.

57

Management believes the Company’s ALL is adequate based on currently available information. Future adjustments to the ALL and enhancements to the methodology may be necessary due to changes in economic conditions, regulatory guidance, or management’s assumptions as to future delinquencies or loss rates.

Deposits

Deposits grew by $81.1 million, or 3%, but remained at approximately $2.5 billion at both March 31, 2022 and December 31, 2021.

Noninterest-bearing deposits increased by $4.5 million, or 1%, to $557.8 million, from December 31, 2021 to March 31, 2022. Interest-bearing deposits totaled $2.0 billion at March 31, 2022, an increase of $76.5 million, or 4%, from the $1.9 billion balance at December 31, 2021, despite a decrease in time deposits, due to maturities, of $14.6 million, or 5%.

Deposit growth in the first three months of 2022 was principally due to continued high levels of excess liquidity in the system as well as seasonal increases from public fund clients.

Shareholders' Equity, Capital Adequacy and Regulatory Matters

Capital management in a regulated financial services industry must properly balance return on equity to its shareholders while maintaining sufficient levels of capital and related risk-based regulatory capital ratios to satisfy statutory regulatory requirements. The Company’s capital management strategies have been developed to provide attractive rates of returns to its shareholders, while maintaining a “well capitalized” position of regulatory strength.

Shareholders’ equity totaled $254.8 million at March 31, 2022, a decrease of $16.9 million, or 6%, from $271.7 million at December 31, 2021. The decrease was primarily attributable to other comprehensive losses of $19.1 million due to an increase in unrealized losses on available-for-sale securities caused by a substantial increase in market interest rates, as well as dividends paid of $2.1 million and shared-based compensation costs, inclusive of common share repurchases, of $4.0 million, partially offset by net income of $8.4 million.

The Company routinely evaluates its capital levels in light of its risk profile to assess its capital needs. The Company and the Bank are subject to various regulatory capital requirements administered by federal and state banking agencies. The consolidated asset limit on small bank holding companies is $3.0 billion and a company with assets under that limit is not subject to the FRB consolidated capital rules, but may file reports that include capital amounts and ratios. The Company has elected to file those reports.

At March 31, 2022 and December 31, 2021, the Bank was considered well capitalized under applicable banking regulations. Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Bank must meet specific guidelines that involve quantitative measures of assets, liabilities and certain off-balance sheet items as calculated under regulatory accounting practices. Prompt corrective action provisions are not applicable to bank holding companies, including financial holding companies.

Note 8, Shareholders' Equity and Regulatory Capital, to the Notes to Unaudited Condensed Consolidated Financial Statements under Part I, Item 1, "Financial Information," includes a table presenting capital amounts and ratios for the Company and the Bank at March 31, 2022 and December 31, 2021.

In addition to the minimum capital ratio requirement and minimum capital ratio to be well capitalized presented in the referenced table in Note 8, the Bank must maintain a capital conservation buffer as more fully described in the Company's Annual Report on Form 10-K for the year ended December 31, 2021, Item 1 - Business, under the topic Basel III Capital Rules. At March 31, 2022, the Bank's capital conservation buffer, based on the most restrictive Total Capital to risk weighted assets capital ratio, was 5.8%, which is greater than the 2.5% requirement.

58

Liquidity

The primary function of asset/liability management is to ensure adequate liquidity and manage the Company’s sensitivity to changing interest rates. Liquidity management involves the ability to meet the cash flow requirements of clients who may be either depositors wanting to withdraw funds or borrowers needing assurance that sufficient funds will be available to meet their credit needs. The Company's primary sources of funds consist of deposit inflows, loan repayments, maturities and sales of investment securities, the sale of mortgage loans and borrowings from the FHLB of Pittsburgh. While maturities and scheduled amortization of loans and investment securities are predictable sources of funds, deposit flows and mortgage prepayments are greatly influenced by general interest rates, economic conditions and competition. The maximum borrowing capacity from the FHLB is $914.0 million at March 31, 2022.

The Company regularly adjusts its investments in liquid assets based upon our assessment of expected loan demand, expected deposit flows, yields available on interest-earning deposits and investment securities and the objectives of our asset/liability management policy. Unencumbered investment securities totaled $238.8 million at March 31, 2022. At March 31, 2022, the Company had $18.0 million of investment securities pledged at the FRB Discount Window, with no associated borrowings outstanding.

Supplemental Reporting of Non-GAAP Measures

As a result of acquisitions, the Company had intangible assets consisting of goodwill and core deposit and other intangible assets totaling $22.6 million and $22.9 million at March 31, 2022 and December 31, 2021, respectively.

Management believes providing certain “non-GAAP” financial information will assist investors in their understanding of the effect of acquisition activity on reported results, particularly to overcome comparability issues related to the influence of intangibles (principally goodwill) created in acquisitions. Management also believes providing certain other "non-GAAP" financial information will provide investors with clarity on its ALL to total loans ratios. The Company believes that excluding SBA-guaranteed loans, due to their credit enhancement, from loans held for investment is useful due to the size and effect on the total and ratio.

Tangible book value per share and the ALL to non-SBA guarantee loans, as used by the Company in this supplemental reporting presentation, are determined by methods other than in accordance with GAAP. While we believe this information is a useful supplement to GAAP-based measures presented in this Form 10-Q, readers are cautioned that this non-GAAP disclosure has limitations as an analytical tool, should not be viewed as a substitute for financial measures determined in accordance with GAAP, and should not be considered in isolation or as a substitute for analysis of our results and financial condition as reported under GAAP, nor are such measures necessarily comparable to non-GAAP performance measures that may be presented by other companies. This supplemental presentation should not be construed as an inference that our future results will be unaffected by similar adjustments to be determined in accordance with GAAP. The decrease in tangible book value per share (non-GAAP) from December 31, 2021 to March 31, 2022 is primarily due to an increase in other comprehensive losses, net of taxes, of $19.1 million due to higher unrealized losses on available-for-sale securities.

The following table presents the computation of each non-GAAP based measure shown together with its most directly comparable GAAP based measure.

	March 31, 2022		December 31, 2021
Tangible Book Value per Common Share
Shareholders' equity	$	254,804	$	271,656
Less: Goodwill	18,724		18,724
Other intangible assets	3,891		4,183
Related tax effect	(817)		(878)
Tangible common equity (non-GAAP)	$	233,006	$	249,627
Common shares outstanding	11,079		11,183
Book value per share (most directly comparable GAAP based measure)	$	23.00	$	24.29
Intangible assets per share	1.97		1.97
Tangible book value per share (non-GAAP)	$	21.03	$	22.32

59

	March 31, 2022			December 31, 2021
Allowance for Loan Losses to Non-SBA Guaranteed Loans:
Allowance for loan losses	$	21,508		$	21,180
Gross loans	$	1,978,307		$	1,979,986
less: SBA guaranteed loans	(124,545)			(195,585)
Non-SBA guaranteed loans	$	1,853,762		$	1,784,401
Allowance for loan losses to non-SBA guaranteed loans	1.2		%	1.2		%

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market risk comprises exposure to interest rate risk, foreign currency exchange rate risk, commodity price risk, and other relevant market rate or price risks. In the banking industry, a major risk exposure is changing interest rates. The primary objective of monitoring our interest rate sensitivity, or risk, is to provide management the tools necessary to manage the balance sheet to minimize adverse changes in net interest income as a result of changes in the direction and level of interest rates. FRB monetary control efforts, economic uncertainty and legislative changes have been significant factors affecting the task of managing interest rate sensitivity positions in recent years.

Interest Rate Risk

Interest rate risk is the exposure to fluctuations in the Company’s future earnings (earnings at risk) and value (value at risk) resulting from changes in interest rates. This exposure results from differences between the amounts of interest-earning assets and interest-bearing liabilities that reprice within a specified time period as a result of scheduled maturities, scheduled and unscheduled repayments, the propensity of borrowers and depositors to react to changes in their economic interests, and loan contractual interest rate changes.

We attempt to manage the level of repricing and maturity mismatch through our asset/liability management process so that fluctuations in net interest income are maintained within policy limits across a range of market conditions, while satisfying liquidity and capital requirements. Management recognizes that a certain amount of interest rate risk is inherent, appropriate and necessary to ensure the Company’s profitability. Thus, the goal of interest rate risk management is to evaluate the amount of reward for taking risk and adjusting both the size and composition of the balance sheet relative to the level of reward available for taking risk.

We attempt to manage the level of repricing and maturity mismatch through our asset/liability management process so that fluctuations in net interest income are maintained within policy limits across a range of market conditions, while satisfying liquidity and capital requirements. Management recognizes that a certain amount of interest rate risk is inherent, appropriate and necessary to ensure the Company’s profitability. Thus, the goal of interest rate risk management is to evaluate the amount of reward for taking risk and adjusting both the size and composition of the balance sheet relative to the level of reward available for taking risk.

Management endeavors to control the exposure to changes in interest rates by understanding, reviewing and making decisions based on its risk position. The Company primarily uses its securities portfolio, FHLB advances, interest rate swaps and brokered deposits to manage its interest rate risk position. Additionally, pricing, promotion and product development activities are directed in an effort to emphasize the loan and deposit term or repricing characteristics that best meet current interest rate risk objectives.

We use simulation analysis to assess earnings at risk and net present value analysis to assess value at risk. These methods allow management to regularly monitor both the direction and magnitude of our interest rate risk exposure. These analyses require numerous assumptions including, but not limited to, changes in balance sheet mix, prepayment rates on loans and securities, cash flows and repricing of all financial instruments, changes in volumes and pricing, future shapes of the yield curve, relationship of market interest rates to each other (basis risk), credit spread and deposit sensitivity. Assumptions are based on management’s best estimates but may not accurately reflect actual results under certain changes in interest rate due to the timing, magnitude and frequency of rate changes and changes in market conditions and management strategies, among other factors. However, the analyses are useful in quantifying risk and providing a relative gauge of our interest rate risk position over time.

Our asset/liability committee operates under management policies, approved by the Board of Directors, which define guidelines and limits on the level of risk. The committee meets regularly and reviews our interest rate risk position and monitors various liquidity ratios to ensure a satisfactory liquidity position. By utilizing our analyses, we can determine changes

60

that may need to be made to the asset and liability mixes to mitigate the change in net interest income under various interest rate scenarios. Management continually evaluates the condition of the economy, the pattern of market interest rates and other economic data to inform the committee on the selection of investment securities. Regulatory authorities also monitor our interest rate risk position along with other liquidity ratios.

Net Interest Income Sensitivity

Simulation analysis evaluates the effect of upward and downward changes in market interest rates on future net interest income. The analysis involves changing the interest rates used in determining net interest income over the next twelve months. The resulting percentage change in net interest income in various rate scenarios is an indication of our short-term interest rate risk. The analysis assumes recent pricing trends in new loan and deposit volumes will continue while balances remain constant. Additional assumptions are applied to modify pricing under the various rate scenarios.

The simulation analysis results are presented in the Net Interest Income table below. At March 31, 2022 and December 31, 2021, results indicated the Company would be better positioned over the subsequent 12 months in an increasing rate environment than it would be if interest rates decreased. This is due to the composition of the balance sheet between fixed- and floating-rate assets, and liabilities that will reprice more rapidly as deposits migrate from certificates of deposit to non-maturity deposits. The Company has become more asset sensitive due to the increase in liquidity and overall size of the balance sheet size and mix, specifically through non-maturity deposits. As such, an increase in interest rates would benefit the Company.

Economic Value

Net present value analysis provides information on the risk inherent in the balance sheet that might not be considered in the simulation analysis due to the short time horizon used in that analysis. The net present value of the balance sheet incorporates the discounted present value of expected asset cash flows minus the discounted present value of expected liability cash flows. The analysis involves changing the interest rates used in determining the expected cash flows and in discounting the cash flows. The resulting percentage change in net present value in various rate scenarios is an indication of the longer term repricing risk and options embedded in the balance sheet.

At March 31, 2022, similar to December 31, 2021, the results indicate the Company is asset sensitive and would benefit in a rising interest rate environment more than it would be if interest rates decreased. The results at March 31, 2022 are still driven by the impact of the low interest rate environment, the composition of the balance sheet and the duration of assets. To improve the comparability across periods, the Company follows best practices related to the assumption setting and maintains the size and mix of the period end balance sheet; thus, the results do not reflect actions management may take through the normal course of business that would impact results.

Net Interest Income					Economic Value
	% Change in Net Interest Income					% Change in Market Value
Change in Market Interest Rates (basis points)	March 31, 2022		December 31, 2021		Change in Market Interest Rates (basis points)	March 31, 2022		December 31, 2021
(100)	(6.0)	%	(1.4)	%	(100)	(24.3)	%	(43.8)	%
100	3.3	%	3.7	%	100	14.4	%	25.8	%
200	4.9	%	6.7	%	200	21.3	%	41.2	%
300	3.7	%	6.7	%	300	23.9	%	49.3	%

Item 4. Controls and Procedures

Based on the evaluation required by Securities Exchange Act Rules 13a-15(b) and 15d-15(b), the Company's management, including the Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of its disclosure controls and procedures, as defined in Securities Exchange Act Rules 13a-15(e) and 15d-15(e), at March 31, 2022. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective at March 31, 2022. There have been no changes in internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting during the three months ended March 31, 2022.

61

PART II – OTHER INFORMATION

Item 1 – Legal Proceedings

Information regarding legal proceedings is included in Note 12, Contingencies, to the Consolidated Financial Statements under Part I, Item 1, "Financial Statements" and incorporated herein by reference.

Item 1A – Risk Factors

There have been no material changes from the risk factors as disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021.

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

	(a)	(b)		(c)	(d)
Period	Total number of shares (or units) purchased	Average price paid per share (or unit)		Total number of shares (or units) purchased as part of publicly announced plans or programs	Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs
January 1, 2022 to January 31, 2022	30,250	$	24.84	30,250	713,580
February 1, 2022 to February 28, 2022	68,961	24.65		68,961	644,619
March 1, 2022 to March 31, 2022	82,424	23.76		82,424	562,195
Total	181,635	$	24.27	181,635

In September 2015, the Board of Directors of the Company authorized a share repurchase program under which the Company may repurchase up to 5% of the Company's outstanding shares of common stock, or approximately 416,000 shares, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act. On April 19, 2021, the Board of Directors authorized the additional future repurchase of up to 562,000 shares of its outstanding common stock. When and if appropriate, repurchases may be made in open market or privately negotiated transactions, depending on market conditions, regulatory requirements and other corporate considerations, as determined by management. Share repurchases may not occur and may be discontinued at any time. For the three months ended March 31, 2022, the Company repurchased 181,635 shares of its common stock at an average price of $24.27 per share. At March 31, 2022, 415,805 shares had been repurchased under the program at a total cost of $8.9 million, or $21.35 per share. Common stock available for future repurchase totals approximately 562,195 shares, or 5% of the Company's outstanding common stock at March 31, 2022.

Item 3 – Defaults Upon Senior Securities

Not applicable.

Item 4 – Mine Safety Disclosures

Not applicable.

Item 5 – Other Information

None.

62

Item 6 – Exhibits

3.1	Articles of Incorporation as amended, incorporated by reference to Exhibit 3.1 of the Registrant’s Report on Form 8-K filed on January 29, 2010.
3.2	By-laws as amended, incorporated by reference to Exhibit 3.2 to the Registrant’s Report on Form 8-K filed June 2, 2021.
4.1	Specimen Common Stock Certificate, incorporated by reference to the Registrant’s Registration Statement on Form S-3 filed February 8, 2010 (File No. 333-164780).
10.1	Amended and Restated Change in Control Agreement between Orrstown Financial Services, Inc., Orrstown Bank and Neelesh Kalani "incorporated by reference to Exhibit 10.1 to the Registrant's Form 8-K filed April 11, 2022."
31.1	Rule 13a – 14(a)/15d-14(a) Certification (Principal Executive Officer)
31.2	Rule 13a – 14(a)/15d-14(a) Certifications (Principal Financial Officer)
32.1	Section 1350 Certifications (Principal Executive Officer)
32.2	Section 1350 Certifications (Principal Financial Officer)
101.LAB	XBRL Taxonomy Extension Label Linkbase
101.PRE	XBRL Taxonomy Extension Presentation Linkbase
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema
101.CAL	XBRL Taxonomy Extension Calculation Linkbase
101.DEF	XBRL Taxonomy Extension Definition Linkbase
104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

All other exhibits for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are not required under the related instructions or are inapplicable and therefore have been omitted.

63

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

/s/ Thomas R. Quinn, Jr.

Thomas R. Quinn, Jr.

President and Chief Executive Officer

(Principal Executive Officer)

/s/ Neelesh Kalani

Neelesh Kalani

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

Date: May 5, 2022

64

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Thomas R. Quinn, Jr., certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Orrstown Financial Services, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 5, 2022	By:	/s/ Thomas R. Quinn, Jr.
		Thomas R. Quinn, Jr.
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Neelesh Kalani, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Orrstown Financial Services, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 5, 2022	By:	/s/ Neelesh Kalani
		Neelesh Kalani
		Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Orrstown Financial Services, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2022 as filed with the Securities and Exchange Commission on the date therein specified (the “Report”), I, Thomas R. Quinn, Jr., President and Chief Executive Officer (Principal Executive Officer) of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: May 5, 2022	By:	/s/ Thomas R. Quinn, Jr.
		Thomas R. Quinn, Jr.
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Orrstown Financial Services, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2022 as filed with the Securities and Exchange Commission on the date therein specified (the “Report”), I, Neelesh Kalani, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: May 5, 2022	By:	/s/ Neelesh Kalani
		Neelesh Kalani
		Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

XML

Cover - shares	3 Months Ended
	Mar. 31, 2022	May 02, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-34292
Entity Registrant Name	ORRSTOWN FINANCIAL SERVICES, INC.
Entity Incorporation, State or Country Code	PA
Entity Tax Identification Number	23-2530374
Entity Address, Address Line One	77 East King Street
Entity Address, Address Line Two	P. O. Box 250
Entity Address, City or Town	Shippensburg
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	17257
City Area Code	(717)
Local Phone Number	532-6114
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	ORRF
Securities Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		11,054,814
Entity Central Index Key	0000826154
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Assets
Cash and due from banks	$ 26,446	$ 21,217
Interest-bearing deposits with banks	187,792	187,493
Cash and cash equivalents	214,238	208,710
Restricted investments in bank stocks	6,791	7,252
Securities available for sale (amortized cost of $548,305 and $466,806 at March 31, 2022 and December 31, 2021, respectively)	529,730	472,438
Loans held for sale, at fair value	7,403	8,868
Loans	1,978,307	1,979,986
Less: Allowance for loan losses	(21,508)	(21,180)
Net loans	1,956,799	1,958,806
Premises and equipment, net	33,704	34,045
Cash surrender value of life insurance	70,622	70,217
Goodwill	18,724	18,724
Other intangible assets, net	3,891	4,183
Accrued interest receivable	8,642	8,234
Other assets	49,993	43,088
Total assets	2,900,537	2,834,565
Deposits:
Noninterest-bearing	557,756	553,238
Interest-bearing	1,988,236	1,911,691
Total deposits	2,545,992	2,464,929
Securities sold under agreements to repurchase	24,624	23,301
FHLB advances and other borrowings	1,788	1,896
Subordinated notes	31,978	31,963
Other liabilities	41,351	40,820
Total liabilities	2,645,733	2,562,909
Shareholders’ Equity
Preferred stock, value	0	0
Common stock, value	585	586
Additional paid - in capital	188,033	189,689
Retained earnings	84,943	78,700
Accumulated other comprehensive (loss) income	(14,674)	4,449
Treasury stock—168,555 and 75,117 shares, at cost at March 31, 2022 and December 31, 2021, respectively	(4,083)	(1,768)
Total shareholders’ equity	254,804	271,656
Total liabilities and shareholders’ equity	$ 2,900,537	$ 2,834,565

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Securities available for sale amortized cost	$ 548,305	$ 466,806
Preferred stock, par value (usd per share)	$ 1.25	$ 1.25
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, stated value (usd per share)	$ 0.05205	$ 0.05205
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	11,247,545	11,258,167
Common stock, shares outstanding (in shares)	11,078,990	11,183,050
Treasury stock - common - shares (in shares)	168,555	75,117

XML

Condensed Consolidated Statements of (Loss) Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Interest income
Loans	$ 21,369	$ 21,511
Investment securities - taxable	1,598	1,879
Investment securities - tax-exempt	722	500
Short-term investments	101	39
Total interest income	23,790	23,929
Interest expense
Deposits	685	1,392
Securities sold under agreements to repurchase	7	9
FHLB advances and other borrowings	22	171
Subordinated notes	503	502
Total interest expense	1,217	2,074
Net interest income	22,573	21,855
Provision for loan losses	300	(1,000)
Net interest income after provision for loan losses	22,273	22,855
Noninterest income
Service charges on deposit accounts	920	737
Interchange income	981	955
Other service charges and fees	153	148
Swap fee income	953	53
Trust and investment management income	1,941	1,912
Brokerage income	928	811
Mortgage banking activities	721	2,189
Income from life insurance	566	557
Investment securities (losses) gains	(146)	145
Other income	457	37
Total noninterest income	7,474	7,544
Noninterest expenses
Salaries and employee benefits	11,337	10,197
Occupancy	1,288	1,240
Furniture and equipment	1,279	1,278
Data processing	1,053	1,019
Automated teller and interchange fees	305	249
Advertising and bank promotions	355	425
FDIC insurance	283	194
Professional services	808	721
Directors' compensation	231	234
Taxes other than income	564	451
Intangible asset amortization	292	334
Other operating expenses	1,569	1,441
Total noninterest expenses	19,364	17,783
Income before income tax expense	10,383	12,616
Income tax expense	2,015	2,409
Net income	$ 8,368	$ 10,207
Per share information:
Basic earnings per share (in usd per share)	$ 0.77	$ 0.93
Diluted earnings per share (in usd per share)	0.76	0.92
Dividends paid per share (in usd per share)	$ 0.19	$ 0.18

XML

Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 8,368	$ 10,207
Other comprehensive (loss) income, net of tax:
Unrealized losses on securities available for sale arising during the period	(24,353)	(721)
Reclassification adjustment for losses (gains) realized in net income	146	(145)
Net unrealized losses on securities available for sale	(24,207)	(866)
Tax effect	5,084	182
Total other comprehensive loss, net of tax and reclassification adjustments on securities available for sale	(19,123)	(684)
Unrealized gains on interest rate swaps used in cash flow hedges	0	739
Reclassification adjustment for losses realized in net income	0	87
Net unrealized gains on interest rate swaps used in cash flow hedges	0	826
Tax effect	0	(173)
Total other comprehensive gains, net of tax and reclassification adjustments on interest rate swaps used in cash flow hedges	0	653
Total other comprehensive loss, net of tax and reclassification adjustments	(19,123)	(31)
Total comprehensive (loss) income	$ (10,755)	$ 10,176

XML

Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance at Dec. 31, 2020	$ 246,249	$ 586	$ 189,066	$ 54,099	$ 3,346	$ (848)
Increase (Decrease) in Shareholders' Equity
Net income	10,207			10,207
Total other comprehensive income (loss) net of taxes	(31)				(31)
Cash dividends	(2,004)			(2,004)
Shares-based compensation plans:
Shares issued, shares acquired including compensation expense	27	0	(555)			582
Ending balance at Mar. 31, 2021	254,448	586	188,511	62,302	3,315	(266)
Beginning balance at Dec. 31, 2021	271,656	586	189,689	78,700	4,449	(1,768)
Increase (Decrease) in Shareholders' Equity
Net income	8,368			8,368
Total other comprehensive income (loss) net of taxes	(19,123)				(19,123)
Cash dividends	(2,125)			(2,125)
Shares-based compensation plans:
Shares issued, shares acquired including compensation expense	(3,972)	(1)	(1,656)			(2,315)
Ending balance at Mar. 31, 2022	$ 254,804	$ 585	$ 188,033	$ 84,943	$ (14,674)	$ (4,083)

XML

Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Stockholders' Equity [Abstract]
Dividends per share (in usd per share)	$ 0.19	$ 0.18
Common shares issued during the period (in shares)	10,622	8,671
Treasury stock, shares issued/acquired (in shares)	93,438	40,970
Compensation expense, issuance of stock	$ 338	$ 467

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities
Net income	$ 8,368	$ 10,207
Adjustments to reconcile net income to net cash provided by operating activities:
Net premium amortization / (discount accretion)	68	(738)
Depreciation and amortization expense	1,210	1,353
Provision for loan losses	300	(1,000)
Share-based compensation	338	467
Gains on sales of loans originated for sale	(319)	(1,320)
Mortgage loans originated for sale	(32,903)	(55,720)
Proceeds from sales of loans originated for sale	32,749	56,959
Gains on sale of portfolio loans	(271)	0
Net loss on disposal of premises and equipment	12	0
Deferred income taxes	1,638	(1,600)
Investment securities (losses) gains	146	(145)
Income from life insurance	(566)	(557)
Increase in accrued interest receivable	(408)	(143)
Increase in accrued interest payable and other liabilities	531	12,095
Other, net	(4,251)	(3,225)
Net cash provided by operating activities	6,642	16,633
Cash flows from investing activities
Proceeds from sales of AFS securities	3,075	75,736
Maturities, repayments and calls of AFS securities	9,536	11,406
Purchases of AFS securities	(94,903)	(29,233)
Net redemptions of restricted investments in bank stocks	461	256
Distributions from investments in limited partnerships	1,146	0
Net decrease (increase) in loans	52	(64,634)
Proceeds from sales of portfolio loans	3,913	0
Purchases of bank premises and equipment	(235)	(156)
Net cash used in investing activities	(76,955)	(6,625)
Cash flows from financing activities
Net increase in deposits	81,060	190,198
Net increase in borrowings with original maturities less than 90 days	1,323	3,328
Payments on FHLB advances and other borrowings	(108)	(103)
Dividends paid	(2,125)	(2,004)
Acquisition of treasury stock	(4,166)	0
Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting	(232)	(514)
Proceeds from issuance of employee stock purchase plan shares	89	74
Net cash provided by financing activities	75,841	190,979
Net increase in cash and cash equivalents	5,528	200,987
Cash and cash equivalents at beginning of period	208,710	125,258
Cash and cash equivalents at end of period	214,238	326,245
Cash paid during the period for:
Interest	710	1,629
Supplemental schedule of noncash activities:
Loans transferred from LHFS to portfolio loans	1,510	0
Securities purchases not yet settled	$ 0	$ 11,699

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

See the Glossary of Defined Terms at the beginning of this Report for terms used throughout the unaudited condensed consolidated financial statements and related notes of this Form 10-Q.

Nature of Operations – Orrstown Financial Services, Inc. is a financial holding company that operates Orrstown Bank, a commercial bank providing banking and financial advisory services in Berks, Cumberland, Dauphin, Franklin, Lancaster, Perry and York Counties, Pennsylvania, and in Anne Arundel, Baltimore, Howard and Washington Counties, Maryland. The Company operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services, including checking, savings, time, and money market deposits. The Company also provides fiduciary, investment advisory, insurance and brokerage services. The Company and the Bank are subject to regulation by certain federal and state agencies and undergo periodic examinations by such regulatory authorities.

Basis of Presentation – The accompanying unaudited condensed consolidated financial statements include the accounts of Orrstown Financial Services, Inc. and its wholly owned subsidiary, the Bank. The Company has prepared these unaudited condensed consolidated financial statements in accordance with GAAP for interim financial information, SEC rules that permit reduced disclosure for interim periods, and Article 10 of Regulation S-X. In the opinion of management, all adjustments (all of which are of a normal recurring nature) that are necessary for a fair statement are reflected in the unaudited condensed consolidated financial statements. The December 31, 2021 consolidated balance sheet information contained in this Quarterly Report on Form 10-Q was derived from the Company's 2021 audited consolidated financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. All significant intercompany transactions and accounts have been eliminated.

The Company's management has evaluated all activity of the Company and concluded that subsequent events are properly reflected in the Company's unaudited condensed consolidated financial statements and notes as required by GAAP.

To prepare financial statements in conformity with GAAP, management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ.

Derivatives - FASB ASC 815, Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments.

As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge.

The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Company's objectives in using interest rate derivatives are to add stability to interest income and to manage its exposure to interest rate movements. To accomplish this objective, the Company uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of fixed amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount.

Changes to the fair value of derivatives designated and that qualify as cash flow hedges are recorded in AOCI and are subsequently reclassified into earnings in the period that the hedged transaction affects earnings. The Company discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in AOCI are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. At March 31, 2022 and December 31, 2021, the Company had no interest rate derivative designated as a hedging instrument.

Derivatives not designated as hedges are not speculative and result from a service the Company provides to certain customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting derivatives that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions. As the interest rate derivatives associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer derivatives and the offsetting derivatives are recognized directly in earnings. At March 31, 2022 and December 31, 2021, the Company had interest rate swaps not designated as hedges with a total notional value of $120.6 million and $75.8 million, respectively.

Leases - The Company evaluates its contracts at inception to determine if an arrangement either is a lease or contains one. Operating lease ROU assets are included in other assets and operating lease liabilities in accrued interest payable and other liabilities in the unaudited condensed consolidated balance sheets. The Company had no finance leases at March 31, 2022.

ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company's leases do not provide an implicit rate, so the Company's incremental borrowing rate is used, which approximates its fully collateralized borrowing rate, based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is reevaluated upon lease modification. The operating lease ROU asset also includes any initial direct costs and prepaid lease payments made less any lease incentives. In calculating the present value of lease payments, the Company may include options to extend the lease when it is reasonably certain that it will exercise that option.

In accordance with ASU 2016-02, “Leases (Topic 842)” (“ASU 2016-02”), the Company keeps leases with an initial term of 12 months or less off of the balance sheet. The Company recognizes these lease payments in the unaudited condensed consolidated statements of income on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components and has elected the practical expedient to account for them as a single lease component.

The Company's operating leases relate primarily to bank branches and office space. The difference between the lease asset and lease liabilities primarily consists of deferred rent liabilities reclassified upon adoption to reduce the measurement of the lease assets. The standard does not materially impact the Company's unaudited condensed consolidated statements of income.

Recent Accounting Pronouncements - ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). The amendments in this update require an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. Organizations will continue to use judgment to determine which loss estimation method is appropriate for their circumstances. Additionally, the amendments in this update amend the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For certain public companies, this update was effective for interim and annual periods beginning after December 15, 2019. The implementation deadline of ASU 2016-13 was extended for smaller reporting and other companies until the fiscal year and interim periods beginning after December 15, 2022. The Company will implement ASU 2016-13 effective January 1, 2023.

ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates ("ASU 2019-10"), extended the implementation deadline of ASU 2016-13 for smaller reporting and other companies until the fiscal year and interim periods beginning after December 15, 2022. The Company meets the requirements to be considered a smaller reporting company under SEC Regulation S-K and SEC Rule 405, and will adopt ASU 2016-13 effective January 1, 2023. The Company is evaluating the impact of the adoption of ASU 2016-13, and is working with a third-party vendor solution to assist with the application of ASU 2016-13 and finalizing the loss estimation models to be used. Once management determines which methods will be utilized, another third party vendor will be contracted to perform a model validation prior to adoption. The Company expects to recognize a one-time cumulative-effect adjustment to the

allowance for credit losses as of the date of adoption of the new standard. While the Company anticipates the allowance for loan losses will increase under its current assumptions, it expects the impact of adopting ASU 2016-13 will be influenced by the composition, characteristics and quality of its loan and investment securities portfolios, as well as general economic conditions and forecasts at the adoption date. The other provisions of ASU 2019-10 were not applicable to the Company.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"). ASU 2020-04 contains optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The optional expedients apply consistently to all contracts or transactions within the scope of this topic, while the optional expedients for hedging relationships can be elected on an individual basis. The Company has formed a cross-functional working group to lead the transition from LIBOR to a planned adoption of an alternate index. The Company currently plans to replace LIBOR with the 30-Day Average SOFR or Term SOFR in its loan agreements. The Company implemented fallback language for loans with maturities after 2021. The Company expects to adopt the LIBOR transition relief allowed under this standard, and is currently evaluating the potential impact of this guidance on its financial statements.

In March 2022, the FASB issued ASU No. 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (“ASU 2022-02”). ASU 2022-02 eliminates the troubled debt restructuring accounting model. This change will require all loan modifications to be accounted for under the general loan modification guidance in Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs, and subject entities to new disclosure requirements on loan modifications to borrowers experiencing financial difficulty. For entities that have adopted Topic 326, ASU 2022-02 is effective for periods beginning after December 15, 2022. For entities adopting Topic 326 in periods after December 15, 2022, ASU 2022-02 is effective when the company adopts Topic 326. The Company will implement ASU 2022-02 effective January 1, 2023, and is evaluating the impact.

XML

INVESTMENT SECURITIES

3 Months Ended

Mar. 31, 2022

Investments, Debt and Equity Securities [Abstract]

INVESTMENT SECURITIES

INVESTMENT SECURITIESAt March 31, 2022 and December 31, 2021, all investment securities were classified as AFS. The following table summarizes amortized cost and fair value of investment securities, and the corresponding amounts of gross unrealized gains and losses recognized in AOCI, at March 31, 2022 and December 31, 2021:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
March 31, 2022
U.S. Treasury securities	$	20,081	$	—	$	1,543	$	18,538
States and political subdivisions	244,922		1,984		9,346		237,560
GSE residential MBSs	61,239		—		2,010		59,229
GSE residential CMOs	74,023		48		3,044		71,027
Non-agency CMOs	29,832		3		2,832		27,003
Asset-backed	117,805		—		1,835		115,970
Other	403		—		—		403
Totals	$	548,305	$	2,035	$	20,610	$	529,730
December 31, 2021
U.S. Treasury securities	$	20,084	$	—	$	382	$	19,702
States and political subdivisions	185,437		8,606		673		193,370
GSE residential MBSs	41,260		44		578		40,726
GSE residential CMOs	66,430		436		944		65,922
Non-agency CMOs	30,676		—		978		29,698
Asset-backed	122,520		401		300		122,621
Other	399		—		—		399
Totals	$	466,806	$	9,487	$	3,855	$	472,438

The following table summarizes investment securities with unrealized losses at March 31, 2022 and December 31, 2021, aggregated by major investment security type and the length of time in a continuous unrealized loss position.

	Less Than 12 Months					12 Months or More					Total
	# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses
March 31, 2022
U.S. Treasury securities	3	$	18,538	$	1,543	—	$	—	$	—	3	$	18,538	$	1,543
States and political subdivisions	30	166,305		9,346		—	—		—		30	166,305		9,346
GSE residential MBSs	14	59,229		2,010		—	—		—		14	59,229		2,010
GSE residential CMOs	12	66,516		2,782		1	3,501		262		13	70,017		3,044
Non-agency CMOs	3	22,303		2,832		—	—		—		3	22,303		2,832
Asset-backed	12	83,667		1,352		3	31,910		483		15	115,577		1,835
Totals	74	$	416,558	$	19,865	4	$	35,411	$	745	78	$	451,969	$	20,610
December 31, 2021
U.S. Treasury securities	3	$	19,702	$	382	—	$	—	$	—	3	$	19,702	$	382
States and political subdivisions	12	45,522		673		—	—		—		12	45,522		673
GSE residential MBSs	9	37,899		578		—	—		—		9	37,899		578
GSE residential CMOs	7	41,163		944		—	—		—		7	41,163		944
Non-agency CMOs	3	24,661		978		—	—		—		3	24,661		978
Asset-backed	3	21,245		138		3	34,180		162		6	55,425		300
Totals	37	$	190,192	$	3,693	3	$	34,180	$	162	40	$	224,372	$	3,855

The Company determines whether unrealized losses are temporary in nature in accordance with FASB ASC 320-10, Investments - Overall, (“FASB ASC 320-10”) and FASB ASC 325-40, Investments – Beneficial Interests in Securitized Financial Assets, when applicable. The evaluation is based upon factors such as the creditworthiness of the underlying borrowers, performance of the underlying collateral, if applicable, and the level of credit support in the security structure. Management also evaluates other factors and circumstances that may be indicative of an OTTI condition. This includes, but is not limited to, an evaluation of the type of security, length of time and extent to which the fair value has been less than cost and near-term prospects of the issuer.

FASB ASC 320-10 requires the Company to assess if an OTTI exists by considering whether the Company has the intent to sell the security or it is more likely than not that it will be required to sell the security before recovery. If either of these situations applies, the guidance requires the Company to record an OTTI charge to earnings on debt securities for the difference between the amortized cost basis of the security and the fair value of the security. If neither of these situations applies, the Company is required to assess whether it is expected to recover the entire amortized cost basis of the security. If the Company is not expected to recover the entire amortized cost basis of the security, the guidance requires the Company to bifurcate the identified OTTI into a credit loss component and a component representing loss related to other factors. A discount rate is applied which equals the effective yield of the security. The difference between the present value of the expected flows and the amortized book value is considered a credit loss, which would be recorded through earnings as an OTTI charge. When a market price is not readily available, the market value of the security is determined using the same expected cash flows; the discount rate is a rate the Company determines from the open market and other sources as appropriate for the security. The difference between the market value and the present value of cash flows expected to be collected is recognized in AOCI on the unaudited condensed consolidated statements of financial condition.

U.S. Treasury Securities. The unrealized losses presented in the table above have been caused by an increase in rates from the time these securities were purchased. Management considers the full faith and credit of the U.S. government in determining whether a security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at March 31, 2022 or December 31, 2021.

States and Political Subdivisions. The unrealized losses presented in the table above have been caused by a rise in interest rates from the time these securities were purchased. Management considers the investment rating, the state of the issuer of the security and other credit support in determining whether the security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at March 31, 2022 or December 31, 2021.

GSE Residential CMOs and GSE Residential MBS. The unrealized losses presented in the table above have been caused by a widening of spreads and a rise in interest rates from the time these securities were purchased. The contractual terms of these securities do not permit the issuer to settle the securities at a price less than its par value basis. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at March 31, 2022 or December 31, 2021.

Non-Agency CMOs. The unrealized losses presented in the table above were caused by a widening of spreads and a rise in interest rates from the time the securities were purchased. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at March 31, 2022 or December 31, 2021, except for one $14.7 million par value non-agency CMO security. For the three months ended March 31, 2022, the Company had $171 thousand in cumulative OTTI on this non-agency CMO security, which was included in securities gains and losses in the unaudited condensed consolidated statements of income. This security is expected to be called by the issuer in the second quarter of 2022 due to an anticipated default caused by increased prepayment speeds on the underlying collateral.

Asset-backed. The unrealized losses presented in the table above were caused by a widening of spreads from the time the securities were purchased. Management considers the investment rating and other credit support in determining whether a security is OTTI. Because the Company does not intend to sell these securities and it is not more likely than not that the Company will be required to sell them before recovery of their amortized cost basis, which may be maturity, the Company does not consider these securities to be OTTI at March 31, 2022 or December 31, 2021.

The following table summarizes amortized cost and fair value of investment securities by contractual maturity at March 31, 2022. Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity date are shown separately.

	Amortized Cost		Fair Value
Due in one year or less	$	—	$	—
Due after one year through five years	3,376		3,509
Due after five years through ten years	79,079		75,367
Due after ten years	182,951		177,625
CMOs and MBSs	165,094		157,259
Asset-backed	117,805		115,970
Totals	$	548,305	$	529,730

The following table summarizes proceeds from sales of investment securities and gross gains and gross losses for the three months ended March 31, 2022 and 2021:

	Three months ended March 31,
	2022		2021
Proceeds from sale of investment securities	$	3,075	$	75,736
Gross gains	25		1,351
Gross losses	—		1,206

During the three months ended March 31, 2022, net investment security gains, excluding the OTTI charge noted above, of $25 thousand were recorded, compared to net gains of $145 thousand for the three months ended March 31, 2021. During the three months ended March 31, 2022, a partial sale of one security with a principal balance of $3.1 million was sold for proceeds of $3.1 million compared to 14 securities with a principal balance of $75.6 million were sold for proceeds of $75.7 million during the three months ended March 31, 2021. Investment securities with a fair value of $291.0 million and $295.6 million at March 31, 2022 and December 31, 2021, respectively, were pledged to secure public funds and for other purposes as required or permitted by law.

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES

3 Months Ended

Mar. 31, 2022

Receivables [Abstract]

LOANS AND ALLOWANCE FOR LOAN LOSSES

LOANS AND ALLOWANCE FOR LOAN LOSSES

Consistent with ASU 2010-20, Disclosures about the Credit Quality of Financing Receivables and the Allowance for Loan Losses, the Company’s loan portfolio is grouped into segments which are further broken down into classes to allow management to monitor the performance by the borrower and to monitor the yield on the portfolio.

The risks associated with lending activities differ among the various loan classes and are subject to the impact of changes in interest rates, market conditions of collateral securing the loans, and general economic conditions. All of these factors may adversely impact both the borrower’s ability to repay its loans and associated collateral.

The Company has various types of commercial real estate loans, which have differing levels of credit risk. Owner occupied commercial real estate loans are generally dependent upon the successful operation of the borrower’s business, with the cash flows generated from the business being the primary source of repayment of the loan. If the business suffers a downturn in sales or profitability, the borrower’s ability to repay the loan could be in jeopardy.

Non-owner occupied and multi-family commercial real estate loans and non-owner occupied residential loans present a different credit risk to the Company than owner occupied commercial real estate loans, as the repayment of the loan is dependent upon the borrower’s ability to generate a sufficient level of occupancy to produce rental income that exceeds debt service requirements and operating expenses. Lower occupancy or lease rates may result in a reduction in cash flows, which hinders the ability of the borrower to meet debt service requirements, and may result in lower collateral values. The Company generally recognizes that greater risk is inherent in these credit relationships compared to owner occupied loans mentioned above.

Acquisition and development loans consist of 1-4 family residential construction and commercial and land development loans. The risk of loss on these loans is largely dependent on the Company’s ability to assess the property’s value at the completion of the project, which should exceed the property’s construction costs. During the construction phase, a number of factors could potentially negatively impact the collateral value, including cost overruns, delays in completing the project, competition, and real estate market conditions, which may change based on the supply of similar properties in the area. In the event the collateral value at the completion of the project is not sufficient to cover the outstanding loan balance, the Company must rely upon other repayment sources, if any, including the guarantors of the project or other collateral securing the loan.

On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act was enacted. The CARES Act established the SBA PPP. The SBA PPP is intended to provide economic relief to small businesses nationwide adversely impacted under the COVID-19 Emergency Declaration issued on March 13, 2020. The SBA PPP, which began on April 3, 2020, provided small businesses with funds to cover up to 24 weeks of payroll costs and other expenses, including benefits. It also provides for forgiveness of up to the full principal amount of qualifying loans. In total, the Bank closed and funded almost 6,500 loans for a total gross loan amount of $699.4 million through December 31, 2021.

Commercial and industrial loans include advances to local and regional businesses for general commercial purposes and include permanent and short-term working capital, machinery and equipment financing, and may be either in the form of lines of credit or term loans. Although commercial and industrial loans may be unsecured to our highest-rated borrowers, the majority of these loans are secured by the borrower’s accounts receivable, inventory and machinery and equipment. In a significant number of these loans, the collateral also includes the business real estate or the business owner’s personal real estate or assets. Commercial and industrial loans present credit exposure to the Company, as they are more susceptible to risk of loss during a downturn in the economy as borrowers may have greater difficulty in meeting their debt service requirements and the value of the collateral may decline. The Company attempts to mitigate this risk through its underwriting standards, including evaluating the creditworthiness of the borrower and, to the extent available, credit ratings on the business. Additionally, monitoring of the loans through annual renewals and meetings with the borrowers are typical. However, these procedures cannot eliminate the risk of loss associated with commercial and industrial lending. At March 31, 2022 and December 31, 2021, commercial and industrial loans include $122.5 million and $189.9 million, respectively, of loans, net of deferred fees and costs, originated through the SBA PPP. At March 31, 2022, the Bank has $2.4 million of net deferred SBA PPP fees remaining to be recognized through net interest income over the life of the loans, which is between two and five years. The timing of the recognition of these fees is dependent upon the loan forgiveness process established by the SBA. As these loans are 100% guaranteed by the SBA, there is no associated ALL at March 31, 2022.

Municipal loans consist of extensions of credit to municipalities and school districts within the Company’s market area. These loans generally present a lower risk than commercial and industrial loans, as they are generally secured by the municipality’s full taxing authority, by revenue obligations, or by its ability to raise assessments on its clients for a specific utility.

The Company originates loans to its retail clients, including fixed-rate and adjustable first lien mortgage loans, with the underlying 1-4 family owner occupied residential property securing the loan. The Company’s risk exposure is minimized in these types of loans through the evaluation of the creditworthiness of the borrower, including credit scores and debt-to-income ratios, and underwriting standards, which limit the loan-to-value ratio to generally no more than 80% upon loan origination, unless the borrower obtains private mortgage insurance.

Home equity loans, including term loans and lines of credit, present a slightly higher risk to the Company than 1-4 family first liens, as these loans can be first or second liens on 1-4 family owner occupied residential property, but can have loan-to-value ratios of no greater than 85% of the value of the real estate taken as collateral. The creditworthiness of the borrower is also considered, including credit scores and debt-to-income ratios.

Installment and other loans’ credit risk is mitigated through prudent underwriting standards, including evaluation of the creditworthiness of the borrower through credit scores and debt-to-income ratios and, if secured, the collateral value of the assets. These loans can be unsecured or secured by assets the value of which may depreciate quickly or may fluctuate, and may present a greater risk to the Company than 1-4 family residential loans.

In an effort to assist clients that were negatively impacted by the COVID-19 pandemic, the Bank offered various mitigation options, including a loan payment deferral program. Under this program, most commercial deferrals were for a 90-day period, while most consumer deferrals were for a 180-day period. In accordance with the revised Interagency Statement on Loan Modifications by Financial Institutions Working with Customers Affected by the Coronavirus issued by the federal bank regulatory agencies on April 7, 2020, these deferrals are exempt from TDR status as they meet the specified requirements. At March 31, 2022 and December 31, 2021, the remaining loan deferral balances were inconsequential.

The following table presents the loan portfolio by segment and class, excluding residential mortgage LHFS, at March 31, 2022 and December 31, 2021:

	March 31, 2022		December 31, 2021
Commercial real estate:
Owner occupied	$	256,526	$	238,668
Non-owner occupied	558,999		551,783
Multi-family	93,158		93,255
Non-owner occupied residential	102,269		106,112
Acquisition and development:
1-4 family residential construction	15,115		12,279
Commercial and land development	105,204		93,925
Commercial and industrial (1)	443,170		485,728
Municipal	14,626		14,989
Residential mortgage:
First lien	203,231		198,831
Home equity - term	5,820		6,081
Home equity - lines of credit	164,818		160,705
Installment and other loans	15,371		17,630
Total loans	$	1,978,307	$	1,979,986

(1) This balance includes $122.5 million and $189.9 million of SBA PPP loans, net of deferred fees and costs, at March 31, 2022 and December 31, 2021, respectively.

In order to monitor ongoing risk associated with its loan portfolio and specific loans within the segments, management uses an internal grading system. The first several rating categories, representing the lowest risk to the Bank, are combined and given a “Pass” rating. Management generally follows regulatory definitions in assigning criticized ratings to loans, including "Special Mention," "Substandard," "Doubtful" or "Loss." The Special Mention category includes loans that have potential weaknesses that may, if not monitored or corrected, weaken the asset or inadequately protect the Bank's position at some future date. These assets pose elevated risk, but their weakness does not yet justify a more severe, or classified rating. Substandard loans are classified as they have a well-defined weakness, or weaknesses that jeopardize liquidation of the debt. These loans are characterized by the distinct possibility that the Bank will sustain some loss if the deficiencies are not corrected. Substandard loans include loans that management has determined not to be impaired, as well as loans considered to be impaired. A Doubtful loan has a high probability of total or substantial loss, but because of specific pending events that may strengthen the asset, its

classification as Loss is deferred. Loss loans are considered uncollectible, as the borrowers are often in bankruptcy, have suspended debt repayments, or have ceased business operations. Once a loan is classified as Loss, there is little prospect of collecting the loan’s principal or interest and it is charged-off.

The Company has a loan review policy and program, which is designed to identify and monitor risk in the lending function. The Management ERM Committee, comprised of executive officers, senior officers and loan department personnel, is charged with the oversight of overall credit quality and risk exposure of the Company's loan portfolio. This includes the monitoring of the lending activities of all Company personnel with respect to underwriting and processing new loans and the timely follow-up and corrective action for loans showing signs of deterioration in quality. A loan review program provides the Company with an independent review of the commercial loan portfolio on an ongoing basis. Generally, consumer and residential mortgage loans are included in the Pass categories unless a specific action, such as extended delinquencies, bankruptcy, repossession or death of the borrower occurs, which heightens awareness as to a possible credit event.

Internal loan reviews are completed annually on all commercial relationships with a committed loan balance in excess of $1.0 million, which includes confirmation of risk rating by an independent credit officer. In addition, all commercial relationships greater than $500 thousand rated Substandard, Doubtful or Loss are reviewed quarterly and corresponding risk ratings are reaffirmed by the Company's Problem Loan Committee, with subsequent reporting to the Management ERM Committee and the Board of Directors.

The following table summarizes the Company’s loan portfolio ratings based on its internal risk rating system at March 31, 2022 and December 31, 2021:

	Pass		Special Mention		Non-Impaired Substandard		Impaired - Substandard		Doubtful		PCI Loans		Total
March 31, 2022
Commercial real estate:
Owner occupied	$	242,529	$	6,360	$	2,277	$	3,062	$	—	$	2,298	$	256,526
Non-owner occupied	537,505		18,771		2,419		—		—		304		558,999
Multi-family	84,541		8,158		459		—		—		—		93,158
Non-owner occupied residential	99,545		1,005		1,014		100		—		605		102,269
Acquisition and development:
1-4 family residential construction	15,115		—		—		—		—		—		15,115
Commercial and land development	103,486		1,236		482		—		—		—		105,204
Commercial and industrial	424,425		7,642		8,792		161		—		2,150		443,170
Municipal	14,626		—		—		—		—		—		14,626
Residential mortgage:
First lien	196,217		—		221		2,278		—		4,515		203,231
Home equity - term	5,798		—		—		6		—		16		5,820
Home equity - lines of credit	164,327		19		46		426		—		—		164,818
Installment and other loans	15,314		—		—		52		—		5		15,371
	$	1,903,428	$	43,191	$	15,710	$	6,085	$	—	$	9,893	$	1,978,307
December 31, 2021
Commercial real estate:
Owner occupied	$	219,250	$	7,239	$	6,087	$	3,763	$	—	$	2,329	$	238,668
Non-owner occupied	528,010		23,297		166		—		—		310		551,783
Multi-family	84,414		8,238		603		—		—		—		93,255
Non-owner occupied residential	102,588		1,065		1,153		122		—		1,184		106,112
Acquisition and development:
1-4 family residential construction	12,279		—		—		—		—		—		12,279
Commercial and land development	92,049		1,385		491		—		—		—		93,925
Commercial and industrial	470,579		7,917		4,720		250		—		2,262		485,728
Municipal	14,989		—		—		—		—		—		14,989
Residential mortgage:
First lien	191,386		—		225		2,635		—		4,585		198,831
Home equity - term	6,058		—		—		7		—		16		6,081
Home equity - lines of credit	160,203		20		46		436		—		—		160,705
Installment and other loans	17,584		—		—		40		—		6		17,630
	$	1,899,389	$	49,161	$	13,491	$	7,253	$	—	$	10,692	$	1,979,986

For commercial real estate, acquisition and development and commercial and industrial loans, a loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by

management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays and payment shortfalls generally are not classified as impaired. Generally, loans that are more than 90 days past due are deemed impaired. Management determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed to determine if the loan should be placed on nonaccrual status. Nonaccrual loans in the commercial and commercial real estate portfolios and any TDRs are, by definition, deemed to be impaired. Impairment is measured on a loan-by-loan basis for commercial, construction and restructured loans by either the present value of the expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price, or the fair value of the collateral if the loan is collateral dependent. A loan is collateral dependent if the repayment of the loan is expected to be provided solely by the underlying collateral. For loans that are deemed to be impaired for extended periods of time, periodic updates on fair values are obtained, which may include updated appraisals. Updated fair values are incorporated into the impairment analysis in the next reporting period.

Loan charge-offs, which may include partial charge-offs, are taken on an impaired loan that is collateral dependent if the loan’s carrying balance exceeds its collateral’s appraised value, the loan has been identified as uncollectible, and it is deemed to be a confirmed loss. Typically, impaired loans with a charge-off or partial charge-off will continue to be considered impaired, unless the note is split into two, and management expects the performing note to continue to perform and is adequately secured. The second, or non-performing note, would be charged-off. Generally, an impaired loan with a partial charge-off may continue to have an impairment reserve on it after the partial charge-off, if factors warrant.

At March 31, 2022 and December 31, 2021, nearly all of the Company’s loan impairments were measured based on the estimated fair value of the collateral securing the loan, except for TDRs. By definition, TDRs are considered impaired. All TDR impairment analyses are initially based on discounted cash flows for those loans. For real estate loans, collateral generally consists of commercial real estate, but in the case of commercial and industrial loans, it could also consist of accounts receivable, inventory, equipment or other business assets. Commercial and industrial loans may also have real estate collateral.

Updated appraisals are generally required every 18 months for classified commercial loans in excess of $250 thousand. The “as is" value provided in the appraisal is often used as the fair value of the collateral in determining impairment, unless circumstances, such as subsequent improvements, approvals, or other circumstances, dictate that another value than that provided by the appraiser is more appropriate.

Generally, impaired commercial loans secured by real estate, other than performing TDRs, are measured at fair value using certified real estate appraisals that had been completed within the last 18 months. Appraised values are discounted for estimated costs to sell the property and other selling considerations to arrive at the property’s fair value. In those situations in which it is determined an updated appraisal is not required for loans individually evaluated for impairment, fair values are based on either an existing appraisal or a discounted cash flow analysis as determined by management. The approaches are discussed below:

•Existing appraisal – if the existing appraisal provides a strong loan-to-value ratio (generally 70% or lower) and, after consideration of market conditions and knowledge of the property and area, it is determined by the Credit Administration staff that there has not been a significant deterioration in the collateral value, the existing certified appraised value may be used. Discounts to the appraised value, as deemed appropriate for selling costs, are factored into the fair value.

•Discounted cash flows – in limited cases, discounted cash flows may be used on projects in which the collateral is liquidated to reduce the borrowings outstanding, and is used to validate collateral values derived from other approaches.

Collateral on certain impaired loans is not limited to real estate, and may consist of accounts receivable, inventory, equipment or other business assets. Estimated fair values are determined based on borrowers’ financial statements, inventory ledgers, accounts receivable aging or appraisals from individuals with knowledge in the business. Stated balances are generally discounted for the age of the financial information or the quality of the assets. In determining fair value, liquidation discounts are applied to this collateral based on existing loan evaluation policies.

The Company distinguishes substandard loans on both an impaired and non-impaired basis, as it places less emphasis on a loan’s classification, and increased reliance on whether the loan was performing in accordance with the contractual terms. A substandard classification does not automatically meet the definition of impaired. Loss potential, while existing in the aggregate amount of substandard loans, does not have to exist in individual extensions of credit classified as substandard. As a result, the Company’s methodology includes an evaluation of certain accruing commercial real estate, acquisition and development, and commercial and industrial loans rated substandard to be collectively evaluated for impairment. Although the Company believes

these loans meet the definition of substandard, they are generally performing and management has concluded that it is likely the Company will be able to collect the scheduled payments of principal and interest when due according to the contractual terms of the loan agreement.

Larger groups of smaller balance homogeneous loans are collectively evaluated for impairment. Generally, the Company does not separately identify individual consumer and residential loans for impairment disclosures, unless such loans are the subject of a restructuring agreement due to financial difficulties of the borrower.

The following table, which excludes accruing PCI loans, summarizes impaired loans by segment and class, segregated by those for which a specific allowance was required and those for which a specific allowance was not required at March 31, 2022 and December 31, 2021. The recorded investment in loans excludes accrued interest receivable due to insignificance. Related allowances established generally pertain to those loans in which loan forbearance agreements were in the process of being negotiated or updated appraisals were pending, and any partial charge-off will be recorded when final information is received.

	Impaired Loans with a Specific Allowance						Impaired Loans with No Specific Allowance
	Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)		Related Allowance		Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)
March 31, 2022
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,062	$	4,840
Non-owner occupied residential	—		—		—		100		214
Commercial and industrial	—		—		—		161		447
Residential mortgage:
First lien	338		338		29		1,940		2,938
Home equity—term	—		—		—		6		9
Home equity—lines of credit	—		—		—		426		651
Installment and other loans	—		—		—		52		52
	$	338	$	338	$	29	$	5,747	$	9,151
December 31, 2021
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,763	$	4,902
Non-owner occupied residential	—		—		—		122		259
Commercial and industrial	—		—		—		250		547
Residential mortgage:
First lien	341		341		28		2,294		3,337
Home equity—term	—		—		—		7		10
Home equity—lines of credit	—		—		—		436		653
Installment and other loans	—		—		—		40		40
	$	341	$	341	$	28	$	6,912	$	9,748

The following table, which excludes accruing PCI loans, summarizes the average recorded investment in impaired loans and related recognized interest income for the three months ended March 31, 2022 and 2021:

	2022				2021
	Average Impaired Balance		Interest Income Recognized		Average Impaired Balance		Interest Income Recognized
Three Months Ended March 31,
Commercial real estate:
Owner occupied	$	3,422	$	—	$	3,448	$	1
Multi-family	—		—		19		—
Non-owner occupied residential	107		—		267		—
Acquisition and development:
Commercial and land development	—		—		614		—
Commercial and industrial	218		—		2,878		—
Residential mortgage:
First lien	2,406		7		2,636		11
Home equity - term	7		—		12		—
Home equity - lines of credit	432		—		616		—
Installment and other loans	45		—		15		—
	$	6,637	$	7	$	10,505	$	12

The following table presents impaired loans that are TDRs, with the recorded investment at March 31, 2022 and December 31, 2021:

	March 31, 2022			December 31, 2021
	Number of Contracts	Recorded Investment		Number of Contracts	Recorded Investment
Accruing:
Residential mortgage:
First lien	7	$	575	8	$	804
Nonaccruing:
Residential mortgage:
First lien	6	276		5	285
	13	$	851	13	$	1,089

There was one new first lien residential mortgage TDR on non-accrual status for the three months ended March 31, 2022 of $4 thousand. There were no new TDRs in 2021.

Management further monitors the performance and credit quality of the loan portfolio by analyzing the length of time a portfolio is past due, by aggregating loans based on its delinquencies. The following table presents the classes of loan portfolio summarized by aging categories of performing loans and nonaccrual loans at March 31, 2022 and December 31, 2021:

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
March 31, 2022
Commercial real estate:
Owner occupied	$	250,844	$	322	$	—	$	—	$	322	$	3,062	$	254,228
Non-owner occupied	558,695		—		—		—		—		—		558,695
Multi-family	93,158		—		—		—		—		—		93,158
Non-owner occupied residential	101,254		310		—		—		310		100		101,664
Acquisition and development:
1-4 family residential construction	15,115		—		—		—		—		—		15,115
Commercial and land development	105,204		—		—		—		—		—		105,204
Commercial and industrial	440,652		207		—		—		207		161		441,020
Municipal	14,626		—		—		—		—		—		14,626
Residential mortgage:
First lien	194,216		2,741		—		56		2,797		1,703		198,716
Home equity - term	5,786		12		—		—		12		6		5,804
Home equity - lines of credit	163,725		437		230		—		667		426		164,818
Installment and other loans	15,231		83		—		—		83		52		15,366
Subtotal	1,958,506		4,112		230		56		4,398		5,510		1,968,414
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,298		—		—		—		—		—		2,298
Non-owner occupied	304		—		—		—		—		—		304
Non-owner occupied residential	494		—		—		111		111		—		605
Commercial and industrial	2,150		—		—		—		—		—		2,150
Residential mortgage:
First lien	3,837		608		—		70		678		—		4,515
Home equity - term	15		—		—		1		1		—		16
Installment and other loans	2		3		—		—		3		—		5
Subtotal	9,100		611		—		182		793		—		9,893
	$	1,967,606	$	4,723	$	230	$	238	$	5,191	$	5,510	$	1,978,307

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
December 31, 2021
Commercial real estate:
Owner occupied	$	231,371	$	314	$	—	$	891	$	1,205	$	3,763	$	236,339
Non-owner occupied	551,473		—		—		—		—		—		551,473
Multi-family	93,255		—		—		—		—		—		93,255
Non-owner occupied residential	104,645		161		—		—		161		122		104,928
Acquisition and development:
1-4 family residential construction	12,279		—		—		—		—		—		12,279
Commercial and land development	93,793		132		—		—		132		—		93,925
Commercial and industrial	483,088		128		—		—		128		250		483,466
Municipal	14,989		—		—		—		—		—		14,989
Residential mortgage:
First lien	189,043		2,995		281		96		3,372		1,831		194,246
Home equity - term	6,042		16		—		—		16		7		6,065
Home equity - lines of credit	159,628		641		—		—		641		436		160,705
Installment and other loans	17,467		109		8		—		117		40		17,624
Subtotal	1,957,073		4,496		289		987		5,772		6,449		1,969,294
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,329		—		—		—		—		—		2,329
Non-owner occupied	310		—		—		—		—		—		310
Non-owner occupied residential	479		—		587		118		705		—		1,184
Commercial and industrial	2,262		—		—		—		—		—		2,262
Residential mortgage:
First lien	3,937		387		166		95		648		—		4,585
Home equity - term	15		—		—		1		1		—		16
Installment and other loans	6		—		—		—		—		—		6
Subtotal	9,338		387		753		214		1,354		—		10,692
	$	1,966,411	$	4,883	$	1,042	$	1,201	$	7,126	$	6,449	$	1,979,986

The Company maintains its ALL at a level management believes adequate for probable incurred credit losses. The ALL is established and maintained through a provision for loan losses charged to earnings. On a quarterly basis, management assesses the adequacy of the ALL utilizing a defined methodology, which considers specific credit evaluation of impaired loans as discussed above, historical loan loss experience, and qualitative factors. Management believes its approach properly addresses relevant accounting guidance for loans individually identified as impaired and for loans collectively evaluated for impairment, and other bank regulatory guidance.

In connection with its quarterly evaluation of the adequacy of the ALL, management reviews its methodology to determine if it properly addresses the current risk in the loan portfolio. For each loan class, general allowances based on quantitative factors, principally historical loss trends, are provided for loans that are collectively evaluated for impairment. An

adjustment to historical loss factors may be incorporated for delinquency and other potential risk not elsewhere defined within the ALL methodology.

In addition to this quantitative analysis, adjustments to the ALL requirements are allocated on loans collectively evaluated for impairment based on additional qualitative factors, including:

Nature and Volume of Loans – including loan growth in the current and subsequent quarters based on the Company’s targeted growth and strategic plan, coupled with the types of loans booked based on risk management and credit culture; the number of exceptions to loan policy; and supervisory loan to value exceptions.

Concentrations of Credit and Changes within Credit Concentrations – including the composition of the Company’s overall portfolio makeup and management's evaluation related to concentration risk management and the inherent risk associated with the concentrations identified.

Underwriting Standards and Recovery Practices – including changes to underwriting standards and perceived impact on anticipated losses; trends in the number of exceptions to loan policy; supervisory loan to value exceptions; and administration of loan recovery practices.

Delinquency Trends – including delinquency percentages noted in the portfolio relative to economic conditions; severity of the delinquencies; and whether the ratios are trending upwards or downwards.

Classified Loans Trends – including internal loan ratings of the portfolio; severity of the ratings; whether the loan segment’s ratings show a more favorable or less favorable trend; and underlying market conditions and impact on the collateral values securing the loans.

Experience, Ability and Depth of Management/Lending staff – including the level of experience of senior and middle management and the lending staff; turnover of the staff; and instances of repeat criticisms.

Quality of Loan Review – including the level of experience of the loan review staff; in-house versus outsourced provider of review; turnover of the staff; and instances of repeat criticisms.

National and Local Economic Conditions – including trends in the consumer price index, unemployment rates, the housing price index, housing statistics compared to the prior year, bankruptcy rates, regulatory and legal environment risks and competition.

All factors noted above were deemed appropriate at March 31, 2022 and were unchanged for the three months ended March 31, 2022, except for a reduction in the National and Local Economic Conditions. This factor had been previously increased to account for economic concerns in the commercial real estate portfolio associated with the COVID-19 pandemic. The additional allocation was removed at March 31, 2022 as these concerns have subsided.

The following table presents the activity in the ALL for the three months ended March 31, 2022 and 2021:

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
Three Months Ended
March 31, 2022
Balance, beginning of period	$	12,037	$	2,062	$	3,814	$	30	$	17,943	$	2,785	$	215	$	3,000	$	237	$	21,180
Provision for loan losses	(523)		258		500		(1)		234		72		(6)		66		—		300
Charge-offs	—		—		(61)		—		(61)		(10)		(13)		(23)		—		(84)
Recoveries	32		1		48		—		81		26		5		31		—		112
Balance, end of period	$	11,546	$	2,321	$	4,301	$	29	$	18,197	$	2,873	$	201	$	3,074	$	237	$	21,508
March 31, 2021
Balance, beginning of period	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151
Provision for loan losses	(494)		(69)		(54)		(2)		(619)		(289)		(106)		(395)		14		(1,000)
Charge-offs	—		—		(454)		—		(454)		(21)		(20)		(41)		—		(495)
Recoveries	14		1		280		—		295		6		10		16		—		311
Balance, end of period	$	10,671	$	1,046	$	3,714	$	38	$	15,469	$	3,058	$	208	$	3,266	$	232	$	18,967

The following table summarizes the ending loan balance individually evaluated for impairment based upon loan segment, as well as the related ALL loss allocation for each at March 31, 2022 and December 31, 2021. Accruing PCI loans are excluded from loans individually evaluated for impairment.

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
March 31, 2022
Loans allocated by:
Individually evaluated for impairment	$	3,162	$	—	$	161	$	—	$	3,323	$	2,710	$	52	$	2,762	$	—	$	6,085
Collectively evaluated for impairment	1,007,790		120,319		443,009		14,626		1,585,744		371,159		15,319		386,478		—		1,972,222
	$	1,010,952	$	120,319	$	443,170	$	14,626	$	1,589,067	$	373,869	$	15,371	$	389,240	$	—	$	1,978,307
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	29	$	—	$	29	$	—	$	29
Collectively evaluated for impairment	11,546		2,321		4,301		29		18,197		2,844		201		3,045		237		21,479
	$	11,546	$	2,321	$	4,301	$	29	$	18,197	$	2,873	$	201	$	3,074	$	237	$	21,508
December 31, 2021
Loans allocated by:
Individually evaluated for impairment	$	3,885	$	—	$	250	$	—	$	4,135	$	3,078	$	40	$	3,118	$	—	$	7,253
Collectively evaluated for impairment	985,933		106,204		485,478		14,989		1,592,604		362,539		17,590		380,129		—		1,972,733
	$	989,818	$	106,204	$	485,728	$	14,989	$	1,596,739	$	365,617	$	17,630	$	383,247	$	—	$	1,979,986
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	28	$	—	$	28	$	—	$	28
Collectively evaluated for impairment	12,037		2,062		3,814		30		17,943		2,757		215		2,972		237		21,152
	$	12,037	$	2,062	$	3,814	$	30	$	17,943	$	2,785	$	215	$	3,000	$	237	$	21,180

The following table provides activity for the accretable yield of purchased impaired loans for the three months ended March 31, 2022 and 2021:

	Three Months Ended
	March 31, 2022		March 31, 2021
Accretable yield, beginning of period	$	2,661	$	3,438
Accretion of income	(314)		(466)
Reclassifications from nonaccretable difference due to improvement in expected cash flows	243		44
Other changes, net	(73)		56
Accretable yield, end of period	$	2,517	$	3,072

XML

LEASES

3 Months Ended

Mar. 31, 2022

Leases [Abstract]

LEASES

LEASES

A lease provides the lessee the right to control the use of an identified asset for a period of time in exchange for consideration. The Company has primarily entered into operating leases for branches and office space. Most of the Company's leases contain renewal options, which the Company is reasonably certain to exercise. Including renewal options, the Company's leases range from 6 to 31 years. Operating lease right-of-use assets and lease liabilities are included in other assets and accrued interest and other liabilities on the Company's unaudited condensed consolidated balance sheets.

The Company uses its incremental borrowing rate to determine the present value of the lease payments, as the rate implicit in the Company's leases is not readily determinable. Lease agreements that contain non-lease components are generally accounted for as a single lease component, while variable costs, such as common area maintenance expenses and property taxes, are expensed as incurred.

The following table summarizes the Company's operating leases at March 31, 2022 and December 31, 2021:

	March 31, 2022			December 31, 2021
Operating lease ROU assets	$	10,305		$	10,515
Operating lease ROU liabilities	10,937			11,119
Weighted-average remaining lease term (in years)	14.4			14.6
Weighted-average discount rate	4.1		%	4.1		%

The following table presents information related to the Company's operating leases for the three months ended March 31, 2022 and 2021:

	Three Months Ended
	March 31, 2022		March 31, 2021
Cash paid for operating lease liabilities	$	294	$	343
Operating lease expense	394		403

The following table presents expected future maturities of the Company's lease liabilities as of March 31, 2022:

2022	$	868
2023	1,216
2024	1,246
2025	1,269
2026	1,302
Thereafter	9,687
	15,588
Less: imputed interest	4,651
Total lease liabilities	$	10,937

XML

GOODWILL AND OTHER INTANGIBLE ASSETS

3 Months Ended

Mar. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

GOODWILL AND OTHER INTANGIBLE ASSETS

The following table presents changes in goodwill for the three months ended March 31, 2022 and 2021:

	March 31, 2022		March 31, 2021
Balance, beginning of year	$	18,724	$	18,724
Balance, end of period	$	18,724	$	18,724

Goodwill is not amortized but is reviewed for potential impairment on at least an annual basis, with testing between annual tests if an event occurs or circumstances change that could potentially reduce the fair value of a reporting unit.

The Company conducted its last annual goodwill impairment test as of November 30, 2021 using generally accepted valuation methods. As a result of that impairment test, no goodwill impairment was identified. No changes occurred that would impact the results of that analysis through March 31, 2022.

The following table presents changes in and components of other intangible assets for the three months ended March 31, 2022 and 2021:

	Three Months Ended March 31,
	2022		2021
Beginning of period	$	4,183	$	5,458
Amortization expense	(292)		(334)
Balance, end of period	$	3,891	$	5,124

No impairment charges were recorded in the three months ended March 31, 2022 and March 31, 2021.

The following table presents the components of other identifiable intangible assets at March 31, 2022 and December 31, 2021:

	March 31, 2022				December 31, 2021
	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
Amortized intangible assets:
Core deposit intangibles	$	8,390	$	4,500	$	8,390	$	4,208
Other customer relationship intangibles	25		24		25		24
Total	$	8,415	$	4,524	$	8,415	$	4,232

The following table presents future estimated aggregate amortization expense for intangible assets remaining at March 31, 2022:

2022	$	813
2023	935
2024	766
2025	596
2026	427
Thereafter	354
	$	3,891

XML

SHARE-BASED COMPENSATION PLANS

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

SHARE-BASED COMPENSATION PLANS

SHARE-BASED COMPENSATION PLANS

The Company maintains share-based compensation plans under the shareholder-approved 2011 Plan. The purpose of the share-based compensation plans is to provide officers, employees, and non-employee members of the Board of Directors of the Company with additional incentive to further the success of the Company. At March 31, 2022, 881,920 shares of the common stock of the Company were reserved, of which 137,443 shares are available to be issued. At the Company's 2022 Annual Meeting of Shareholders held on April 26, 2022, the Company's shareholders approved an amendment to the 2011 Plan increasing the number of shares available for issuance under the 2011 Plan by 400,000.

The 2011 Plan incentive awards may consist of grants of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, deferred stock units and performance shares. All employees and members of the Board of Directors of the Company and its subsidiaries, are eligible to participate in the 2011 Plan. The 2011 Plan allows for the Compensation Committee of the Board of Directors to determine the type of incentive to be awarded, its term, manner of exercise, vesting and restrictions on shares. Generally, awards are nonqualified under the IRC, unless the awards are deemed to be incentive awards to employees at the Compensation Committee’s discretion.

The following table presents a summary of nonvested restricted shares activity for the three months ended March 31, 2022:

	Shares	Weighted Average Grant Date Fair Value
Nonvested shares, beginning of year	274,697	$	20.05
Granted	121,949	25.02
Forfeited	(10,622)	20.02
Vested	(54,054)	19.31
Nonvested shares, at period end	331,970	$	22.00

The following table presents restricted shares compensation expense, with tax benefit information, and fair value of shares vested, for the three months ended March 31, 2022 and 2021:

	Three months ended March 31,
	2022		2021
Restricted share award expense	$	330	$	434
Restricted share award tax benefit	69		91
Fair value of shares vested	1,324		1,028

The unrecognized compensation expense related to the share awards totaled $4.6 million at March 31, 2022 and $2.3 million at December 31, 2021. The unrecognized compensation expense at March 31, 2022 is expected to be recognized over a weighted-average period of 2.3 years.

The Company maintains an employee stock purchase plan to provide its employees with an opportunity to purchase Company common stock. Eligible employees may purchase shares in an amount that does not exceed 10% of their annual salary, at the lower of 95% of the fair market value of the shares on the semi-annual offering date or related purchase date. The purchases occur in March and September of each year. The Company reserved 350,000 shares of its common stock to be issued under the employee stock purchase plan. At March 31, 2022, 147,527 shares were available to be issued under the employee stock purchase plan.

The following table presents information for the employee stock purchase plan for the three months ended March 31, 2022 and 2021:

	Three months ended March 31,
	2022		2021
Shares purchased	3,953		5,484
Weighted average price of shares purchased	$	22.46	$	13.44
Compensation expense recognized	8		33

The Company issues new shares or treasury shares, depending on market conditions, in its share-based compensation plans.

XML

DERIVATIVE FINANCIAL INSTRUMENTS

3 Months Ended

Mar. 31, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE FINANCIAL INSTRUMENTS

DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risk arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used as risk management tools by the Company to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings and are not used for trading or speculative purposes.

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. The Company, however, discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in AOCI are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. At March 31, 2022 and December 31, 2021, the Company had no interest rate derivative designated as a hedging instrument.

The Company enters into interest rate swaps that allow its commercial loan customers to effectively convert a variable-rate commercial loan agreement to a fixed-rate commercial loan agreement. Under these agreements, the Company enters into a variable-rate loan agreement with a customer in addition to an interest rate swap agreement, which serves to effectively swap the customer’s variable-rate loan into a fixed-rate loan. The Company then enters into a corresponding swap agreement with a third party in order to economically hedge its exposure through the customer agreement. The interest rate swaps with both the customers and third parties are not designated as hedges and are marked through earnings. At March 31, 2022, the Company had 14 customer and 14 corresponding third-party broker interest rate derivatives not designated as a hedging instrument with an aggregate notional amount of $120.6 million. The Company had $75.8 million in notional amount of such derivative instruments at December 31, 2021. During the three months ended March 31, 2022 and 2021, the Company entered into new interest rate swaps with its commercial loan customers and recognized swap fee income of $953 thousand and zero, respectively, which is included in noninterest income in the unaudited condensed consolidated statements of income. At March 31, 2022 and December 31, 2021, the Company provided cash collateral of zero and $260 thousand to the counterparties for these derivatives, respectively. At March 31, 2022 and December 31, 2021, the Company was holding cash collateral of $2.6 million and $490 thousand from the counterparties for these derivatives, respectively.

The Company entered into a risk participation agreement with a financial institution counterparty (the “Agent Bank”) for an interest rate derivative contract related to a loan in which the Company is a participant. The risk participation agreement provides credit protection to the Agent Bank should the borrower fail to perform on its interest rate derivative contracts with the Agent Bank. The Company received an upfront fee of $53 thousand upon entry into the risk participation agreement during the three months ended March 31, 2021, and is included in noninterest income in the unaudited condensed consolidated statements of income. The Company manages its credit risk on the risk participation agreement by monitoring the creditworthiness of the borrower, which is based on the same credit review process as though the Company had entered into the derivative instruments directly with the borrower. The notional amount of such risk participation agreement reflects the Company’s pro-rata share of the derivative instrument, consistent with its share of the related participated loan. The total notional amount of the risk participation agreement was $15.9 million at both March 31, 2022 and December 31, 2021.

As a part of its normal residential mortgage operations, the Company will enter into an interest rate lock commitment with a potential borrower. The Company will enter into a corresponding commitment with an investor to sell that loan at a specific price shortly after origination. In accordance with FASB ASC 820, adjustments are recorded through earnings to account for the net change in fair value of these transactions for the held for sale pipeline.

The following table summarizes the fair value of the Company's derivative instruments at March 31, 2022 and December 31, 2021:

	March 31, 2022					December 31, 2021
	Notional Amount		Balance Sheet Location	Fair Value		Notional Amount		Balance Sheet Location	Fair Value
Derivatives not designated as hedging instruments:
Interest rate swaps	$	60,279	Other assets	$	3,067	$	37,915	Other assets	$	764
Interest rate swaps	60,279		Other liabilities	(3,024)		37,915		Other liabilities	(758)
Risk participation	15,855		Other liabilities	(1)		15,855		Other liabilities	(2)
Interest rate lock commitments with customers	12,302		Other assets	300		16,604		Other assets	353
Forward sale commitment	7,537		Other assets	353		8,665		Other assets	52
Total derivatives not designated as hedging instruments				$	695				$	409

The following tables summarize the effect of the Company's derivative financial instruments on OCI and net income for the three months ended March 31, 2022 and 2021:

	Amount of Gain Recognized in OCI on Derivative
	Three Months Ended March 31,
	2022		2021
Derivatives in cash flow hedging relationships:
Interest rate products	$	—	$	739
Total	$	—	$	739

	Amount of Loss Reclassified from AOCI into Income				Location of Loss Recognized from AOCI into Income
	Three Months Ended March 31,
	2022		2021
Derivatives in cash flow hedging relationships:
Interest rate products	$	—	$	(87)	Interest expense
Total	$	—	$	(87)

During the three months ended September 30, 2021, the Company terminated its interest rate swap designated as a hedging instrument of $50.0 million.

	Amount of Gain (Loss) Recognized in Income				Location of Gain (Loss) Recognized in Income
	Three Months Ended March 31,
	2022		2021
Derivatives not designated as hedging instruments:
Interest rate products	$	37	$	52	Other operating expenses
Risk participation agreement	2		4		Other operating expenses
Interest rate lock commitments with customers	(53)		(1)		Mortgage banking activities
Forward sale commitment	300		254		Mortgage banking activities
Total	$	286	$	309

XML

SHAREHOLDERS' EQUITY AND REGULATORY CAPITAL

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

SHAREHOLDERS’ EQUITY AND REGULATORY CAPITAL

SHAREHOLDERS’ EQUITY AND REGULATORY CAPITALBanks and bank holding companies are subject to regulatory capital requirements administered by federal banking agencies. Capital adequacy guidelines and, additionally for banks, prompt corrective action regulations, involve quantitative measures of assets, liabilities and certain off-balance sheet items calculated under regulatory accounting practices. Capital

amounts and classifications are also subject to qualitative judgments by regulators. Failure to meet capital requirements can initiate regulatory action. Under the Basel Committee on Banking Supervision's capital guidelines for U.S. Banks ("Basel III rules"), an entity must hold a capital conservation buffer above the adequately capitalized risk-based capital ratios. The Company and the Bank have elected not to include net unrealized gains or losses included in AOCI in computing regulatory capital.

The consolidated asset limit on small bank holding companies is $3.0 billion and a company with assets under that limit is not subject to the FRB consolidated capital rules, but may file reports that include capital amounts and ratios. The Company has elected to file those reports.

Management believes that the Company and the Bank met all capital adequacy requirements to which they are subject at March 31, 2022 and December 31, 2021.

Prompt corrective action regulations provide five classifications: well capitalized, adequately capitalized, undercapitalized, significantly undercapitalized and critically undercapitalized, although these terms are not used to represent overall financial condition. If adequately capitalized, regulatory approval is required to accept brokered deposits. If undercapitalized, capital distributions are limited, as is asset growth and expansion, and capital restoration plans are required. At March 31, 2022, the most recent regulatory notifications categorized the Bank as well capitalized under the regulatory framework for prompt corrective action. There are no conditions or events since that notification that management believes have changed the Bank's classification.

The following table presents capital amounts and ratios at March 31, 2022 and December 31, 2021:

	Actual				For Capital Adequacy Purposes (includes applicable capital conservation buffer)				To Be Well Capitalized Under Prompt Corrective Action Provisions
	Amount		Ratio		Amount		Ratio		Amount		Ratio
March 31, 2022
Total risk-based capital:
Orrstown Financial Services, Inc.	$	300,952	14.3	%	$	220,591	10.5	%	n/a		n/a
Orrstown Bank	288,988		13.8	%	220,509		10.5	%	$	210,009	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	245,833		11.7	%	178,574		8.5	%	n/a		n/a
Orrstown Bank	265,847		12.7	%	178,508		8.5	%	168,007		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	245,833		11.7	%	147,061		7.0	%	n/a		n/a
Orrstown Bank	265,847		12.7	%	147,006		7.0	%	136,506		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	245,833		8.8	%	112,328		4.0	%	n/a		n/a
Orrstown Bank	265,847		9.5	%	112,352		4.0	%	140,440		5.0	%
December 31, 2021
Total risk-based capital:
Orrstown Financial Services, Inc.	$	297,823	15.0	%	$	208,617	10.5	%	n/a		n/a
Orrstown Bank	278,780		14.0	%	208,550		10.5	%	$	198,619	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	243,075		12.2	%	168,880		8.5	%	n/a		n/a
Orrstown Bank	255,995		12.9	%	168,826		8.5	%	158,895		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	243,075		12.2	%	139,078		7.0	%	n/a		n/a
Orrstown Bank	255,995		12.9	%	139,033		7.0	%	129,102		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	243,075		8.5	%	114,384		4.0	%	n/a		n/a
Orrstown Bank	255,995		8.9	%	114,470		4.0	%	143,087		5.0	%

In September 2015, the Board of Directors of the Company authorized a share repurchase program under which the Company may repurchase up to 5% of the Company's outstanding shares of common stock, or approximately 416,000 shares, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Exchange Act of 1934, as amended. On April 19, 2021, the Board of Directors authorized the additional future repurchase of up to 562,000 shares of its outstanding common stock. When and if appropriate, repurchases may be made in the open market or privately negotiated transactions, depending on market conditions, regulatory requirements and other corporate considerations, as determined by management. Share repurchases may not occur and may be discontinued at any time. At March 31, 2022, 415,805 shares had been repurchased at a total cost of $8.9 million, or $21.35 per share. Common stock available for future repurchase totals approximately 562,195 shares, or 5% of the Company's outstanding common stock at March 31, 2022.

On April 18, 2022, the Board declared a cash dividend of $0.19 per common share, which will be paid on May 9, 2022 to shareholders of record at May 2, 2022.

XML

EARNINGS PER SHARE

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

EARNINGS PER SHARE

EARNINGS PER SHARE

The following table presents earnings per share for the three months ended March 31, 2022 and 2021:

	Three Months Ended March 31,
	2022		2021
Net income	$	8,368	$	10,207
Weighted average shares outstanding - basic	10,860		10,975
Dilutive effect of share-based compensation	147		99
Weighted average shares outstanding - diluted	11,007		11,074
Per share information:
Basic earnings per share	$	0.77	$	0.93
Diluted earnings per share	0.76		0.92

Average outstanding restricted award shares totaling 112,223 and 0 for the three months ended March 31, 2022 and 2021, respectively, were not included in the computation of earnings per share because the effect was antidilutive. The dilutive effect of share-based compensation in each period above relates principally to restricted stock awards.

XML

FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK

3 Months Ended

Mar. 31, 2022

Fair Value Disclosures [Abstract]

FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK

FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK

The Company is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its clients. These financial instruments include commitments to extend credit and standby letters of credit. Those instruments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the unaudited condensed consolidated balance sheets. The contract amounts of those instruments reflect the extent of involvement the Company has in particular classes of financial instruments.

The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and standby letters of credit and financial guarantees written is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet instruments. The following table presents these contractual, or notional, amounts:

	Contractual or Notional Amount
	March 31, 2022		December 31, 2021
Commitments to fund:
Home equity lines of credit	$	273,734	$	261,580
1-4 family residential construction loans	56,330		40,348
Commercial real estate, construction and land development loans	142,301		124,488
Commercial, industrial and other loans	368,199		378,996
Standby letters of credit	20,772		19,724

Commitments to extend credit are agreements to lend to a client as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The Company evaluates each client’s credit-worthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management’s credit evaluation of the client. Collateral varies but may include accounts receivable, inventory, equipment, residential real estate, and income-producing commercial properties.

Standby letters of credit and financial guarantees written are conditional commitments issued by the Company to guarantee the performance of a client to a third party. Those guarantees are primarily issued to support public and private borrowing arrangements. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loans to clients. The Company holds collateral supporting those commitments when deemed necessary by management. The liability at March 31, 2022 and December 31, 2021 for guarantees under standby letters of credit issued was not considered to be material.

The Company maintains a reserve, based on historical loss experience of the related loan class and utilization assumptions, for off-balance sheet credit exposures that currently are not funded, in other liabilities on the unaudited condensed consolidated balance sheets. This reserve totaled approximately $1.6 million at both March 31, 2022 and December 31, 2021.

XML

FAIR VALUE

3 Months Ended

Mar. 31, 2022

Fair Value Disclosures [Abstract]

FAIR VALUE

FAIR VALUE

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Certain financial instruments and all non-financial instruments are excluded from disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company.

The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market participant assumptions based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are:

Level 1 – quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access at the measurement date.

Level 2 – significant other observable inputs other than Level 1 prices such as prices for similar assets and liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 – at least one significant unobservable input that reflects a company's own assumptions about the assumptions that market participants would use in pricing an asset or liability.

In instances in which multiple levels of inputs are used to measure fair value, hierarchy classification is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

The Company used the following methods and significant assumptions to estimate fair value for instruments measured on a recurring basis:

Where quoted prices are available in an active market, investment securities are classified within Level 1 of the valuation hierarchy. Level 1 investment securities include highly liquid government bonds, mortgage products and exchange traded equities. If quoted market prices are not available, investment securities are classified within Level 2 and fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flow. Level 2 investment securities include U.S. agency securities, MBS, obligations of states and political subdivisions and certain corporate, asset backed and other securities. In certain cases where there is limited activity or less transparency around inputs to the valuation, investment securities are classified within Level 3 of the valuation hierarchy. The Company’s investment securities are classified as available for sale.

The fair values of interest rate swaps and risk participation derivatives are determined using models that incorporate readily observable market data into a market standard methodology. This methodology nets the discounted future cash receipts and the discounted expected cash payments. The discounted variable cash receipts and payments are based on expectations of future interest rates derived from observable market interest rate curves. In addition, fair value is adjusted for the effect of nonperformance risk by incorporating credit valuation adjustments for the Company and its counterparties. These assets and liabilities are classified as Level 2 fair values, based upon the lowest level of input that is significant to the fair value measurements.

The following table summarizes assets and liabilities measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
March 31, 2022
Financial Assets
Investment securities:
U.S. Treasury securities	$	18,538	$	—	$	—	$	18,538
States and political subdivisions	—		230,539		7,021		237,560
GSE residential MBSs	—		59,229		—		59,229
GSE residential CMOs	—		71,027		—		71,027
Nonagency CMOs	—		15,390		11,613		27,003
Asset-backed	—		115,970		—		115,970
Other	403		—		—		403
Loans held for sale	—		7,403		—		7,403
Derivatives	—		3,067		300		3,367
Totals	$	18,941	$	502,625	$	18,934	$	540,500
Financial Liabilities
Derivatives	$	—	$	3,025	$	—	$	3,025
December 31, 2021
Financial Assets
Investment securities:
U.S. Treasury securities	$	19,702	$	—	$	—	$	19,702
States and political subdivisions	—		183,171		10,199		193,370
GSE residential MBSs	—		40,726		—		40,726
GSE residential CMOs	—		65,922		—		65,922
Nonagency CMOs	—		16,750		12,948		29,698
Asset-backed	—		122,621		—		122,621
Other	399		—		—		399
Loans held for sale	—		8,868		—		8,868
Derivatives	—		764		353		1,117
Totals	$	20,101	$	438,822	$	23,500	$	482,423
Financial Liabilities
Derivatives	$	—	$	760	$	—	$	760

The Company had one municipal bond and one CMO measured at fair value on a recurring basis using significant unobservable inputs (Level 3) at both March 31, 2022 and December 31, 2021. The Level 3 valuation is based on a non-executable broker quote, which is considered a significant unobservable input. Such quotes are updated as available and may remain constant for a period of time for certain broker-quoted securities that do not move with the market or that are not interest rate sensitive as a result of their structure or overall attributes.

The Company’s residential mortgage LHFS are recorded at fair value utilizing Level 2 measurements. This fair value measurement is determined based upon third party quotes obtained on similar loans. For LHFS, for which the fair value option has been elected, the aggregate fair value declined below the aggregate principal balance by $195 thousand as of March 31, 2022, and exceeded the aggregate principal balance by $150 thousand as of December 31, 2021.

The determination of the fair value of interest rate lock commitments on residential mortgages is based on agreed upon pricing with the respective investor on each loan and includes a pull through percentage. The pull through percentage represents an estimate of loans in the pipeline to be delivered to an investor versus the total loans committed for delivery. Significant changes in this input could result in a significantly higher or lower fair value measurement. As the pull through percentage is a significant unobservable input, this is deemed a Level 3 valuation input. The average pull through percentage, which is based

upon historical experience, was 93% as of March 31, 2022. An increase or decrease of 5% in the pull through assumption would result in a positive or negative change of $6 thousand in the fair value of interest rate lock commitments at March 31, 2022.

The following provides details of the Level 3 fair value measurement activity for the periods ended March 31, 2022 and 2021:

Investment securities:

	Three Months Ended March 31,
	2022		2021
Balance, beginning of period	$	23,147	$	31,503
Unrealized loss included in OCI	(1,360)		(665)
Net discount accretion	71		129
Principal payments and other	—		(1,858)
Sales	(3,053)		(3,545)
OTTI	(171)		—
Balance, end of period	$	18,634	$	25,564

Interest rate lock commitments on residential mortgages:

	Three Months Ended March 31,
	2022		2021
Balance, beginning of period	$	353	$	673
Total losses
Included in earnings	(53)		(1)
Balance, end of period	$	300	$	672

Certain financial assets are measured at fair value on a nonrecurring basis. Adjustments to the fair value of these assets usually results from the application of lower of cost or market accounting or write-downs of individual assets. The Company used the following methods and significant assumptions to estimate fair value for these financial assets.

Impaired Loans

Loans are designated as impaired when, in the judgment of management and based on current information and events, it is probable that all amounts due, according to the contractual terms of the loan agreement, will not be collected. The measurement of loss associated with impaired loans for all loan classes can be based on either the observable market price of the loan, the fair value of the collateral, or discounted cash flows using the rate of return implicit in the original loan for TDRs. For collateral-dependent loans, fair value is measured based on the value of the collateral securing the loan, less estimated costs to sell. Collateral may be in the form of real estate or business assets including equipment, inventory, and accounts receivable. The value of the real estate collateral is determined utilizing an income or market valuation approach based on an appraisal conducted by an independent, licensed appraiser outside of the Company using observable market data (Level 2). However, if the collateral is a house or building in the process of construction, or if management adjusts the appraisal value, then the fair value is considered Level 3. The value of business equipment is based upon an outside appraisal, if deemed significant, or the net book value on the applicable business’ financial statements if not considered significant using observable market data. Likewise, values for inventory and accounts receivable collateral are based on financial statement balances or aging reports (Level 3). Impaired loans with an allocation to the ALL are measured at fair value on a nonrecurring basis. Any fair value adjustments are recorded in the period incurred as provision for loan losses on the unaudited condensed consolidated statements of income.

Any changes in the fair value of impaired loans still held were not material for the three months ended March 31, 2022 and 2021.

Foreclosed Real Estate

OREO property acquired through foreclosure is initially recorded at the fair value of the property at the transfer date less estimated selling cost. Subsequently, OREO is carried at the lower of its carrying value or the fair value less estimated selling cost. Fair value is usually determined based upon an independent third-party appraisal of the property or occasionally upon a recent sales offer. The Company had no OREO balances at March 31, 2022 and December 31, 2021.

Mortgage Servicing Rights

The MSR fair value is estimated to be equal to its carrying value, unless the quarterly valuation model calculates the present value of the estimated net servicing income is less than its carrying value, in which case an impairment charge is taken. At March 31, 2022 and December 31, 2021, an impairment reserve of $47 thousand and $79 thousand, respectively, existed on the MSR portfolio. For the three months ended March 31, 2022 and 2021, impairment valuation allowance reversals of $32 thousand and $606 thousand were included, respectively, in mortgage banking activities on the unaudited condensed consolidated statements of income. The reversals in the three months ended March 31, 2022 and 2021 were due to subsequent increases in market rates.

The following table summarizes assets measured at fair value on a nonrecurring basis at March 31, 2022 and December 31, 2021:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
March 31, 2022
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	144	$	144
Non-owner occupied residential	—		—		18		18
Residential mortgage:
First lien	—		—		491		491
Home equity - lines of credit	—		—		69		69
Total impaired loans	$	—	$	—	$	722	$	722
Mortgage servicing rights	$	—	$	—	$	322	$	322
December 31, 2021
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	751	$	751
Non-owner occupied residential	—		—		24		24
Residential mortgage:
First lien	—		—		545		545
Home equity - lines of credit	—		—		72		72
Total impaired loans	$	—	$	—	$	1,392	$	1,392
Mortgage servicing rights	$	—	$	—	$	322	$	322

The following table presents additional qualitative information about assets measured on a nonrecurring basis and for which the Company has utilized Level 3 inputs to determine fair value:

	Fair Value Estimate		Valuation Techniques	Unobservable Input	Range
March 31, 2022
Impaired loans	$	722	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	0% - 25% discount
				- Management adjustments for liquidation expenses	4.73% - 17.93% discount
Mortgage servicing rights	$	322	Discounted cash flows	Weighted average CPR	8.23%
				- Weighted average discount rate	9.03%
December 31, 2021
Impaired loans	$	1,392	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	10% - 25% discount
				- Management adjustments for liquidation expenses	6.08% - 17.93% discount
Mortgage servicing rights	$	322	Discounted cash flows	Weighted average CPR	12.60%
				- Weighted average discount rate	9.03%

Fair values of financial instruments

GAAP requires disclosure of the fair value of financial assets and liabilities, including those that are not measured and reported at fair value on a recurring or nonrecurring basis. The following table presents carrying amounts and estimated fair values of the financial assets and liabilities at March 31, 2022 and December 31, 2021:

	Carrying Amount		Fair Value		Level 1		Level 2		Level 3
March 31, 2022
Financial Assets
Cash and due from banks	$	26,446	$	26,446	$	26,446	$	—	$	—
Interest-bearing deposits with banks	187,792		187,792		187,792		—		—
Restricted investments in bank stock	6,791		n/a		n/a		n/a		n/a
Investment securities	529,730		529,730		18,941		492,155		18,634
Loans held for sale	7,403		7,403		—		7,403		—
Loans, net of allowance for loan losses	1,956,799		1,906,140		—		—		1,906,140
Derivatives	3,367		3,367		—		3,067		300
Accrued interest receivable	8,642		8,642		—		2,940		5,702
Financial Liabilities
Deposits	2,545,992		2,545,739		—		2,545,739		—
Securities sold under agreements to repurchase	24,624		24,624		—		24,624		—
FHLB advances and other borrowings	1,788		1,865		—		1,865		—
Subordinated notes	31,978		33,094		—		33,094		—
Derivatives	3,025		3,025		—		3,025		—
Accrued interest payable	661		661		—		661		—
Off-balance sheet instruments	—		—		—		—		—
December 31, 2021
Financial Assets
Cash and due from banks	$	21,217	$	21,217	$	21,217	$	—	$	—
Interest-bearing deposits with banks	187,493		187,493		187,493		—		—
Restricted investments in bank stock	7,252		n/a		n/a		n/a		n/a
Investment securities	472,438		472,438		20,101		429,190		23,147
Loans held for sale	8,868		8,868		—		8,868		—
Loans, net of allowance for loan losses	1,958,806		1,946,365		—		—		1,946,365
Derivatives	1,117		1,117		—		764		353
Accrued interest receivable	8,234		8,235		—		2,203		6,032
Financial Liabilities
Deposits	2,464,929		2,466,191		—		2,466,191		—
Securities sold under agreements to repurchase	23,301		23,301		—		23,301		—
FHLB advances and other borrowings	1,896		2,035		—		2,035		—
Subordinated notes	31,963		31,815		—		31,815		—
Derivatives	760		760		—		760		—
Accrued interest payable	154		154		—		154		—
Off-balance sheet instruments	—		—		—		—		—

In accordance with the Company's adoption of ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, the methods utilized to measure the fair value of financial instruments at March 31, 2022 and December 31, 2021 represent an approximation of exit price; however, an actual exit price may differ.

XML

CONTINGENCIES

3 Months Ended

Mar. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

CONTINGENCIES

CONTINGENCIES

The nature of the Company’s business generates a certain amount of litigation involving matters arising out of the ordinary course of business. Except as described below, in the opinion of management, there are no legal proceedings that might have a material effect on the results of operations, liquidity, or the financial position of the Company at this time.

On May 25, 2012, SEPTA filed a putative class action complaint in the U.S. District Court for the Middle District of Pennsylvania against the Company, the Bank and certain current and former directors and officers (collectively, the “Orrstown Defendants”). The complaint alleged, among other things, that (i) in connection with the Company’s Registration Statement on Form S-3 dated February 23, 2010 and its Prospectus Supplement dated March 23, 2010, and (ii) during the purported class period of March 24, 2010 through October 27, 2011, the Company issued materially false and misleading statements regarding the Company’s lending practices and financial results, including misleading statements concerning the stringent nature of the Bank’s credit practices and underwriting standards, the quality of its loan portfolio, and the intended use of the proceeds from the Company’s March 2010 public offering of common stock. The complaint asserted claims under Sections 11, 12(a) and 15 of the Securities Act of 1933, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, and sought class certification, unspecified money damages, interest, costs, fees and equitable or injunctive relief. Under the Private Securities Litigation Reform Act of 1995 (“PSLRA”), the Court appointed SEPTA Lead Plaintiff on August 20, 2012.

On March 4, 2013, SEPTA filed an amended complaint. The amended complaint expanded the list of defendants in the action to include the Company’s former independent registered public accounting firm, Smith Elliott Kearns & Company, LLC (“SEK”), and the underwriters of the Company’s March 2010 public offering of common stock. In addition, among other things, the amended complaint extended the purported 1934 Exchange Act class period from March 15, 2010 through April 5, 2012.

On June 22, 2015, in a 96-page Memorandum, the Court dismissed without prejudice SEPTA’s amended complaint against all defendants, finding that SEPTA failed to state a claim under either the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. On February 8, 2016, the Court granted SEPTA’s motion for leave to amend again and SEPTA filed its second amended complaint that same day.

On December 7, 2016, the Court issued an Order and Memorandum granting in part and denying in part defendants’ motions to dismiss SEPTA’s second amended complaint. The Court granted the motions to dismiss the Securities Act claims against all defendants, and granted the motions to dismiss the Exchange Act Section 10(b) and Rule 10b-5 claims against all defendants except Orrstown Financial Services, Inc., Orrstown Bank, Thomas R. Quinn, Jr., Bradley S. Everly, and Jeffrey W. Embly. The Court also denied the motions to dismiss the Exchange Act Section 20(a) claims against Quinn, Everly, and Embly.

On December 15, 2017, the Orrstown Defendants and SEPTA exchanged expert reports in opposition to and in support of class certification, respectively. On January 15, 2018, the parties exchanged expert rebuttal reports. SEPTA has not yet filed a motion for class certification.

On August 9, 2018, SEPTA filed a motion to compel the production of Confidential Supervisory Information (CSI) of non-parties the Board of Governors of the FRB and the Pennsylvania Department of Banking and Securities, in the possession of Orrstown and third parties. On August 30, 2018, the FRB filed an unopposed motion to intervene in the Action for the purpose of opposing SEPTA’s motion to compel. On February 12, 2019, the Court denied SEPTA’s motion to compel the production of CSI on the ground that SEPTA had failed to exhaust its administrative remedies.

On April 11, 2019, SEPTA filed a motion for leave to file a third amended complaint. The proposed third amended complaint seeks to reassert the Securities Act claims that the Court dismissed as to all defendants on December 7, 2016, when the Court granted in part and denied in part defendants’ motions to dismiss SEPTA’s second amended complaint. The proposed third amended complaint also seeks to reassert the Exchange Act claims against those defendants that the Court dismissed from the case on December 7, 2016.

On June 13, 2019, Orrstown filed a motion for protective order to stay discovery pending resolution of SEPTA’s motion for leave to file a third amended complaint. On July 17, 2019, the Court entered an Order partially granting Orrstown’s motion for protective order, ruling that all deposition discovery in the case was stayed pending a decision on SEPTA’s motion for leave to file a third amended complaint. Party and non-party document discovery in the case has largely been completed.

On February 14, 2020, the Court issued an Order and Memorandum granting SEPTA’s motion for leave to file a third amended complaint. The third amended complaint is now the operative complaint. It reinstates the Orrstown Defendants, as well as SEK and the underwriter defendants, previously dismissed from the case on December 7, 2016. The third amended complaint also revives the previously dismissed Securities Act claim against the Orrstown Defendants, SEK, and the

underwriter defendants. Defendants filed their motions to dismiss the third amended complaint on April 24, 2020. SEPTA’s opposition was filed on July 8, 2020, and Orrstown’s reply brief was filed on August 12, 2020.

Additionally, on February 24, 2020, the Orrstown Defendants, and the underwriter defendants and SEK, separately filed motions under 28 U.S.C. § 1292(b) asking the District Court to certify its February 14, 2020 Order granting leave to file the third amended complaint for interlocutory appeal to the Third Circuit Court of Appeals. The District Court granted those motions on July 17, 2020, and defendants filed their Petition for Permission to Appeal with the Third Circuit on July 27, 2020. The Third Circuit granted permission to appeal the Order pursuant to 28 U.S.C. § 1292(b) on August 13, 2020. Defendants filed their joint Opening Brief in the Third Circuit on November 2, 2020, asking the Court to reverse the district court’s Order. SEPTA filed its responsive brief on December 2, 2020 and defendants filed their reply brief on December 23, 2020. Oral argument was held on February 10, 2021. On September 2, 2021, the Third Circuit affirmed the District Court's February 14, 2020 Order granting SEPTA leave to file a third amended complaint. Defendants' motions to dismiss the third amended complaint are still pending in the District Court.

The Company believes that SEPTA’s allegations and claims against the defendants are without merit, and the Company intends to defend itself vigorously against those claims. It is not possible at this time to reasonably estimate possible losses, or even a range of reasonably possible losses, in connection with the litigation.

On March 25, 2022, a customer of the Bank filed a putative class action complaint against the Bank in the Court of Common Pleas of Cumberland County, Pennsylvania in a case captioned Alleman, on behalf of himself and all others similarly situated, v. Orrstown Bank. The complaint alleges, among other things, that the Bank breached its account agreements by charging certain overdraft fees. The complaint seeks a refund of all allegedly improper fees, damages in an amount to be proven at trial, attorneys’ fees and costs, and an injunction against the Bank’s allegedly improper overdraft practices. This lawsuit is similar to lawsuits recently filed against other financial institutions pertaining to overdraft fee disclosures. Based on information available at present, it is not possible at this time to reasonably estimate possible losses, or even a range of reasonably possible losses, in connection with the litigation. Accordingly, the Company has not recognized any liability associated with this action. The Bank believes that the allegations and claims against the Bank are without merit, and intends to defend itself vigorously against those claims.

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Nature of Operations

Nature of Operations – Orrstown Financial Services, Inc. is a financial holding company that operates Orrstown Bank, a commercial bank providing banking and financial advisory services in Berks, Cumberland, Dauphin, Franklin, Lancaster, Perry and York Counties, Pennsylvania, and in Anne Arundel, Baltimore, Howard and Washington Counties, Maryland. The Company operates in the community banking segment and engages in lending activities, including commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services, including checking, savings, time, and money market deposits. The Company also provides fiduciary, investment advisory, insurance and brokerage services. The Company and the Bank are subject to regulation by certain federal and state agencies and undergo periodic examinations by such regulatory authorities.

Basis of Presentation

Basis of Presentation – The accompanying unaudited condensed consolidated financial statements include the accounts of Orrstown Financial Services, Inc. and its wholly owned subsidiary, the Bank. The Company has prepared these unaudited condensed consolidated financial statements in accordance with GAAP for interim financial information, SEC rules that permit reduced disclosure for interim periods, and Article 10 of Regulation S-X. In the opinion of management, all adjustments (all of which are of a normal recurring nature) that are necessary for a fair statement are reflected in the unaudited condensed consolidated financial statements. The December 31, 2021 consolidated balance sheet information contained in this Quarterly Report on Form 10-Q was derived from the Company's 2021 audited consolidated financial statements. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. Operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending December 31, 2022. All significant intercompany transactions and accounts have been eliminated.

The Company's management has evaluated all activity of the Company and concluded that subsequent events are properly reflected in the Company's unaudited condensed consolidated financial statements and notes as required by GAAP.

To prepare financial statements in conformity with GAAP, management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ.

Derivatives

Derivatives - FASB ASC 815, Derivatives and Hedging (“ASC 815”), provides the disclosure requirements for derivatives and hedging activities with the intent to provide users of financial statements with an enhanced understanding of: (a) how and why an entity uses derivative instruments, (b) how the entity accounts for derivative instruments and related hedged items, and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. Further, qualitative disclosures are required that explain the Company’s objectives and strategies for using derivatives, as well as quantitative disclosures about the fair value of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative instruments.

As required by ASC 815, the Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge.

The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Company's objectives in using interest rate derivatives are to add stability to interest income and to manage its exposure to interest rate movements. To accomplish this objective, the Company uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of fixed amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount.

Changes to the fair value of derivatives designated and that qualify as cash flow hedges are recorded in AOCI and are subsequently reclassified into earnings in the period that the hedged transaction affects earnings. The Company discontinues cash flow hedge accounting if it is probable the forecasted hedged transactions will not occur in the initially identified time period due to circumstances, such as the impact of the COVID-19 pandemic. Upon discontinuance, the associated gains and losses deferred in AOCI are reclassified immediately into earnings and subsequent changes in the fair value of the cash flow hedge are recognized in earnings. At March 31, 2022 and December 31, 2021, the Company had no interest rate derivative designated as a hedging instrument.Derivatives not designated as hedges are not speculative and result from a service the Company provides to certain customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting derivatives that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions. As the interest rate derivatives associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer derivatives and the offsetting derivatives are recognized directly in earnings.

Leases

Leases - The Company evaluates its contracts at inception to determine if an arrangement either is a lease or contains one. Operating lease ROU assets are included in other assets and operating lease liabilities in accrued interest payable and other liabilities in the unaudited condensed consolidated balance sheets. The Company had no finance leases at March 31, 2022.

ROU assets represent the right to use an underlying asset for the lease term, and lease liabilities represent an obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company's leases do not provide an implicit rate, so the Company's incremental borrowing rate is used, which approximates its fully collateralized borrowing rate, based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is reevaluated upon lease modification. The operating lease ROU asset also includes any initial direct costs and prepaid lease payments made less any lease incentives. In calculating the present value of lease payments, the Company may include options to extend the lease when it is reasonably certain that it will exercise that option.

In accordance with ASU 2016-02, “Leases (Topic 842)” (“ASU 2016-02”), the Company keeps leases with an initial term of 12 months or less off of the balance sheet. The Company recognizes these lease payments in the unaudited condensed consolidated statements of income on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components and has elected the practical expedient to account for them as a single lease component.

The Company's operating leases relate primarily to bank branches and office space. The difference between the lease asset and lease liabilities primarily consists of deferred rent liabilities reclassified upon adoption to reduce the measurement of the lease assets. The standard does not materially impact the Company's unaudited condensed consolidated statements of income.

Recent Accounting Pronouncements

Recent Accounting Pronouncements - ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). The amendments in this update require an organization to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions and other organizations will use forward-looking information to better inform their credit loss estimates. Many of the loss estimation techniques applied today will still be permitted, although the inputs to those techniques will change to reflect the full amount of expected credit losses. Organizations will continue to use judgment to determine which loss estimation method is appropriate for their circumstances. Additionally, the amendments in this update amend the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. For certain public companies, this update was effective for interim and annual periods beginning after December 15, 2019. The implementation deadline of ASU 2016-13 was extended for smaller reporting and other companies until the fiscal year and interim periods beginning after December 15, 2022. The Company will implement ASU 2016-13 effective January 1, 2023.

ASU No. 2019-10, Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates ("ASU 2019-10"), extended the implementation deadline of ASU 2016-13 for smaller reporting and other companies until the fiscal year and interim periods beginning after December 15, 2022. The Company meets the requirements to be considered a smaller reporting company under SEC Regulation S-K and SEC Rule 405, and will adopt ASU 2016-13 effective January 1, 2023. The Company is evaluating the impact of the adoption of ASU 2016-13, and is working with a third-party vendor solution to assist with the application of ASU 2016-13 and finalizing the loss estimation models to be used. Once management determines which methods will be utilized, another third party vendor will be contracted to perform a model validation prior to adoption. The Company expects to recognize a one-time cumulative-effect adjustment to the

allowance for credit losses as of the date of adoption of the new standard. While the Company anticipates the allowance for loan losses will increase under its current assumptions, it expects the impact of adopting ASU 2016-13 will be influenced by the composition, characteristics and quality of its loan and investment securities portfolios, as well as general economic conditions and forecasts at the adoption date. The other provisions of ASU 2019-10 were not applicable to the Company.

In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"). ASU 2020-04 contains optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The optional expedients apply consistently to all contracts or transactions within the scope of this topic, while the optional expedients for hedging relationships can be elected on an individual basis. The Company has formed a cross-functional working group to lead the transition from LIBOR to a planned adoption of an alternate index. The Company currently plans to replace LIBOR with the 30-Day Average SOFR or Term SOFR in its loan agreements. The Company implemented fallback language for loans with maturities after 2021. The Company expects to adopt the LIBOR transition relief allowed under this standard, and is currently evaluating the potential impact of this guidance on its financial statements.

In March 2022, the FASB issued ASU No. 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (“ASU 2022-02”). ASU 2022-02 eliminates the troubled debt restructuring accounting model. This change will require all loan modifications to be accounted for under the general loan modification guidance in Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs, and subject entities to new disclosure requirements on loan modifications to borrowers experiencing financial difficulty. For entities that have adopted Topic 326, ASU 2022-02 is effective for periods beginning after December 15, 2022. For entities adopting Topic 326 in periods after December 15, 2022, ASU 2022-02 is effective when the company adopts Topic 326. The Company will implement ASU 2022-02 effective January 1, 2023, and is evaluating the impact.

XML

INVESTMENT SECURITIES (Tables)

3 Months Ended

Mar. 31, 2022

Investments, Debt and Equity Securities [Abstract]

Amortized Cost and Fair Values of AFS Securities

At March 31, 2022 and December 31, 2021, all investment securities were classified as AFS. The following table summarizes amortized cost and fair value of investment securities, and the corresponding amounts of gross unrealized gains and losses recognized in AOCI, at March 31, 2022 and December 31, 2021:

	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
March 31, 2022
U.S. Treasury securities	$	20,081	$	—	$	1,543	$	18,538
States and political subdivisions	244,922		1,984		9,346		237,560
GSE residential MBSs	61,239		—		2,010		59,229
GSE residential CMOs	74,023		48		3,044		71,027
Non-agency CMOs	29,832		3		2,832		27,003
Asset-backed	117,805		—		1,835		115,970
Other	403		—		—		403
Totals	$	548,305	$	2,035	$	20,610	$	529,730
December 31, 2021
U.S. Treasury securities	$	20,084	$	—	$	382	$	19,702
States and political subdivisions	185,437		8,606		673		193,370
GSE residential MBSs	41,260		44		578		40,726
GSE residential CMOs	66,430		436		944		65,922
Non-agency CMOs	30,676		—		978		29,698
Asset-backed	122,520		401		300		122,621
Other	399		—		—		399
Totals	$	466,806	$	9,487	$	3,855	$	472,438

Summary of AFS Securities with Unrealized Losses

The following table summarizes investment securities with unrealized losses at March 31, 2022 and December 31, 2021, aggregated by major investment security type and the length of time in a continuous unrealized loss position.

	Less Than 12 Months					12 Months or More					Total
	# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses		# of Securities	Fair Value		Unrealized Losses
March 31, 2022
U.S. Treasury securities	3	$	18,538	$	1,543	—	$	—	$	—	3	$	18,538	$	1,543
States and political subdivisions	30	166,305		9,346		—	—		—		30	166,305		9,346
GSE residential MBSs	14	59,229		2,010		—	—		—		14	59,229		2,010
GSE residential CMOs	12	66,516		2,782		1	3,501		262		13	70,017		3,044
Non-agency CMOs	3	22,303		2,832		—	—		—		3	22,303		2,832
Asset-backed	12	83,667		1,352		3	31,910		483		15	115,577		1,835
Totals	74	$	416,558	$	19,865	4	$	35,411	$	745	78	$	451,969	$	20,610
December 31, 2021
U.S. Treasury securities	3	$	19,702	$	382	—	$	—	$	—	3	$	19,702	$	382
States and political subdivisions	12	45,522		673		—	—		—		12	45,522		673
GSE residential MBSs	9	37,899		578		—	—		—		9	37,899		578
GSE residential CMOs	7	41,163		944		—	—		—		7	41,163		944
Non-agency CMOs	3	24,661		978		—	—		—		3	24,661		978
Asset-backed	3	21,245		138		3	34,180		162		6	55,425		300
Totals	37	$	190,192	$	3,693	3	$	34,180	$	162	40	$	224,372	$	3,855

Schedule of Amortized Cost and Fair Values of AFS Securities by Contractual Maturity

The following table summarizes amortized cost and fair value of investment securities by contractual maturity at March 31, 2022. Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity date are shown separately.

	Amortized Cost		Fair Value
Due in one year or less	$	—	$	—
Due after one year through five years	3,376		3,509
Due after five years through ten years	79,079		75,367
Due after ten years	182,951		177,625
CMOs and MBSs	165,094		157,259
Asset-backed	117,805		115,970
Totals	$	548,305	$	529,730

Proceeds From Sale of AFS Securities and Gross Gains and Gross Losses

The following table summarizes proceeds from sales of investment securities and gross gains and gross losses for the three months ended March 31, 2022 and 2021:

	Three months ended March 31,
	2022		2021
Proceeds from sale of investment securities	$	3,075	$	75,736
Gross gains	25		1,351
Gross losses	—		1,206

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES (Tables)

3 Months Ended

Mar. 31, 2022

Receivables [Abstract]

Summary of Loan Portfolio, Excluding Residential Loans Held for Sale, Broken Out by Classes

The following table presents the loan portfolio by segment and class, excluding residential mortgage LHFS, at March 31, 2022 and December 31, 2021:

	March 31, 2022		December 31, 2021
Commercial real estate:
Owner occupied	$	256,526	$	238,668
Non-owner occupied	558,999		551,783
Multi-family	93,158		93,255
Non-owner occupied residential	102,269		106,112
Acquisition and development:
1-4 family residential construction	15,115		12,279
Commercial and land development	105,204		93,925
Commercial and industrial (1)	443,170		485,728
Municipal	14,626		14,989
Residential mortgage:
First lien	203,231		198,831
Home equity - term	5,820		6,081
Home equity - lines of credit	164,818		160,705
Installment and other loans	15,371		17,630
Total loans	$	1,978,307	$	1,979,986

(1) This balance includes $122.5 million and $189.9 million of SBA PPP loans, net of deferred fees and costs, at March 31, 2022 and December 31, 2021, respectively.

Loan Portfolio Ratings Based on Internal Risk Rating System

The following table summarizes the Company’s loan portfolio ratings based on its internal risk rating system at March 31, 2022 and December 31, 2021:

	Pass		Special Mention		Non-Impaired Substandard		Impaired - Substandard		Doubtful		PCI Loans		Total
March 31, 2022
Commercial real estate:
Owner occupied	$	242,529	$	6,360	$	2,277	$	3,062	$	—	$	2,298	$	256,526
Non-owner occupied	537,505		18,771		2,419		—		—		304		558,999
Multi-family	84,541		8,158		459		—		—		—		93,158
Non-owner occupied residential	99,545		1,005		1,014		100		—		605		102,269
Acquisition and development:
1-4 family residential construction	15,115		—		—		—		—		—		15,115
Commercial and land development	103,486		1,236		482		—		—		—		105,204
Commercial and industrial	424,425		7,642		8,792		161		—		2,150		443,170
Municipal	14,626		—		—		—		—		—		14,626
Residential mortgage:
First lien	196,217		—		221		2,278		—		4,515		203,231
Home equity - term	5,798		—		—		6		—		16		5,820
Home equity - lines of credit	164,327		19		46		426		—		—		164,818
Installment and other loans	15,314		—		—		52		—		5		15,371
	$	1,903,428	$	43,191	$	15,710	$	6,085	$	—	$	9,893	$	1,978,307
December 31, 2021
Commercial real estate:
Owner occupied	$	219,250	$	7,239	$	6,087	$	3,763	$	—	$	2,329	$	238,668
Non-owner occupied	528,010		23,297		166		—		—		310		551,783
Multi-family	84,414		8,238		603		—		—		—		93,255
Non-owner occupied residential	102,588		1,065		1,153		122		—		1,184		106,112
Acquisition and development:
1-4 family residential construction	12,279		—		—		—		—		—		12,279
Commercial and land development	92,049		1,385		491		—		—		—		93,925
Commercial and industrial	470,579		7,917		4,720		250		—		2,262		485,728
Municipal	14,989		—		—		—		—		—		14,989
Residential mortgage:
First lien	191,386		—		225		2,635		—		4,585		198,831
Home equity - term	6,058		—		—		7		—		16		6,081
Home equity - lines of credit	160,203		20		46		436		—		—		160,705
Installment and other loans	17,584		—		—		40		—		6		17,630
	$	1,899,389	$	49,161	$	13,491	$	7,253	$	—	$	10,692	$	1,979,986

Impaired Loans by Segment and Class

The following table, which excludes accruing PCI loans, summarizes impaired loans by segment and class, segregated by those for which a specific allowance was required and those for which a specific allowance was not required at March 31, 2022 and December 31, 2021. The recorded investment in loans excludes accrued interest receivable due to insignificance. Related allowances established generally pertain to those loans in which loan forbearance agreements were in the process of being negotiated or updated appraisals were pending, and any partial charge-off will be recorded when final information is received.

	Impaired Loans with a Specific Allowance						Impaired Loans with No Specific Allowance
	Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)		Related Allowance		Recorded Investment (Book Balance)		Unpaid Principal Balance (Legal Balance)
March 31, 2022
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,062	$	4,840
Non-owner occupied residential	—		—		—		100		214
Commercial and industrial	—		—		—		161		447
Residential mortgage:
First lien	338		338		29		1,940		2,938
Home equity—term	—		—		—		6		9
Home equity—lines of credit	—		—		—		426		651
Installment and other loans	—		—		—		52		52
	$	338	$	338	$	29	$	5,747	$	9,151
December 31, 2021
Commercial real estate:
Owner-occupied	$	—	$	—	$	—	$	3,763	$	4,902
Non-owner occupied residential	—		—		—		122		259
Commercial and industrial	—		—		—		250		547
Residential mortgage:
First lien	341		341		28		2,294		3,337
Home equity—term	—		—		—		7		10
Home equity—lines of credit	—		—		—		436		653
Installment and other loans	—		—		—		40		40
	$	341	$	341	$	28	$	6,912	$	9,748

Average Recorded Investment in Impaired Loans and Related Interest Income

The following table, which excludes accruing PCI loans, summarizes the average recorded investment in impaired loans and related recognized interest income for the three months ended March 31, 2022 and 2021:

	2022				2021
	Average Impaired Balance		Interest Income Recognized		Average Impaired Balance		Interest Income Recognized
Three Months Ended March 31,
Commercial real estate:
Owner occupied	$	3,422	$	—	$	3,448	$	1
Multi-family	—		—		19		—
Non-owner occupied residential	107		—		267		—
Acquisition and development:
Commercial and land development	—		—		614		—
Commercial and industrial	218		—		2,878		—
Residential mortgage:
First lien	2,406		7		2,636		11
Home equity - term	7		—		12		—
Home equity - lines of credit	432		—		616		—
Installment and other loans	45		—		15		—
	$	6,637	$	7	$	10,505	$	12

Troubled Debt Restructurings

The following table presents impaired loans that are TDRs, with the recorded investment at March 31, 2022 and December 31, 2021:

	March 31, 2022			December 31, 2021
	Number of Contracts	Recorded Investment		Number of Contracts	Recorded Investment
Accruing:
Residential mortgage:
First lien	7	$	575	8	$	804
Nonaccruing:
Residential mortgage:
First lien	6	276		5	285
	13	$	851	13	$	1,089

Loan Portfolio Summarized by Aging Categories of Performing Loans and Nonaccrual Loans

The following table presents the classes of loan portfolio summarized by aging categories of performing loans and nonaccrual loans at March 31, 2022 and December 31, 2021:

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
March 31, 2022
Commercial real estate:
Owner occupied	$	250,844	$	322	$	—	$	—	$	322	$	3,062	$	254,228
Non-owner occupied	558,695		—		—		—		—		—		558,695
Multi-family	93,158		—		—		—		—		—		93,158
Non-owner occupied residential	101,254		310		—		—		310		100		101,664
Acquisition and development:
1-4 family residential construction	15,115		—		—		—		—		—		15,115
Commercial and land development	105,204		—		—		—		—		—		105,204
Commercial and industrial	440,652		207		—		—		207		161		441,020
Municipal	14,626		—		—		—		—		—		14,626
Residential mortgage:
First lien	194,216		2,741		—		56		2,797		1,703		198,716
Home equity - term	5,786		12		—		—		12		6		5,804
Home equity - lines of credit	163,725		437		230		—		667		426		164,818
Installment and other loans	15,231		83		—		—		83		52		15,366
Subtotal	1,958,506		4,112		230		56		4,398		5,510		1,968,414
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,298		—		—		—		—		—		2,298
Non-owner occupied	304		—		—		—		—		—		304
Non-owner occupied residential	494		—		—		111		111		—		605
Commercial and industrial	2,150		—		—		—		—		—		2,150
Residential mortgage:
First lien	3,837		608		—		70		678		—		4,515
Home equity - term	15		—		—		1		1		—		16
Installment and other loans	2		3		—		—		3		—		5
Subtotal	9,100		611		—		182		793		—		9,893
	$	1,967,606	$	4,723	$	230	$	238	$	5,191	$	5,510	$	1,978,307

			Days Past Due
	Current		30-59		60-89		90+ (still accruing)		Total Past Due		Non- Accrual		Total Loans
December 31, 2021
Commercial real estate:
Owner occupied	$	231,371	$	314	$	—	$	891	$	1,205	$	3,763	$	236,339
Non-owner occupied	551,473		—		—		—		—		—		551,473
Multi-family	93,255		—		—		—		—		—		93,255
Non-owner occupied residential	104,645		161		—		—		161		122		104,928
Acquisition and development:
1-4 family residential construction	12,279		—		—		—		—		—		12,279
Commercial and land development	93,793		132		—		—		132		—		93,925
Commercial and industrial	483,088		128		—		—		128		250		483,466
Municipal	14,989		—		—		—		—		—		14,989
Residential mortgage:
First lien	189,043		2,995		281		96		3,372		1,831		194,246
Home equity - term	6,042		16		—		—		16		7		6,065
Home equity - lines of credit	159,628		641		—		—		641		436		160,705
Installment and other loans	17,467		109		8		—		117		40		17,624
Subtotal	1,957,073		4,496		289		987		5,772		6,449		1,969,294
Loans acquired with credit deterioration:
Commercial real estate:
Owner occupied	2,329		—		—		—		—		—		2,329
Non-owner occupied	310		—		—		—		—		—		310
Non-owner occupied residential	479		—		587		118		705		—		1,184
Commercial and industrial	2,262		—		—		—		—		—		2,262
Residential mortgage:
First lien	3,937		387		166		95		648		—		4,585
Home equity - term	15		—		—		1		1		—		16
Installment and other loans	6		—		—		—		—		—		6
Subtotal	9,338		387		753		214		1,354		—		10,692
	$	1,966,411	$	4,883	$	1,042	$	1,201	$	7,126	$	6,449	$	1,979,986

Summary of Activity in the ALL and Ending Loan Balances Individually Evaluated for Impairment Based on Loan Segment

The following table presents the activity in the ALL for the three months ended March 31, 2022 and 2021:

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
Three Months Ended
March 31, 2022
Balance, beginning of period	$	12,037	$	2,062	$	3,814	$	30	$	17,943	$	2,785	$	215	$	3,000	$	237	$	21,180
Provision for loan losses	(523)		258		500		(1)		234		72		(6)		66		—		300
Charge-offs	—		—		(61)		—		(61)		(10)		(13)		(23)		—		(84)
Recoveries	32		1		48		—		81		26		5		31		—		112
Balance, end of period	$	11,546	$	2,321	$	4,301	$	29	$	18,197	$	2,873	$	201	$	3,074	$	237	$	21,508
March 31, 2021
Balance, beginning of period	$	11,151	$	1,114	$	3,942	$	40	$	16,247	$	3,362	$	324	$	3,686	$	218	$	20,151
Provision for loan losses	(494)		(69)		(54)		(2)		(619)		(289)		(106)		(395)		14		(1,000)
Charge-offs	—		—		(454)		—		(454)		(21)		(20)		(41)		—		(495)
Recoveries	14		1		280		—		295		6		10		16		—		311
Balance, end of period	$	10,671	$	1,046	$	3,714	$	38	$	15,469	$	3,058	$	208	$	3,266	$	232	$	18,967

The following table summarizes the ending loan balance individually evaluated for impairment based upon loan segment, as well as the related ALL loss allocation for each at March 31, 2022 and December 31, 2021. Accruing PCI loans are excluded from loans individually evaluated for impairment.

	Commercial										Consumer
	Commercial Real Estate		Acquisition and Development		Commercial and Industrial		Municipal		Total		Residential Mortgage		Installment and Other		Total		Unallocated		Total
March 31, 2022
Loans allocated by:
Individually evaluated for impairment	$	3,162	$	—	$	161	$	—	$	3,323	$	2,710	$	52	$	2,762	$	—	$	6,085
Collectively evaluated for impairment	1,007,790		120,319		443,009		14,626		1,585,744		371,159		15,319		386,478		—		1,972,222
	$	1,010,952	$	120,319	$	443,170	$	14,626	$	1,589,067	$	373,869	$	15,371	$	389,240	$	—	$	1,978,307
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	29	$	—	$	29	$	—	$	29
Collectively evaluated for impairment	11,546		2,321		4,301		29		18,197		2,844		201		3,045		237		21,479
	$	11,546	$	2,321	$	4,301	$	29	$	18,197	$	2,873	$	201	$	3,074	$	237	$	21,508
December 31, 2021
Loans allocated by:
Individually evaluated for impairment	$	3,885	$	—	$	250	$	—	$	4,135	$	3,078	$	40	$	3,118	$	—	$	7,253
Collectively evaluated for impairment	985,933		106,204		485,478		14,989		1,592,604		362,539		17,590		380,129		—		1,972,733
	$	989,818	$	106,204	$	485,728	$	14,989	$	1,596,739	$	365,617	$	17,630	$	383,247	$	—	$	1,979,986
ALL allocated by:
Individually evaluated for impairment	$	—	$	—	$	—	$	—	$	—	$	28	$	—	$	28	$	—	$	28
Collectively evaluated for impairment	12,037		2,062		3,814		30		17,943		2,757		215		2,972		237		21,152
	$	12,037	$	2,062	$	3,814	$	30	$	17,943	$	2,785	$	215	$	3,000	$	237	$	21,180

Schedule of Activity for the Accretable Yield of Purchased Impaired Loans

The following table provides activity for the accretable yield of purchased impaired loans for the three months ended March 31, 2022 and 2021:

	Three Months Ended
	March 31, 2022		March 31, 2021
Accretable yield, beginning of period	$	2,661	$	3,438
Accretion of income	(314)		(466)
Reclassifications from nonaccretable difference due to improvement in expected cash flows	243		44
Other changes, net	(73)		56
Accretable yield, end of period	$	2,517	$	3,072

XML

LEASES (Tables)

3 Months Ended

Mar. 31, 2022

Leases [Abstract]

Summary of ROU Assets and Related Lease Liabilities

The following table summarizes the Company's operating leases at March 31, 2022 and December 31, 2021:

	March 31, 2022			December 31, 2021
Operating lease ROU assets	$	10,305		$	10,515
Operating lease ROU liabilities	10,937			11,119
Weighted-average remaining lease term (in years)	14.4			14.6
Weighted-average discount rate	4.1		%	4.1		%

Information Related to Operating Leases

The following table presents information related to the Company's operating leases for the three months ended March 31, 2022 and 2021:

	Three Months Ended
	March 31, 2022		March 31, 2021
Cash paid for operating lease liabilities	$	294	$	343
Operating lease expense	394		403

Schedule of Maturities of Lease Liabilities

The following table presents expected future maturities of the Company's lease liabilities as of March 31, 2022:

2022	$	868
2023	1,216
2024	1,246
2025	1,269
2026	1,302
Thereafter	9,687
	15,588
Less: imputed interest	4,651
Total lease liabilities	$	10,937

XML

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

3 Months Ended

Mar. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of in Changes in Goodwill

The following table presents changes in goodwill for the three months ended March 31, 2022 and 2021:

	March 31, 2022		March 31, 2021
Balance, beginning of year	$	18,724	$	18,724
Balance, end of period	$	18,724	$	18,724

Schedule of Changes in Other Intangible Assets

The following table presents changes in and components of other intangible assets for the three months ended March 31, 2022 and 2021:

	Three Months Ended March 31,
	2022		2021
Beginning of period	$	4,183	$	5,458
Amortization expense	(292)		(334)
Balance, end of period	$	3,891	$	5,124

Schedule of Components of Other Intangible Assets

The following table presents the components of other identifiable intangible assets at March 31, 2022 and December 31, 2021:

	March 31, 2022				December 31, 2021
	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
Amortized intangible assets:
Core deposit intangibles	$	8,390	$	4,500	$	8,390	$	4,208
Other customer relationship intangibles	25		24		25		24
Total	$	8,415	$	4,524	$	8,415	$	4,232

Schedule of Estimated Aggregated Amortization Expense

The following table presents future estimated aggregate amortization expense for intangible assets remaining at March 31, 2022:

2022	$	813
2023	935
2024	766
2025	596
2026	427
Thereafter	354
	$	3,891

XML

SHARE-BASED COMPENSATION PLANS (Tables)

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Summary of Nonvested Restricted Shares Activity

The following table presents a summary of nonvested restricted shares activity for the three months ended March 31, 2022:

	Shares	Weighted Average Grant Date Fair Value
Nonvested shares, beginning of year	274,697	$	20.05
Granted	121,949	25.02
Forfeited	(10,622)	20.02
Vested	(54,054)	19.31
Nonvested shares, at period end	331,970	$	22.00

Schedule of Restricted Shares Compensation Expense

The following table presents restricted shares compensation expense, with tax benefit information, and fair value of shares vested, for the three months ended March 31, 2022 and 2021:

	Three months ended March 31,
	2022		2021
Restricted share award expense	$	330	$	434
Restricted share award tax benefit	69		91
Fair value of shares vested	1,324		1,028

Schedule of Employee Stock Purchase Plan

The following table presents information for the employee stock purchase plan for the three months ended March 31, 2022 and 2021:

	Three months ended March 31,
	2022		2021
Shares purchased	3,953		5,484
Weighted average price of shares purchased	$	22.46	$	13.44
Compensation expense recognized	8		33

XML

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)

3 Months Ended

Mar. 31, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair Value of Derivative Instruments

The following table summarizes the fair value of the Company's derivative instruments at March 31, 2022 and December 31, 2021:

	March 31, 2022					December 31, 2021
	Notional Amount		Balance Sheet Location	Fair Value		Notional Amount		Balance Sheet Location	Fair Value
Derivatives not designated as hedging instruments:
Interest rate swaps	$	60,279	Other assets	$	3,067	$	37,915	Other assets	$	764
Interest rate swaps	60,279		Other liabilities	(3,024)		37,915		Other liabilities	(758)
Risk participation	15,855		Other liabilities	(1)		15,855		Other liabilities	(2)
Interest rate lock commitments with customers	12,302		Other assets	300		16,604		Other assets	353
Forward sale commitment	7,537		Other assets	353		8,665		Other assets	52
Total derivatives not designated as hedging instruments				$	695				$	409

Effect of Derivative Financial Instruments on OCI and Net Income

The following tables summarize the effect of the Company's derivative financial instruments on OCI and net income for the three months ended March 31, 2022 and 2021:

	Amount of Gain Recognized in OCI on Derivative
	Three Months Ended March 31,
	2022		2021
Derivatives in cash flow hedging relationships:
Interest rate products	$	—	$	739
Total	$	—	$	739

	Amount of Loss Reclassified from AOCI into Income				Location of Loss Recognized from AOCI into Income
	Three Months Ended March 31,
	2022		2021
Derivatives in cash flow hedging relationships:
Interest rate products	$	—	$	(87)	Interest expense
Total	$	—	$	(87)

During the three months ended September 30, 2021, the Company terminated its interest rate swap designated as a hedging instrument of $50.0 million.

	Amount of Gain (Loss) Recognized in Income				Location of Gain (Loss) Recognized in Income
	Three Months Ended March 31,
	2022		2021
Derivatives not designated as hedging instruments:
Interest rate products	$	37	$	52	Other operating expenses
Risk participation agreement	2		4		Other operating expenses
Interest rate lock commitments with customers	(53)		(1)		Mortgage banking activities
Forward sale commitment	300		254		Mortgage banking activities
Total	$	286	$	309

XML

SHAREHOLDERS' EQUITY AND REGULATORY CAPITAL (Tables)

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Capital Amounts and Ratios

The following table presents capital amounts and ratios at March 31, 2022 and December 31, 2021:

	Actual				For Capital Adequacy Purposes (includes applicable capital conservation buffer)				To Be Well Capitalized Under Prompt Corrective Action Provisions
	Amount		Ratio		Amount		Ratio		Amount		Ratio
March 31, 2022
Total risk-based capital:
Orrstown Financial Services, Inc.	$	300,952	14.3	%	$	220,591	10.5	%	n/a		n/a
Orrstown Bank	288,988		13.8	%	220,509		10.5	%	$	210,009	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	245,833		11.7	%	178,574		8.5	%	n/a		n/a
Orrstown Bank	265,847		12.7	%	178,508		8.5	%	168,007		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	245,833		11.7	%	147,061		7.0	%	n/a		n/a
Orrstown Bank	265,847		12.7	%	147,006		7.0	%	136,506		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	245,833		8.8	%	112,328		4.0	%	n/a		n/a
Orrstown Bank	265,847		9.5	%	112,352		4.0	%	140,440		5.0	%
December 31, 2021
Total risk-based capital:
Orrstown Financial Services, Inc.	$	297,823	15.0	%	$	208,617	10.5	%	n/a		n/a
Orrstown Bank	278,780		14.0	%	208,550		10.5	%	$	198,619	10.0	%
Tier 1 risk-based capital:
Orrstown Financial Services, Inc.	243,075		12.2	%	168,880		8.5	%	n/a		n/a
Orrstown Bank	255,995		12.9	%	168,826		8.5	%	158,895		8.0	%
Tier 1 common equity risk-based capital:
Orrstown Financial Services, Inc.	243,075		12.2	%	139,078		7.0	%	n/a		n/a
Orrstown Bank	255,995		12.9	%	139,033		7.0	%	129,102		6.5	%
Tier 1 leverage capital:
Orrstown Financial Services, Inc.	243,075		8.5	%	114,384		4.0	%	n/a		n/a
Orrstown Bank	255,995		8.9	%	114,470		4.0	%	143,087		5.0	%

XML

EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Earnings Per Share

The following table presents earnings per share for the three months ended March 31, 2022 and 2021:

	Three Months Ended March 31,
	2022		2021
Net income	$	8,368	$	10,207
Weighted average shares outstanding - basic	10,860		10,975
Dilutive effect of share-based compensation	147		99
Weighted average shares outstanding - diluted	11,007		11,074
Per share information:
Basic earnings per share	$	0.77	$	0.93
Diluted earnings per share	0.76		0.92

XML

FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK (Tables)

3 Months Ended

Mar. 31, 2022

Fair Value Disclosures [Abstract]

Contractual or Notional Amounts, Commitments to Fund

The following table presents these contractual, or notional, amounts:

	Contractual or Notional Amount
	March 31, 2022		December 31, 2021
Commitments to fund:
Home equity lines of credit	$	273,734	$	261,580
1-4 family residential construction loans	56,330		40,348
Commercial real estate, construction and land development loans	142,301		124,488
Commercial, industrial and other loans	368,199		378,996
Standby letters of credit	20,772		19,724

XML

FAIR VALUE (Tables)

3 Months Ended

Mar. 31, 2022

Fair Value Disclosures [Abstract]

Summary of Assets Measured at Fair Value on Recurring Basis

The following table summarizes assets and liabilities measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
March 31, 2022
Financial Assets
Investment securities:
U.S. Treasury securities	$	18,538	$	—	$	—	$	18,538
States and political subdivisions	—		230,539		7,021		237,560
GSE residential MBSs	—		59,229		—		59,229
GSE residential CMOs	—		71,027		—		71,027
Nonagency CMOs	—		15,390		11,613		27,003
Asset-backed	—		115,970		—		115,970
Other	403		—		—		403
Loans held for sale	—		7,403		—		7,403
Derivatives	—		3,067		300		3,367
Totals	$	18,941	$	502,625	$	18,934	$	540,500
Financial Liabilities
Derivatives	$	—	$	3,025	$	—	$	3,025
December 31, 2021
Financial Assets
Investment securities:
U.S. Treasury securities	$	19,702	$	—	$	—	$	19,702
States and political subdivisions	—		183,171		10,199		193,370
GSE residential MBSs	—		40,726		—		40,726
GSE residential CMOs	—		65,922		—		65,922
Nonagency CMOs	—		16,750		12,948		29,698
Asset-backed	—		122,621		—		122,621
Other	399		—		—		399
Loans held for sale	—		8,868		—		8,868
Derivatives	—		764		353		1,117
Totals	$	20,101	$	438,822	$	23,500	$	482,423
Financial Liabilities
Derivatives	$	—	$	760	$	—	$	760

Level 3 Fair Value Measurement Activity

The following provides details of the Level 3 fair value measurement activity for the periods ended March 31, 2022 and 2021:

Investment securities:

	Three Months Ended March 31,
	2022		2021
Balance, beginning of period	$	23,147	$	31,503
Unrealized loss included in OCI	(1,360)		(665)
Net discount accretion	71		129
Principal payments and other	—		(1,858)
Sales	(3,053)		(3,545)
OTTI	(171)		—
Balance, end of period	$	18,634	$	25,564

Interest rate lock commitments on residential mortgages:

	Three Months Ended March 31,
	2022		2021
Balance, beginning of period	$	353	$	673
Total losses
Included in earnings	(53)		(1)
Balance, end of period	$	300	$	672

Summary of Assets Measured at Fair Value on Nonrecurring Basis

The following table summarizes assets measured at fair value on a nonrecurring basis at March 31, 2022 and December 31, 2021:

	Level 1		Level 2		Level 3		Total Fair Value Measurements
March 31, 2022
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	144	$	144
Non-owner occupied residential	—		—		18		18
Residential mortgage:
First lien	—		—		491		491
Home equity - lines of credit	—		—		69		69
Total impaired loans	$	—	$	—	$	722	$	722
Mortgage servicing rights	$	—	$	—	$	322	$	322
December 31, 2021
Impaired Loans
Commercial real estate:
Owner occupied	$	—	$	—	$	751	$	751
Non-owner occupied residential	—		—		24		24
Residential mortgage:
First lien	—		—		545		545
Home equity - lines of credit	—		—		72		72
Total impaired loans	$	—	$	—	$	1,392	$	1,392
Mortgage servicing rights	$	—	$	—	$	322	$	322

Summary of Additional Qualitative Information

The following table presents additional qualitative information about assets measured on a nonrecurring basis and for which the Company has utilized Level 3 inputs to determine fair value:

	Fair Value Estimate		Valuation Techniques	Unobservable Input	Range
March 31, 2022
Impaired loans	$	722	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	0% - 25% discount
				- Management adjustments for liquidation expenses	4.73% - 17.93% discount
Mortgage servicing rights	$	322	Discounted cash flows	Weighted average CPR	8.23%
				- Weighted average discount rate	9.03%
December 31, 2021
Impaired loans	$	1,392	Appraisal of collateral	Management adjustments on appraisals for property type and recent activity	10% - 25% discount
				- Management adjustments for liquidation expenses	6.08% - 17.93% discount
Mortgage servicing rights	$	322	Discounted cash flows	Weighted average CPR	12.60%
				- Weighted average discount rate	9.03%

Carrying Amounts and Estimated Fair Values of Financial Instruments

The following table presents carrying amounts and estimated fair values of the financial assets and liabilities at March 31, 2022 and December 31, 2021:

	Carrying Amount		Fair Value		Level 1		Level 2		Level 3
March 31, 2022
Financial Assets
Cash and due from banks	$	26,446	$	26,446	$	26,446	$	—	$	—
Interest-bearing deposits with banks	187,792		187,792		187,792		—		—
Restricted investments in bank stock	6,791		n/a		n/a		n/a		n/a
Investment securities	529,730		529,730		18,941		492,155		18,634
Loans held for sale	7,403		7,403		—		7,403		—
Loans, net of allowance for loan losses	1,956,799		1,906,140		—		—		1,906,140
Derivatives	3,367		3,367		—		3,067		300
Accrued interest receivable	8,642		8,642		—		2,940		5,702
Financial Liabilities
Deposits	2,545,992		2,545,739		—		2,545,739		—
Securities sold under agreements to repurchase	24,624		24,624		—		24,624		—
FHLB advances and other borrowings	1,788		1,865		—		1,865		—
Subordinated notes	31,978		33,094		—		33,094		—
Derivatives	3,025		3,025		—		3,025		—
Accrued interest payable	661		661		—		661		—
Off-balance sheet instruments	—		—		—		—		—
December 31, 2021
Financial Assets
Cash and due from banks	$	21,217	$	21,217	$	21,217	$	—	$	—
Interest-bearing deposits with banks	187,493		187,493		187,493		—		—
Restricted investments in bank stock	7,252		n/a		n/a		n/a		n/a
Investment securities	472,438		472,438		20,101		429,190		23,147
Loans held for sale	8,868		8,868		—		8,868		—
Loans, net of allowance for loan losses	1,958,806		1,946,365		—		—		1,946,365
Derivatives	1,117		1,117		—		764		353
Accrued interest receivable	8,234		8,235		—		2,203		6,032
Financial Liabilities
Deposits	2,464,929		2,466,191		—		2,466,191		—
Securities sold under agreements to repurchase	23,301		23,301		—		23,301		—
FHLB advances and other borrowings	1,896		2,035		—		2,035		—
Subordinated notes	31,963		31,815		—		31,815		—
Derivatives	760		760		—		760		—
Accrued interest payable	154		154		—		154		—
Off-balance sheet instruments	—		—		—		—		—

XML

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Derivatives (Details) - Interest rate products $ in Millions	Mar. 31, 2022 USD ($) bank	Dec. 31, 2021 USD ($) bank
Derivative [Line Items]
Number of derivatives | bank	0	0
Derivatives not designated as hedging instruments
Derivative [Line Items]
Derivative, notional amount | $	$ 120.6	$ 75.8

XML

INVESTMENT SECURITIES - Amortized Cost and Fair Values of AFS Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 548,305	$ 466,806
Gross Unrealized Gains	2,035	9,487
Gross Unrealized Losses	20,610	3,855
Fair Value	529,730	472,438
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	20,081	20,084
Gross Unrealized Gains	0	0
Gross Unrealized Losses	1,543	382
Fair Value	18,538	19,702
States and political subdivisions
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	244,922	185,437
Gross Unrealized Gains	1,984	8,606
Gross Unrealized Losses	9,346	673
Fair Value	237,560	193,370
GSE residential MBSs
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	61,239	41,260
Gross Unrealized Gains	0	44
Gross Unrealized Losses	2,010	578
Fair Value	59,229	40,726
GSE residential CMOs
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	74,023	66,430
Gross Unrealized Gains	48	436
Gross Unrealized Losses	3,044	944
Fair Value	71,027	65,922
Non-agency CMOs
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	29,832	30,676
Gross Unrealized Gains	3	0
Gross Unrealized Losses	2,832	978
Fair Value	27,003	29,698
Asset-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	117,805	122,520
Gross Unrealized Gains	0	401
Gross Unrealized Losses	1,835	300
Fair Value	115,970	122,621
Other
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	403	399
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	$ 403	$ 399

XML

INVESTMENT SECURITIES - Narrative (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022 USD ($) security	Mar. 31, 2021 USD ($) security	Dec. 31, 2021 USD ($)
Debt Securities, Available-for-sale [Line Items]
Number of securities with OTTI charges | security	1
Gain on investments	$ 25	$ 145
Number of investments securities, partially sold | security	1
Investment securities	$ 529,730		$ 472,438
Proceeds from sale of investment securities	3,075	$ 75,736
Number of investment securities sold | security		14
Debt Securities
Debt Securities, Available-for-sale [Line Items]
Investment securities	3,100	$ 75,600
Proceeds from sale of investment securities	3,100	$ 75,736
Non-agency CMOs
Debt Securities, Available-for-sale [Line Items]
Investment security, OTTI	14,700
Cumulative OTTI recognized in earnings	171
Investment securities	27,003		29,698
Collateral Pledged
Debt Securities, Available-for-sale [Line Items]
Investment securities pledged to secure public funds, fair value	$ 291,000		$ 295,600

XML

INVESTMENT SECURITIES - Summary of AFS Securities with Unrealized Losses (Details) $ in Thousands	Mar. 31, 2022 USD ($) security	Dec. 31, 2021 USD ($) security
Number of Securities
Less Than 12 Months | security	74	37
12 Months or More | security	4	3
Total | security	78	40
Fair Value
Less Than 12 Months	$ 416,558	$ 190,192
12 Months or More	35,411	34,180
Total	451,969	224,372
Unrealized Losses
Less Than 12 Months	19,865	3,693
12 Months or More	745	162
Total	$ 20,610	$ 3,855
U.S. Treasury securities
Number of Securities
Less Than 12 Months | security	3	3
12 Months or More | security	0	0
Total | security	3	3
Fair Value
Less Than 12 Months	$ 18,538	$ 19,702
12 Months or More	0	0
Total	18,538	19,702
Unrealized Losses
Less Than 12 Months	1,543	382
12 Months or More	0	0
Total	$ 1,543	$ 382
States and political subdivisions
Number of Securities
Less Than 12 Months | security	30	12
12 Months or More | security	0	0
Total | security	30	12
Fair Value
Less Than 12 Months	$ 166,305	$ 45,522
12 Months or More	0	0
Total	166,305	45,522
Unrealized Losses
Less Than 12 Months	9,346	673
12 Months or More	0	0
Total	$ 9,346	$ 673
GSE residential MBSs
Number of Securities
Less Than 12 Months | security	14	9
12 Months or More | security	0	0
Total | security	14	9
Fair Value
Less Than 12 Months	$ 59,229	$ 37,899
12 Months or More	0	0
Total	59,229	37,899
Unrealized Losses
Less Than 12 Months	2,010	578
12 Months or More	0	0
Total	$ 2,010	$ 578
GSE residential CMOs
Number of Securities
Less Than 12 Months | security	12	7
12 Months or More | security	1	0
Total | security	13	7
Fair Value
Less Than 12 Months	$ 66,516	$ 41,163
12 Months or More	3,501	0
Total	70,017	41,163
Unrealized Losses
Less Than 12 Months	2,782	944
12 Months or More	262	0
Total	$ 3,044	$ 944
Non-agency CMOs
Number of Securities
Less Than 12 Months | security	3	3
12 Months or More | security	0	0
Total | security	3	3
Fair Value
Less Than 12 Months	$ 22,303	$ 24,661
12 Months or More	0	0
Total	22,303	24,661
Unrealized Losses
Less Than 12 Months	2,832	978
12 Months or More	0	0
Total	$ 2,832	$ 978
Asset-backed
Number of Securities
Less Than 12 Months | security	12	3
12 Months or More | security	3	3
Total | security	15	6
Fair Value
Less Than 12 Months	$ 83,667	$ 21,245
12 Months or More	31,910	34,180
Total	115,577	55,425
Unrealized Losses
Less Than 12 Months	1,352	138
12 Months or More	483	162
Total	$ 1,835	$ 300

XML

INVESTMENT SECURITIES - Schedule of Amortized Cost and Fair Values of AFS Securities by Contractual Maturity (Details) $ in Thousands	Mar. 31, 2022 USD ($)
Amortized Cost
Due in one year or less	$ 0
Due after one year through five years	3,376
Due after five years through ten years	79,079
Due after ten years	182,951
CMOs and MBSs	165,094
Asset-backed	117,805
Total Amortized Cost	548,305
Fair Value
Due in one year or less	0
Due after one year through five years	3,509
Due after five years through ten years	75,367
Due after ten years	177,625
CMOs and MBSs	157,259
Asset-backed	115,970
Total Fair Value	$ 529,730

XML

INVESTMENT SECURITIES - Proceeds from Sales of AFS Securities and Gross Gains and Gross Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Proceeds from sale of investment securities	$ 3,075	$ 75,736
Gross gains	25	1,351
Gross losses	$ 0	$ 1,206

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Narrative (Details)	3 Months Ended	21 Months Ended
	Mar. 31, 2022 USD ($) note	Dec. 31, 2021 USD ($) loan
Financing Receivable, Allowance for Credit Losses [Line Items]
Number of PPP loans | loan		6,500
Loans, net	$ 1,978,307,000	$ 1,979,986,000
SBA, loan guarantee, percentage	100.00%
Amount of loan on which review have been made annually	$ 1,000,000
Amount of loan on which reviews require approval	$ 500,000
Loans that are deemed impaired, number of days past due (more than)	90 days
Number of notes split | note	2
Appraisals, required period interval	18 months
Minimum amount on which annual updated appraisals for classified loans is required	$ 250,000
Maximum
Financing Receivable, Allowance for Credit Losses [Line Items]
Percentage of loan-to-value ratio upon loan origination	80.00%
Percentage of loan-to-value ratios of the value of the real estate taken as collateral	85.00%
Percentage of strong loan-to-value (or lower)	70.00%
Commercial and industrial
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans, net	$ 443,170,000	485,728,000
SBA | Commercial | Payment Deferral
Financing Receivable, Allowance for Credit Losses [Line Items]
PPP loans generated amount		$ 699,400,000
Loan deferral period	180 days
SBA | Commercial | 2021 Payment Deferrals
Financing Receivable, Allowance for Credit Losses [Line Items]
PPP Loan processing fee income	$ 2,400,000
SBA | Consumer | Payment Deferral
Financing Receivable, Allowance for Credit Losses [Line Items]
Loan deferral period	90 days
SBA | Maximum | Payment Deferral
Financing Receivable, Allowance for Credit Losses [Line Items]
Fee income amortization period		5 years
SBA | Minimum | Payment Deferral
Financing Receivable, Allowance for Credit Losses [Line Items]
Fee income amortization period		2 years
SBA | Commercial and industrial | SBA PPP Loans
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans, net	$ 122,500,000	$ 189,900,000

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Summary of Loan Portfolio, Excluding Residential Loans Held for Sale (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	$ 1,978,307	$ 1,979,986
Commercial real estate | Owner occupied
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	256,526	238,668
Commercial real estate | Non-owner occupied
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	558,999	551,783
Commercial real estate | Multi-family
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	93,158	93,255
Commercial real estate | Non-owner occupied residential
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	102,269	106,112
Acquisition and development | 1-4 family residential construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	15,115	12,279
Acquisition and development | Commercial and land development
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	105,204	93,925
Commercial and industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	443,170	485,728
Commercial and industrial | SBA | SBA PPP Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	122,500	189,900
Municipal
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	14,626	14,989
Residential mortgage | First lien
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	203,231	198,831
Residential mortgage | Home equity - term
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	5,820	6,081
Residential mortgage | Home equity - lines of credit
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	164,818	160,705
Installment and other loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total loans	$ 15,371	$ 17,630

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Company's Loan Portfolio Ratings Based on its Internal Risk Rating System (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Financing Receivable, Recorded Investment [Line Items]
Total loans	$ 1,978,307	$ 1,979,986
Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	256,526	238,668
Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	558,999	551,783
Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	93,158	93,255
Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	102,269	106,112
Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	15,115	12,279
Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	105,204	93,925
Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	443,170	485,728
Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	14,626	14,989
Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	203,231	198,831
Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	5,820	6,081
Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	164,818	160,705
Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	15,371	17,630
Pass
Financing Receivable, Recorded Investment [Line Items]
Total loans	1,903,428	1,899,389
Pass | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	242,529	219,250
Pass | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	537,505	528,010
Pass | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	84,541	84,414
Pass | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	99,545	102,588
Pass | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	15,115	12,279
Pass | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	103,486	92,049
Pass | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	424,425	470,579
Pass | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	14,626	14,989
Pass | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	196,217	191,386
Pass | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	5,798	6,058
Pass | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	164,327	160,203
Pass | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	15,314	17,584
Special Mention
Financing Receivable, Recorded Investment [Line Items]
Total loans	43,191	49,161
Special Mention | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	6,360	7,239
Special Mention | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	18,771	23,297
Special Mention | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	8,158	8,238
Special Mention | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	1,005	1,065
Special Mention | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Special Mention | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	1,236	1,385
Special Mention | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	7,642	7,917
Special Mention | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Special Mention | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Special Mention | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Special Mention | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	19	20
Special Mention | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Non-Impaired Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	15,710	13,491
Non-Impaired Substandard | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,277	6,087
Non-Impaired Substandard | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,419	166
Non-Impaired Substandard | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	459	603
Non-Impaired Substandard | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	1,014	1,153
Non-Impaired Substandard | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Non-Impaired Substandard | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	482	491
Non-Impaired Substandard | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	8,792	4,720
Non-Impaired Substandard | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Non-Impaired Substandard | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	221	225
Non-Impaired Substandard | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Non-Impaired Substandard | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	46	46
Non-Impaired Substandard | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard
Financing Receivable, Recorded Investment [Line Items]
Total loans	6,085	7,253
Impaired - Substandard | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	3,062	3,763
Impaired - Substandard | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	100	122
Impaired - Substandard | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	161	250
Impaired - Substandard | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Impaired - Substandard | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,278	2,635
Impaired - Substandard | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	6	7
Impaired - Substandard | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	426	436
Impaired - Substandard | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	52	40
Doubtful
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
Doubtful | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	9,893	10,692
PCI Loans | Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,298	2,329
PCI Loans | Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment [Line Items]
Total loans	304	310
PCI Loans | Commercial real estate | Multi-family
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans | Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment [Line Items]
Total loans	605	1,184
PCI Loans | Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans | Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans | Commercial and industrial
Financing Receivable, Recorded Investment [Line Items]
Total loans	2,150	2,262
PCI Loans | Municipal
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans | Residential mortgage | First lien
Financing Receivable, Recorded Investment [Line Items]
Total loans	4,515	4,585
PCI Loans | Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment [Line Items]
Total loans	16	16
PCI Loans | Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment [Line Items]
Total loans	0	0
PCI Loans | Installment and other loans
Financing Receivable, Recorded Investment [Line Items]
Total loans	$ 5	$ 6

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Impaired Loans by Segment and Class (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	$ 338	$ 341
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	338	341
Impaired Loans with a Specific Allowance, Related Allowance	29	28
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	5,747	6,912
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	9,151	9,748
Commercial real estate | Owner occupied
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	3,062	3,763
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	4,840	4,902
Commercial real estate | Non-owner occupied residential
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	100	122
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	214	259
Commercial and industrial
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	161	250
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	447	547
Residential mortgage | First lien
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	338	341
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	338	341
Impaired Loans with a Specific Allowance, Related Allowance	29	28
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	1,940	2,294
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	2,938	3,337
Residential mortgage | Home equity - term
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	6	7
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	9	10
Residential mortgage | Home equity - lines of credit
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	426	436
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	651	653
Installment and other loans
Financing Receivable, Impaired [Line Items]
Impaired Loans with a Specific Allowance, Recorded Investment (Book Balance)	0	0
Impaired Loans with a Specific Allowance, Unpaid Principal Balance (Legal Balance)	0	0
Impaired Loans with a Specific Allowance, Related Allowance	0	0
Impaired Loans with No Specific Allowance, Recorded Investment (Book Balance)	52	40
Impaired Loans with No Specific Allowance, Unpaid Principal Balance (Legal Balance)	$ 52	$ 40

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Average Recorded Investment in Impaired Loans and Related Interest Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	$ 6,637	$ 10,505
Interest Income Recognized	7	12
Commercial real estate | Owner occupied
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	3,422	3,448
Interest Income Recognized	0	1
Commercial real estate | Multi-family
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	0	19
Interest Income Recognized	0	0
Commercial real estate | Non-owner occupied residential
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	107	267
Interest Income Recognized	0	0
Acquisition and development | Commercial and land development
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	0	614
Interest Income Recognized	0	0
Commercial and industrial
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	218	2,878
Interest Income Recognized	0	0
Residential mortgage | First lien
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	2,406	2,636
Interest Income Recognized	7	11
Residential mortgage | Home equity - term
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	7	12
Interest Income Recognized	0	0
Residential mortgage | Home equity - lines of credit
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	432	616
Interest Income Recognized	0	0
Installment and other loans
Financing Receivable, Impaired [Line Items]
Average Impaired Balance	45	15
Interest Income Recognized	$ 0	$ 0

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Troubled Debt Restructurings (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022 USD ($) contract	Mar. 31, 2021 contract	Dec. 31, 2021 USD ($) contract
Financing Receivable, Modifications [Line Items]
Number of Contracts | contract	13		13
Recorded Investment | $	$ 851		$ 1,089
Number of new contracts | contract	1	0
Accruing | Residential mortgage | First lien
Financing Receivable, Modifications [Line Items]
Number of Contracts | contract	7		8
Recorded Investment | $	$ 575		$ 804
Nonaccruing | Residential mortgage | First lien
Financing Receivable, Modifications [Line Items]
Number of Contracts | contract	6		5
Recorded Investment | $	$ 276		$ 285
Increase in TDR investment | $	$ 4

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Loan Portfolio Summarized by Aging Categories of Performing Loans and Nonaccrual Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	$ 238	$ 1,201
Non- Accrual	5,510	6,449
Loans, net	1,978,307	1,979,986
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	56	987
Non- Accrual	5,510	6,449
Loans, net	1,968,414	1,969,294
Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	182	214
Non- Accrual	0	0
Loans, net	9,893	10,692
Current
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	1,967,606	1,966,411
Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	1,958,506	1,957,073
Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	9,100	9,338
30 to 59 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	4,723	4,883
30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	4,112	4,496
30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	611	387
60 to 89 Days Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	230	1,042
60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	230	289
60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	753
Total Past Due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	5,191	7,126
Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	4,398	5,772
Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	793	1,354
Commercial real estate | Owner occupied
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	256,526	238,668
Commercial real estate | Owner occupied | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	891
Non- Accrual	3,062	3,763
Loans, net	254,228	236,339
Commercial real estate | Owner occupied | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	2,298	2,329
Commercial real estate | Owner occupied | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	250,844	231,371
Commercial real estate | Owner occupied | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	2,298	2,329
Commercial real estate | Owner occupied | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	322	314
Commercial real estate | Owner occupied | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Owner occupied | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Owner occupied | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Owner occupied | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	322	1,205
Commercial real estate | Owner occupied | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	558,999	551,783
Commercial real estate | Non-owner occupied | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	558,695	551,473
Commercial real estate | Non-owner occupied | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	304	310
Commercial real estate | Non-owner occupied | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	558,695	551,473
Commercial real estate | Non-owner occupied | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	304	310
Commercial real estate | Non-owner occupied | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Multi-family
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	93,158	93,255
Commercial real estate | Multi-family | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	93,158	93,255
Commercial real estate | Multi-family | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	93,158	93,255
Commercial real estate | Multi-family | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Multi-family | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Multi-family | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied residential
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	102,269	106,112
Commercial real estate | Non-owner occupied residential | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	100	122
Loans, net	101,664	104,928
Commercial real estate | Non-owner occupied residential | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	111	118
Non- Accrual	0	0
Loans, net	605	1,184
Commercial real estate | Non-owner occupied residential | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	101,254	104,645
Commercial real estate | Non-owner occupied residential | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	494	479
Commercial real estate | Non-owner occupied residential | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	310	161
Commercial real estate | Non-owner occupied residential | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied residential | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial real estate | Non-owner occupied residential | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	587
Commercial real estate | Non-owner occupied residential | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	310	161
Commercial real estate | Non-owner occupied residential | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	111	705
Acquisition and development | 1-4 family residential construction
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	15,115	12,279
Acquisition and development | 1-4 family residential construction | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	15,115	12,279
Acquisition and development | 1-4 family residential construction | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	15,115	12,279
Acquisition and development | 1-4 family residential construction | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Acquisition and development | 1-4 family residential construction | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Acquisition and development | 1-4 family residential construction | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Acquisition and development | Commercial and land development
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	105,204	93,925
Acquisition and development | Commercial and land development | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	105,204	93,925
Acquisition and development | Commercial and land development | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	105,204	93,793
Acquisition and development | Commercial and land development | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	132
Acquisition and development | Commercial and land development | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Acquisition and development | Commercial and land development | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	132
Commercial and industrial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	443,170	485,728
Commercial and industrial | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	161	250
Loans, net	441,020	483,466
Commercial and industrial | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	2,150	2,262
Commercial and industrial | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	440,652	483,088
Commercial and industrial | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	2,150	2,262
Commercial and industrial | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	207	128
Commercial and industrial | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial and industrial | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial and industrial | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Commercial and industrial | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	207	128
Commercial and industrial | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Municipal
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	14,626	14,989
Municipal | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	14,626	14,989
Municipal | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	14,626	14,989
Municipal | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Municipal | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Municipal | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Residential mortgage | First lien
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	203,231	198,831
Residential mortgage | First lien | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	56	96
Non- Accrual	1,703	1,831
Loans, net	198,716	194,246
Residential mortgage | First lien | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	70	95
Non- Accrual	0	0
Loans, net	4,515	4,585
Residential mortgage | First lien | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	194,216	189,043
Residential mortgage | First lien | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	3,837	3,937
Residential mortgage | First lien | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	2,741	2,995
Residential mortgage | First lien | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	608	387
Residential mortgage | First lien | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	281
Residential mortgage | First lien | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	166
Residential mortgage | First lien | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	2,797	3,372
Residential mortgage | First lien | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	678	648
Residential mortgage | Home equity - term
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	5,820	6,081
Residential mortgage | Home equity - term | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	6	7
Loans, net	5,804	6,065
Residential mortgage | Home equity - term | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	1	1
Non- Accrual	0	0
Loans, net	16	16
Residential mortgage | Home equity - term | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	5,786	6,042
Residential mortgage | Home equity - term | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	15	15
Residential mortgage | Home equity - term | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	12	16
Residential mortgage | Home equity - term | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Residential mortgage | Home equity - term | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Residential mortgage | Home equity - term | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Residential mortgage | Home equity - term | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	12	16
Residential mortgage | Home equity - term | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	1	1
Residential mortgage | Home equity - lines of credit
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	164,818	160,705
Residential mortgage | Home equity - lines of credit | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	426	436
Loans, net	164,818	160,705
Residential mortgage | Home equity - lines of credit | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	163,725	159,628
Residential mortgage | Home equity - lines of credit | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	437	641
Residential mortgage | Home equity - lines of credit | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	230	0
Residential mortgage | Home equity - lines of credit | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	667	641
Installment and other loans
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	15,371	17,630
Installment and other loans | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	52	40
Loans, net	15,366	17,624
Installment and other loans | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ (still accruing) Days Past Due	0	0
Non- Accrual	0	0
Loans, net	5	6
Installment and other loans | Current | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	15,231	17,467
Installment and other loans | Current | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	2	6
Installment and other loans | 30 to 59 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	83	109
Installment and other loans | 30 to 59 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	3	0
Installment and other loans | 60 to 89 Days Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	8
Installment and other loans | 60 to 89 Days Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	0	0
Installment and other loans | Total Past Due | Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	83	117
Installment and other loans | Total Past Due | Loans Acquired with Credit Deterioration
Financing Receivable, Recorded Investment, Past Due [Line Items]
Loans, net	$ 3	$ 0

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Activity in Allowance for Loan Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Activity in allowance for loan losses
Balance, beginning of period	$ 21,180	$ 20,151
Provision for loan losses	300	(1,000)
Charge-offs	(84)	(495)
Recoveries	112	311
Balance, end of period	21,508	18,967
Unallocated
Activity in allowance for loan losses
Balance, beginning of period	237	218
Provision for loan losses	0	14
Charge-offs	0	0
Recoveries	0	0
Balance, end of period	237	232
Commercial
Activity in allowance for loan losses
Balance, beginning of period	17,943	16,247
Provision for loan losses	234	(619)
Charge-offs	(61)	(454)
Recoveries	81	295
Balance, end of period	18,197	15,469
Commercial | Commercial Real Estate
Activity in allowance for loan losses
Balance, beginning of period	12,037	11,151
Provision for loan losses	(523)	(494)
Charge-offs	0	0
Recoveries	32	14
Balance, end of period	11,546	10,671
Commercial | Acquisition and Development
Activity in allowance for loan losses
Balance, beginning of period	2,062	1,114
Provision for loan losses	258	(69)
Charge-offs	0	0
Recoveries	1	1
Balance, end of period	2,321	1,046
Commercial | Commercial and Industrial
Activity in allowance for loan losses
Balance, beginning of period	3,814	3,942
Provision for loan losses	500	(54)
Charge-offs	(61)	(454)
Recoveries	48	280
Balance, end of period	4,301	3,714
Commercial | Municipal
Activity in allowance for loan losses
Balance, beginning of period	30	40
Provision for loan losses	(1)	(2)
Charge-offs	0	0
Recoveries	0	0
Balance, end of period	29	38
Consumer
Activity in allowance for loan losses
Balance, beginning of period	3,000	3,686
Provision for loan losses	66	(395)
Charge-offs	(23)	(41)
Recoveries	31	16
Balance, end of period	3,074	3,266
Consumer | Residential Mortgage
Activity in allowance for loan losses
Balance, beginning of period	2,785	3,362
Provision for loan losses	72	(289)
Charge-offs	(10)	(21)
Recoveries	26	6
Balance, end of period	2,873	3,058
Consumer | Installment and Other
Activity in allowance for loan losses
Balance, beginning of period	215	324
Provision for loan losses	(6)	(106)
Charge-offs	(13)	(20)
Recoveries	5	10
Balance, end of period	$ 201	$ 208

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Summary of Ending Loan Balances Evaluated for Impairment and Related Allowance for Loan Losses Allocation (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Loans allocated by:
Individually evaluated for impairment	$ 6,085	$ 7,253
Collectively evaluated for impairment	1,972,222	1,972,733
Total Loans	1,978,307	1,979,986
ALL allocated by:
Individually evaluated for impairment	29	28
Collectively evaluated for impairment	21,479	21,152
Total allowance for loan losses	21,508	21,180	$ 18,967	$ 20,151
Commercial and Industrial
Loans allocated by:
Total Loans	443,170	485,728
Municipal
Loans allocated by:
Total Loans	14,626	14,989
Installment and Other
Loans allocated by:
Total Loans	15,371	17,630
Commercial
Loans allocated by:
Individually evaluated for impairment	3,323	4,135
Collectively evaluated for impairment	1,585,744	1,592,604
Total Loans	1,589,067	1,596,739
ALL allocated by:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	18,197	17,943
Total allowance for loan losses	18,197	17,943
Commercial | Commercial Real Estate
Loans allocated by:
Individually evaluated for impairment	3,162	3,885
Collectively evaluated for impairment	1,007,790	985,933
Total Loans	1,010,952	989,818
ALL allocated by:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	11,546	12,037
Total allowance for loan losses	11,546	12,037
Commercial | Acquisition and Development
Loans allocated by:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	120,319	106,204
Total Loans	120,319	106,204
ALL allocated by:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	2,321	2,062
Total allowance for loan losses	2,321	2,062
Commercial | Commercial and Industrial
Loans allocated by:
Individually evaluated for impairment	161	250
Collectively evaluated for impairment	443,009	485,478
Total Loans	443,170	485,728
ALL allocated by:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	4,301	3,814
Total allowance for loan losses	4,301	3,814
Commercial | Municipal
Loans allocated by:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	14,626	14,989
Total Loans	14,626	14,989
ALL allocated by:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	29	30
Total allowance for loan losses	29	30
Consumer
Loans allocated by:
Individually evaluated for impairment	2,762	3,118
Collectively evaluated for impairment	386,478	380,129
Total Loans	389,240	383,247
ALL allocated by:
Individually evaluated for impairment	29	28
Collectively evaluated for impairment	3,045	2,972
Total allowance for loan losses	3,074	3,000
Consumer | Residential Mortgage
Loans allocated by:
Individually evaluated for impairment	2,710	3,078
Collectively evaluated for impairment	371,159	362,539
Total Loans	373,869	365,617
ALL allocated by:
Individually evaluated for impairment	29	28
Collectively evaluated for impairment	2,844	2,757
Total allowance for loan losses	2,873	2,785
Consumer | Installment and Other
Loans allocated by:
Individually evaluated for impairment	52	40
Collectively evaluated for impairment	15,319	17,590
Total Loans	15,371	17,630
ALL allocated by:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	201	215
Total allowance for loan losses	201	215
Unallocated
Loans allocated by:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	0	0
Total Loans	0	0
ALL allocated by:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	237	237
Total allowance for loan losses	$ 237	$ 237

XML

LOANS AND ALLOWANCE FOR LOAN LOSSES - Schedule of Accretable Yield of Purchased Impaired Loans (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Accretable Yield Movement Schedule [Roll Forward]
Accretable yield, beginning of period	$ 2,661	$ 3,438
Accretion of income	(314)	(466)
Reclassifications from nonaccretable difference due to improvement in expected cash flows	243	44
Other changes, net	(73)	56
Accretable yield, end of period	$ 2,517	$ 3,072

XML

LEASES - Narrative (Details)	Mar. 31, 2022
Minimum
Lessee, Lease, Description [Line Items]
Lease terms	6 years
Maximum
Lessee, Lease, Description [Line Items]
Lease terms	31 years

XML

LEASES - Summary of Information Related to Operating Leases (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Leases [Abstract]
Operating lease ROU assets	$ 10,305		$ 10,515
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other assets		Other assets
Operating lease ROU liabilities	$ 10,937		$ 11,119
Operating Lease, Liability, Statement of Financial Position [Extensible List]	Other Liabilities		Other Liabilities
Weighted-average remaining lease term (in years)	14 years 4 months 24 days		14 years 7 months 6 days
Weighted-average discount rate	4.10%		4.10%
Cash paid for operating lease liabilities	$ 294	$ 343
Operating lease expense	$ 394	$ 403

XML

LEASES - Schedule of Maturities of Leases Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Leases [Abstract]
2022	$ 868
2023	1,216
2024	1,246
2025	1,269
2026	1,302
Thereafter	9,687
Total	15,588
Less: imputed interest	4,651
Total lease liabilities	$ 10,937	$ 11,119

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Goodwill [Roll Forward]
Balance, beginning of year	$ 18,724	$ 18,724	$ 18,724
Balance, end of period	$ 18,724	$ 18,724	$ 18,724

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($)		3 Months Ended
	Nov. 30, 2021	Mar. 31, 2022	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Impairments	$ 0
Impairment of intangibles		$ 0	$ 0

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Other Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Finite-lived Intangible Assets [Roll Forward]
Beginning of period	$ 4,183	$ 5,458
Amortization expense	(292)	(334)
Balance, end of period	$ 3,891	$ 5,124

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Components of Other Identifiable Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 8,415	$ 8,415
Accumulated Amortization	4,524	4,232
Core deposit intangibles
Finite-Lived Intangible Assets [Line Items]
Gross Amount	8,390	8,390
Accumulated Amortization	4,500	4,208
Other customer relationship intangibles
Finite-Lived Intangible Assets [Line Items]
Gross Amount	25	25
Accumulated Amortization	$ 24	$ 24

XML

GOODWILL AND OTHER INTANGIBLE ASSETS - Schedule of Estimated Aggregate Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]
2022	$ 813
2023	935
2024	766
2025	596
2026	427
Thereafter	354
Total	$ 3,891	$ 4,183	$ 5,124	$ 5,458

XML

SHARE-BASED COMPENSATION PLANS - Narrative (Details) - USD ($) $ in Millions		3 Months Ended
	Apr. 26, 2022	Mar. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense, recognition period		2 years 3 months 18 days
Orrstown 2011 Incentive Stock Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved to be issued (in shares)		881,920
Number of shares available to be issued under employee stock purchase plan (in shares)		137,443
Orrstown 2011 Incentive Stock Plan | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense		$ 4.6	$ 2.3
Orrstown 2011 Incentive Stock Plan | Subsequent Event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Increase in number of shares available for issuance	400,000
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares reserved to be issued (in shares)		350,000
Number of shares available to be issued under employee stock purchase plan (in shares)		147,527
Maximum shares that can be purchased, as percentage of annual salary		10.00%
Percentage of value of the shares on the semi-annual offering		95.00%

XML

SHARE-BASED COMPENSATION PLANS - Summary of Nonvested Restricted Shares Activity (Details) - Orrstown 2011 Incentive Stock Plan - Restricted Stock	3 Months Ended
	Mar. 31, 2022 $ / shares shares
Shares
Nonvested shares, beginning of year (in shares) | shares	274,697
Granted (in shares) | shares	121,949
Forfeited (in shares) | shares	(10,622)
Vested (in usd per share) | shares	(54,054)
Nonvested shares, at period end (in shares) | shares	331,970
Weighted Average Grant Date Fair Value
Nonvested shares, beginning of year (in usd per share) | $ / shares	$ 20.05
Granted (in usd per share) | $ / shares	25.02
Forfeited (in usd per share) | $ / shares	20.02
Vested (in usd per share) | $ / shares	19.31
Nonvested shares, at period end (in usd per share) | $ / shares	$ 22.00

XML

SHARE-BASED COMPENSATION PLANS - Schedule of Restricted Shares Compensation Expense (Details) - Orrstown 2011 Incentive Stock Plan - Restricted Stock - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted share award expense	$ 330	$ 434
Restricted share award tax benefit	69	91
Fair value of shares vested	$ 1,324	$ 1,028

XML

SHARE-BASED COMPENSATION PLANS - Schedule of Employee Stock Purchase Plan (Details) - Employee Stock Purchase Plan - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]
Shares purchased (in shares)	3,953	5,484
Weighted average price of shares purchased (in usd per share)	$ 22.46	$ 13.44
Compensation expense recognized	$ 8	$ 33

XML

DERIVATIVE FINANCIAL INSTRUMENTS - Narrative (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2022 USD ($) bank customer	Mar. 31, 2021 USD ($)	Dec. 31, 2021 USD ($) bank	Sep. 30, 2021 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Third-party broker | bank	14
Swap fee income	$ 953,000	$ 53,000
Cash collateral held by counterparty for derivatives	0		$ 260,000
Cash collateral held from counterparties	$ 2,600,000		$ 490,000
Interest rate derivative
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of derivatives | bank	0		0
Swap fee income	$ 953,000	$ 0
Interest rate derivative | Designated as hedging instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount				$ 50,000,000
Interest rate derivative | Derivatives not designated as hedging instruments:
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of customers | customer	14
Derivative, notional amount	$ 120,600,000		$ 75,800,000
Interest rate derivative | Derivatives not designated as hedging instruments: | Other Liabilities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	60,279,000		37,915,000
Risk participation agreement | Agent Bank
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Upfront fee from derivative			53,000
Risk participation agreement | Derivatives not designated as hedging instruments: | Other Liabilities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	15,855,000		15,855,000
Risk participation agreement | Derivatives not designated as hedging instruments: | Agent Bank | Other Liabilities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 15,900,000		$ 15,900,000

XML

DERIVATIVE FINANCIAL INSTRUMENTS - Summary of Fair Value of Derivative Instruments (Details) - Derivatives not designated as hedging instruments: - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value
Total derivatives	$ 695	$ 409
Other Liabilities | Interest rate swap
Notional Amount
Derivative liabilities	60,279	37,915
Fair Value
Derivative liabilities	3,024	758
Other Liabilities | Risk participation agreement
Notional Amount
Derivative liabilities	15,855	15,855
Fair Value
Derivative liabilities	1	2
Other Liabilities | Forward sale commitment
Notional Amount
Derivative asset	7,537
Fair Value
Derivative asset	353
Other assets | Interest rate swap
Notional Amount
Derivative asset	60,279	37,915
Fair Value
Derivative asset	3,067	764
Other assets | Interest rate lock commitments with customers
Notional Amount
Derivative asset	12,302	16,604
Fair Value
Derivative asset	$ 300	353
Other assets | Forward sale commitment
Notional Amount
Derivative asset		8,665
Fair Value
Derivative asset		$ 52

XML

DERIVATIVE FINANCIAL INSTRUMENTS - Effect of Derivative Financial Instruments on OCI and Net Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain Recognized in OCI on Derivative	$ 0	$ 739
Amount of Loss Reclassified from AOCI into Income	0	(87)
Interest expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Loss Reclassified from AOCI into Income	0	(87)
Mortgage banking activities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	286	309
Interest rate products
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain Recognized in OCI on Derivative	0	739
Interest rate products | Interest expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Loss Reclassified from AOCI into Income	0	(87)
Interest rate products | Other operating expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	37	52
Risk participation agreement | Other operating expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	2	4
Interest rate lock commitments with customers | Mortgage banking activities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	(53)	(1)
Forward sale commitment | Mortgage banking activities
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Income	$ 300	$ 254

XML

SHAREHOLDERS’ EQUITY AND REGULATORY CAPITAL - Schedule of Actual and Required Capital Amounts and Ratios (Detail) $ in Thousands	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Orrstown Financial Services, Inc.
Total risk-based capital:
Actual, Amount	$ 300,952	$ 297,823
Actual, Ratio	0.143	0.150
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 220,591	$ 208,617
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.105	0.105
Tier 1 risk-based capital:
Actual, Amount	$ 245,833	$ 243,075
Actual, Ratio	0.117	0.122
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 178,574	$ 168,880
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.085	0.085
Tier 1 common equity risk-based capital:
Actual, Amount	$ 245,833	$ 243,075
Actual, Ratio	11.70%	12.20%
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 147,061	$ 139,078
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	7.00%	7.00%
Tier 1 leverage capital:
Actual, Amount	$ 245,833	$ 243,075
Actual, Ratio	0.088	0.085
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 112,328	$ 114,384
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.040	0.040
Orrstown Bank
Total risk-based capital:
Actual, Amount	$ 288,988	$ 278,780
Actual, Ratio	0.138	0.140
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 220,509	$ 208,550
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.105	0.105
To Be Well Capitalized Under Prompt Corrective Action Regulations, Amount	$ 210,009	$ 198,619
To Be Well Capitalized Under Prompt Corrective Action Regulations, Ratio	0.100	0.100
Tier 1 risk-based capital:
Actual, Amount	$ 265,847	$ 255,995
Actual, Ratio	0.127	0.129
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 178,508	$ 168,826
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.085	0.085
To Be Well Capitalized Under Prompt Corrective Action Regulations, Amount	$ 168,007	$ 158,895
To Be Well Capitalized Under Prompt Corrective Action Regulations, Ratio	0.080	0.080
Tier 1 common equity risk-based capital:
Actual, Amount	$ 265,847	$ 255,995
Actual, Ratio	12.70%	12.90%
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 147,006	$ 139,033
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	7.00%	7.00%
To Be Well Capitalized Under Prompt Corrective Action Regulations, Amount	$ 136,506	$ 129,102
To Be Well Capitalized Under Prompt Corrective Action Regulations, Ratio	6.50%	6.50%
Tier 1 leverage capital:
Actual, Amount	$ 265,847	$ 255,995
Actual, Ratio	0.095	0.089
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Amount	$ 112,352	$ 114,470
For Capital Adequacy Purposes (includes applicable capital conservation buffer), Ratio	0.040	0.040
To Be Well Capitalized Under Prompt Corrective Action Regulations, Amount	$ 140,440	$ 143,087
To Be Well Capitalized Under Prompt Corrective Action Regulations, Ratio	0.050	0.050

XML

SHAREHOLDERS' EQUITY AND REGULATORY CAPITAL - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended
	Apr. 18, 2022	Mar. 31, 2022	Apr. 19, 2021	Sep. 30, 2015
Equity, Class of Treasury Stock [Line Items]
Number of shares authorized to be repurchased (in shares)				416,000
Stock repurchase program, additional number of shares authorized to be repurchased			562,000
Acquisition of treasury stock (in shares)		415,805
Acquisition of treasury stock		$ 8.9
Acquisition of treasury stock (in usd per share)		$ 21.35
Stock repurchase program, shares available for future repurchase		562,195
Stock repurchase program percentage of outstanding shares of common stock available for future purchase		5.00%
Subsequent Event
Equity, Class of Treasury Stock [Line Items]
Dividends declared per share (in usd per share)	$ 0.19
Maximum
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program authorized, maximum percentage of outstanding shares of common stock				5.00%

XML

EARNINGS PER SHARE - Calculation of Basic and Diluted Earnings per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share [Abstract]
Net income	$ 8,368	$ 10,207
Weighted average shares outstanding - basic (in shares)	10,860	10,975
Dilutive effect of share-based compensation (in shares)	147	99
Weighted average shares outstanding - diluted (in shares)	11,007	11,074
Per share information:
Basic earnings per share (in usd per share)	$ 0.77	$ 0.93
Diluted earnings per share (in usd per share)	$ 0.76	$ 0.92

XML

EARNINGS PER SHARE - Narrative (Detail) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share [Abstract]
Average outstanding options excluded from diluted earnings per share (in shares)	112,223	0

XML

FINANCIAL INSTRUMENTS WITH OFF-BALANCE SHEET RISK (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Reserve for off-balance sheet credit exposures	$ 1,600	$ 1,600
Home equity lines of credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Commitments to fund	273,734	261,580
1-4 family residential construction loans
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Commitments to fund	56,330	40,348
Commercial real estate, construction and land development loans
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Commitments to fund	142,301	124,488
Commercial, industrial and other loans
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Commitments to fund	368,199	378,996
Standby letters of credit
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Commitments to fund	$ 20,772	$ 19,724

XML

FAIR VALUE - Summary of Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Financial Assets
Investment securities	$ 529,730	$ 472,438
U.S. Treasury securities
Financial Assets
Investment securities	18,538	19,702
States and political subdivisions
Financial Assets
Investment securities	237,560	193,370
GSE residential MBSs
Financial Assets
Investment securities	59,229	40,726
GSE residential CMOs
Financial Assets
Investment securities	71,027	65,922
Non-agency CMOs
Financial Assets
Investment securities	27,003	29,698
Asset-backed
Financial Assets
Investment securities	115,970	122,621
Other
Financial Assets
Investment securities	403	399
Fair Value, Measurements, Recurring
Financial Assets
Loans held for sale	7,403	8,868
Totals	540,500	482,423
Financial Liabilities
Derivatives	3,025	760
Fair Value, Measurements, Recurring | Derivatives
Financial Assets
Derivatives	3,367	1,117
Fair Value, Measurements, Recurring | U.S. Treasury securities
Financial Assets
Investment securities	18,538	19,702
Fair Value, Measurements, Recurring | States and political subdivisions
Financial Assets
Investment securities	237,560	193,370
Fair Value, Measurements, Recurring | GSE residential MBSs
Financial Assets
Investment securities	59,229	40,726
Fair Value, Measurements, Recurring | GSE residential CMOs
Financial Assets
Investment securities	71,027	65,922
Fair Value, Measurements, Recurring | Non-agency CMOs
Financial Assets
Investment securities	27,003	29,698
Fair Value, Measurements, Recurring | Asset-backed
Financial Assets
Investment securities	115,970	122,621
Fair Value, Measurements, Recurring | Other
Financial Assets
Investment securities	403	399
Fair Value, Measurements, Recurring | Level 1
Financial Assets
Loans held for sale	0	0
Totals	18,941	20,101
Financial Liabilities
Derivatives	0	0
Fair Value, Measurements, Recurring | Level 1 | Derivatives
Financial Assets
Derivatives	0	0
Fair Value, Measurements, Recurring | Level 1 | U.S. Treasury securities
Financial Assets
Investment securities	18,538	19,702
Fair Value, Measurements, Recurring | Level 1 | States and political subdivisions
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 1 | GSE residential MBSs
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 1 | GSE residential CMOs
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Non-agency CMOs
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Asset-backed
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 1 | Other
Financial Assets
Investment securities	403	399
Fair Value, Measurements, Recurring | Level 2
Financial Assets
Loans held for sale	7,403	8,868
Totals	502,625	438,822
Financial Liabilities
Derivatives	3,025	760
Fair Value, Measurements, Recurring | Level 2 | Derivatives
Financial Assets
Derivatives	3,067	764
Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury securities
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 2 | States and political subdivisions
Financial Assets
Investment securities	230,539	183,171
Fair Value, Measurements, Recurring | Level 2 | GSE residential MBSs
Financial Assets
Investment securities	59,229	40,726
Fair Value, Measurements, Recurring | Level 2 | GSE residential CMOs
Financial Assets
Investment securities	71,027	65,922
Fair Value, Measurements, Recurring | Level 2 | Non-agency CMOs
Financial Assets
Investment securities	15,390	16,750
Fair Value, Measurements, Recurring | Level 2 | Asset-backed
Financial Assets
Investment securities	115,970	122,621
Fair Value, Measurements, Recurring | Level 2 | Other
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 3
Financial Assets
Loans held for sale	0	0
Totals	18,934	23,500
Financial Liabilities
Derivatives	0	0
Fair Value, Measurements, Recurring | Level 3 | Derivatives
Financial Assets
Derivatives	300	353
Fair Value, Measurements, Recurring | Level 3 | U.S. Treasury securities
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 3 | States and political subdivisions
Financial Assets
Investment securities	7,021	10,199
Fair Value, Measurements, Recurring | Level 3 | GSE residential MBSs
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 3 | GSE residential CMOs
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 3 | Non-agency CMOs
Financial Assets
Investment securities	11,613	12,948
Fair Value, Measurements, Recurring | Level 3 | Asset-backed
Financial Assets
Investment securities	0	0
Fair Value, Measurements, Recurring | Level 3 | Other
Financial Assets
Investment securities	$ 0	$ 0

XML

FAIR VALUE - Narrative (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2022 USD ($) security	Mar. 31, 2021 USD ($)	Dec. 31, 2021 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value option, aggregate fair value exceeded (less than) principal amount	$ (195)		$ 150
Increase (decrease) in fair value	32,903	$ 55,720
Impairment reserve for mortgage servicing rights	47		$ 79
Reversal charges	32	$ 606
Interest rate lock commitments on residential mortgages
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Increase (decrease) in fair value	$ 6
Level 3 | Municipal Bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of investment securities | security	1
Level 3 | Collateralized Mortgage Obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Number of investment securities | security	1
Level 3 | Measurement Input, Pull Through | Interest rate lock commitments on residential mortgages
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Asset, measurement input (percent)	0.93
Level 3 | Measurement Input, Pull Through Increase (Decrease) | Interest rate lock commitments on residential mortgages
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Asset, measurement input (percent)	0.05

XML

FAIR VALUE - Level 3 Fair Value Measurement Activity (Details) - Level 3 - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Interest rate lock commitments on residential mortgages
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	$ 353	$ 673
OTTI/losses included in earnings	(53)	(1)
Balance, end of period	300	672
Collateralized Mortgage Obligations
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance, beginning of period	23,147	31,503
Unrealized loss included in OCI	(1,360)	(665)
Net discount accretion	71	129
Principal payments and other	0	(1,858)
Sales	(3,053)	(3,545)
OTTI/losses included in earnings	(171)	0
Balance, end of period	$ 18,634	$ 25,564

XML

FAIR VALUE - Summary of Assets Measured at Fair Value on Nonrecurring Basis (Details) - Fair Value, Measurements, Nonrecurring - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	$ 722	$ 1,392
Mortgage servicing rights	322	322
Commercial real estate | Owner occupied
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	144	751
Commercial real estate | Non-owner occupied residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	18	24
Residential mortgage | First lien
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	491	545
Residential mortgage | Home equity - lines of credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	69	72
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Mortgage servicing rights	0	0
Level 1 | Commercial real estate | Owner occupied
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 1 | Commercial real estate | Non-owner occupied residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 1 | Residential mortgage | First lien
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 1 | Residential mortgage | Home equity - lines of credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Mortgage servicing rights	0	0
Level 2 | Commercial real estate | Owner occupied
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 2 | Commercial real estate | Non-owner occupied residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 2 | Residential mortgage | First lien
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 2 | Residential mortgage | Home equity - lines of credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	722	1,392
Mortgage servicing rights	322	322
Level 3 | Commercial real estate | Owner occupied
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	144	751
Level 3 | Commercial real estate | Non-owner occupied residential
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	18	24
Level 3 | Residential mortgage | First lien
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	491	545
Level 3 | Residential mortgage | Home equity - lines of credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total impaired loans	$ 69	$ 72

XML

FAIR VALUE - Summary of Additional Qualitative Information (Details) - Fair Value, Measurements, Nonrecurring $ in Thousands	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Impaired loans | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)		0.0608
Impaired loans | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)		0.1793
Impaired loans | Discount Rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.0473
Impaired loans | Discount Rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.1793
Impaired loans | Appraisal of collateral
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Estimate	$ 722	$ 1,392
Impaired loans | Appraisal of collateral | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)		0.10
Impaired loans | Appraisal of collateral | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)		0.25
Impaired loans | Appraisal of collateral | Discount Rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0
Impaired loans | Appraisal of collateral | Discount Rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.25
Mortgage servicing rights | Discounted cash flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Estimate	$ 322	$ 322
Mortgage servicing rights | Discounted cash flow | Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.0903	0.0903
Mortgage servicing rights | Discounted cash flow | Constant Prepayment Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Asset, measurement input (percent)	0.0823	0.1260

XML

FAIR VALUE - Financial Instruments at Carrying Amounts and Estimated Fair Values (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Financial Assets
Interest-bearing deposits with banks	$ 187,792	$ 187,493
Restricted investments in bank stock	6,791	7,252
Investment securities	529,730	472,438
Financial Liabilities
Securities sold under agreements to repurchase	24,624	23,301
Carrying Amount
Financial Assets
Cash and due from banks	26,446	21,217
Interest-bearing deposits with banks	187,792	187,493
Restricted investments in bank stock	6,791	7,252
Investment securities	529,730	472,438
Loans held for sale	7,403	8,868
Loans, net of allowance for loan losses	1,956,799	1,958,806
Accrued interest receivable	8,642	8,234
Financial Liabilities
Deposits	2,545,992	2,464,929
Securities sold under agreements to repurchase	24,624	23,301
FHLB advances and other borrowings	1,788	1,896
Subordinated notes	31,978	31,963
Accrued interest payable	661	154
Off-balance sheet instruments	0	0
Carrying Amount | Derivatives
Financial Assets
Derivatives	3,367	1,117
Financial Liabilities
Derivatives	3,025	760
Fair Value
Financial Liabilities
Off-balance sheet instruments	0	0
Fair Value | Fair Value, Inputs, Level 1, 2 and 3
Financial Assets
Cash and due from banks	26,446	21,217
Interest-bearing deposits with banks	187,792	187,493
Investment securities	529,730	472,438
Loans held for sale	7,403	8,868
Loans, net of allowance for loan losses	1,906,140	1,946,365
Accrued interest receivable	8,642	8,235
Financial Liabilities
Deposits	2,545,739	2,466,191
Securities sold under agreements to repurchase	24,624	23,301
FHLB advances and other borrowings	1,865	2,035
Subordinated notes	33,094	31,815
Accrued interest payable	661	154
Fair Value | Fair Value, Inputs, Level 1, 2 and 3 | Derivatives
Financial Assets
Derivatives	3,367	1,117
Financial Liabilities
Derivatives	3,025	760
Fair Value | Level 1
Financial Assets
Cash and due from banks	26,446	21,217
Interest-bearing deposits with banks	187,792	187,493
Investment securities	18,941	20,101
Loans held for sale	0	0
Loans, net of allowance for loan losses	0	0
Accrued interest receivable	0	0
Financial Liabilities
Deposits	0	0
Securities sold under agreements to repurchase	0	0
FHLB advances and other borrowings	0	0
Subordinated notes	0	0
Accrued interest payable	0	0
Off-balance sheet instruments	0	0
Fair Value | Level 1 | Derivatives
Financial Assets
Derivatives	0	0
Financial Liabilities
Derivatives	0	0
Fair Value | Level 2
Financial Assets
Cash and due from banks	0	0
Interest-bearing deposits with banks	0	0
Investment securities	492,155	429,190
Loans held for sale	7,403	8,868
Loans, net of allowance for loan losses	0	0
Accrued interest receivable	2,940	2,203
Financial Liabilities
Deposits	2,545,739	2,466,191
Securities sold under agreements to repurchase	24,624	23,301
FHLB advances and other borrowings	1,865	2,035
Subordinated notes	33,094	31,815
Accrued interest payable	661	154
Off-balance sheet instruments	0	0
Fair Value | Level 2 | Derivatives
Financial Assets
Derivatives	3,067	764
Financial Liabilities
Derivatives	3,025	760
Fair Value | Level 3
Financial Assets
Cash and due from banks	0	0
Interest-bearing deposits with banks	0	0
Investment securities	18,634	23,147
Loans held for sale	0	0
Loans, net of allowance for loan losses	1,906,140	1,946,365
Accrued interest receivable	5,702	6,032
Financial Liabilities
Deposits	0	0
Securities sold under agreements to repurchase	0	0
FHLB advances and other borrowings	0	0
Subordinated notes	0	0
Accrued interest payable	0	0
Off-balance sheet instruments	0	0
Fair Value | Level 3 | Derivatives
Financial Assets
Derivatives	300	353
Financial Liabilities
Derivatives	$ 0	$ 0